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Abstract 
Background: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative 
disease that affects motor and extra-motor systems. Diffusion tensor imaging (DTI) can 
be used to assess white matter (WM) tracts and has potential to be a marker of disease 
progression.  
Aims: This study aims to assess the abnormalities in brain white and gray matter in 
patients with amyotrophic lateral sclerosis (ALS) using MRI. It focuses on the white 
matter changes associated with cognitive change and serial studies in patients with 
ALS.  
Methods: MRI data were acquired in a total of 30 patients and 19 healthy controls. 
Patients were scanned up to three times with 6–month intervals on a 3T MRI. ALSFRS-
R and cognitive testing were administered at each clinical visit. The MRI included a 
T1-weighted image and diffusion weighted MRI along 64 directions. MRI data were 
analyzed using voxel-based morphometry (VBM), and tract-based spatial statistics 
(TBSS) for all DTI metrics, sub-grouping ALS patients based on their cognitive 
performance. For the serial studies, TBSS and region-of-interest (ROI) methods were 
applied to the longitudinal datasets. In the 6–month follow-up study, total number of 
ALS subjects was 23, FA and MD were measured for the motor and extra-motor 
pathways and correlated with the revised ALS functional rating scale (ALSFRS–R) and 
disease duration. TBSS and ROI methods, both manual and atlas-based approaches, 
were used for the 12–month follow-up study which included only 15 subjects. Results 
for both ROI approaches were compared.  
Results: There was variability in clinical presentation among patients, with a mixture 
of site of onset and presence/absence of cognitive changes. At the first time-point study, 
all DTI measures and GM volume differed significantly between ALS subjects and 
controls in motor and extra-motor regions. Comparing each ALS subgroup to controls, 
greater DTI changes were present in ALS with cognitive impairment (ALScog) than 
ALS subjects without cognitive impairment (ALSnon-cog) subjects. In ALS compared 
to controls, there were changes on the right side and in a small region in the left middle 
frontal gyrus. Comparing ALS sub-groups, GM results showed reduction in the caudate 
nucleus volume in ALScog subjects. In the serial scans, when comparing all ALS time-
points, the TBSS showed no significant changes between the first two scans or at three 
time-points. Using ROI method for 6-month follow-up, the average changes in FA and 
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MD in the selected ROIs were small and not significant after correcting for multiple 
com parisons. The FA correlated with ALSFRS-R in the genu of corpus callosum (gCC) 
and bilaterally in the forceps minor and inferior longitudinal fasciculus (ILF) at first 
scan but not at the second scan. The MD in the hippocampus WM tracts (Hpc), the 
association fibers and anterior limb of internal capsule (ALIC), gCC and corona radiata 
(CR) correlated with disease duration and ALSFRS-R. Over 12-month follow-up, when 
TBSS group comparison were performed for each time-point compared to controls, the 
changes in serial three time-points were mainly along the cortico-spinal tract (CST) and 
the whole corpus callosum (CC). ROI methods showed no significant differences in the 
average FA in the posterior limb of internal capsule (PLIC) or CST at the pons between 
time-point. There was a significant correlation of the values for the rate of loss in the 
left PLIC with survival and the correlation approached significance for the right PLIC. 
Linear regression analysis showed a significant relationship between the manual and 
atlas based methods for the PLIC but not the pons. However, this study found that 
manual ROI (mROI) is correlated with the atlas-based ROI (aROI). 
Conclusion: The combined DTI and VBM study at the first time point showed changes 
in motor and extra-motor regions in patients with ALS compared to controls. The DTI 
changes were more extensive in ALS with cognitive impairment than pure ALS 
subjects. It is likely that the inclusion of ALS subjects with cognitive impairment in 
previous studies resulted in extra-motor WM abnormalities being reported in ALS 
subjects. Our study finds that there was little change in the DTI over time in patients 
with ALS. However, there was variability in clinical features among patients. For 
individuals there is some correlation with disease progression, measured by ALSFRS-
R and survival. Our results would suggest that better results are obtained from the PLIC 
than the CST in the pons. 
  
 
4  Alruwaili thesis 2016 
 
Declaration by author 
This thesis is composed of my original work, and contains no material previously 
published or written by another person except where due reference has been made in 
the text. I have clearly stated the contribution by others to jointly authored works that I 
have included in my thesis. 
 
I have clearly stated the contribution of others to my thesis as a whole, including 
statistical assistance, survey design, data analysis, significant technical procedures, 
professional editorial advice, and any other original research work used or reported in 
my thesis. The content of my thesis is the result of work I have carried out since the 
commencement of my research higher degree candidature and does not include a 
substantial part of work that has been submitted to qualify for the award of any other 
degree or diploma in any university or other tertiary institution. I have clearly stated 
which parts of my thesis, if any, have been submitted to qualify for another award. 
 
I acknowledge that an electronic copy of my thesis must be lodged with the University 
Library and, subject to the policy and procedures of The University of Queensland, the 
thesis be made available for research and study in accordance with the Copyright Act 
1968 unless a period of embargo has been approved by the Dean of the Graduate 
School.  
 
I acknowledge that copyright of all material contained in my thesis resides with the 
copyright holder(s) of that material. Where appropriate I have obtained copyright 
permission from the copyright holder to reproduce material in this thesis. 
 
 
5  Alruwaili thesis 2016 
 
Publications during candidature 
No publications  
Publications included in this thesis 
No publications  
 
6  Alruwaili thesis 2016 
 
Contributions by others to the thesis  
 
Prof Pamela McCombe (primary supervisor), Dr Robert Henderson (associate 
supervisor), Dr Kerstin Pannek (advisor), Dr Nyoman Kurniwan (advisor), and Dr 
Marcus Gray (advisor) have all made contributions towards the research ideas, 
experimental design, data collection and interpretation of results.  
 
 










7  Alruwaili thesis 2016 
 
Acknowledgements 
First and above all, I praise Allah, the almighty for providing me this opportunity and 
granting me the capability to proceed successfully. I would like to thank my special 
angels; Bensian, Rateem and Muzoon for making me a true “tiger” and a strong fighter. 
You made my life more meaningful and filled it with joy and happiness. Thanks to my 
inspiration and PhD supervisor Pamela McCombe for the meticulous editing of my 
manuscripts, and excellent professional advice and coaching in general. Thanks to my 
advisory team; Robert Henderson, Kerstin Pannek, Nyoman Kurniawan and Marcus 
Gray. I am extremely grateful for your generous support and sound advice throughout 
the course of my PhD. I am fortunate to have had not only one, but five 1st class 
supervisors. Thanks to Judith Greer for the academic and life advices that we used to 
share when working till late during grants submission. Thanks a million to Kerstin 
Pannek for the numerous hours of patient “command line” tuition, and always spending 
time to understand, discuss and especially for keeping me on my toes, sometimes. I’d 
like to thank Robert Henderson for helping me recruiting ALS patients and acquiring 
the healthy volunteer MRI data needed for the study. My sincere thanks also goes to 
Nyoman Kurniawan for the “speedy” help every time I fall into error messages while 
working on my processing and analysis at CAI. Thanks to Marcus Gray for the few 
meetings but insightful discussions about the final statistical design. 
The research in this thesis was funded by the Royal Brisbane Hospital Foundation. I 
am also appreciative for the financial support from my King Saud University. Thanks 
to Matt Devine for all his help with my systematic review and re-checking the eligibility 
of included papers and extracting the required data. Thanks extend to the research 
nurses from the MND clinic at RBWH for their generous help during my recruitments 
and when I needed clinical data.  
A very special thanks to my Dad and Mum and my seven brothers and eight sisters. 
Special thanks to my youngest brother Faris, you’re my hero. I am so blessed to have 
such huge and full of fun family. You all have been supportive throughout all of my 
life journey in every way imaginable, I love you.  
 Finally, I thank my best IT friends who “rescued” me when I didn’t have access to IT 
support over Christmas. Thanks Dr. Abdullah Alenizi for all the Linux and bash 
scripting private lessons. And for teaching me how to transfer my data from CVL to 
CAI workstations safely. Thanks for being “one call away”. Thanks to Saleh Alharbi 
 
8  Alruwaili thesis 2016 
 
for all the Microsoft, Endnote and publishing advices. Thanks to Abdullah Asiri from 
CAI for being my “family” support in Australia. To all my best “countless” friends, 
thank you so much for the continuous care, love and understanding. You don’t know 
how much I appreciated those little surprises celebrating every tiny achievements 
during my PhD life. 
  
 
9  Alruwaili thesis 2016 
 
Keywords 
Magnetic resonance imaging 
Diffusion weighted imaging 
Axonal loss 
Motor neuron disease 
Amyotrophic lateral sclerosis 
Diffusion tensor imaging (DTI) 
Neurodegeneration 
Frontotemporal dementia FTD 
Cortical gray matter, white matter 
 
Australian and New Zealand Standard Research Classifications (ANZSRC) 
 
110320 Radiology and Organ Imaging 40% 
080106 Image Processing 40% 
119999 Medical and Health Sciences not elsewhere classified 20% 
 
Fields of Research (FoR) Classification 
1109 Neurosciences 30% 
1103 Clinical Sciences 40% 




10  Alruwaili thesis 2016 
 
Table of contents 
Table of contents .................................................................................................................... 10 
List of Figures ........................................................................................................................ 16 
List of Tables .......................................................................................................................... 18 
List of Tables in Appendix .................................................................................................... 20 
List of Abbreviations ............................................................................................................. 21 
Thesis ...................................................................................................................................... 23 
Chapter 1: Introduction ........................................................................................................ 24 
Amyotrophic lateral sclerosis .................................................................................. 24 
Cognition in ALS ..................................................................................................... 27 
Prevalence of cognitive disturbance in ALS ........................................................ 27 
Clinic based tools to measure cognition in ALS .................................................. 28 
Biomarkers in ALS .................................................................................................. 30 
Clinical biomarkers .............................................................................................. 30 
Body fluid biomarkers ......................................................................................... 31 
Imaging biomarkers ............................................................................................. 32 
Aims and hypotheses of this study........................................................................... 32 
Chapter 2: Diffusion MRI and imaging in ALS ................................................................. 34 
History of MRI ......................................................................................................... 34 
Diffusion weighted imaging (DWI) ..................................................................... 34 
Radiological pathological correlation of diffusion images ...................................... 39 
Role of MRI in ALS ................................................................................................ 40 
Chapter 3: Methods ............................................................................................................... 42 
Participants ............................................................................................................... 42 
ALS patients......................................................................................................... 42 
Healthy controls ................................................................................................... 43 
11  Alruwaili thesis 2016 
 
Clinical Measures..................................................................................................... 43 
Amyotrophic Lateral Sclerosis Functional Rating (ALSRFS-R) ........................ 43 
Addenbrooke’s Cognitive Examination (ACE) ................................................... 43 
Frontal Assessment Battery (FAB) ...................................................................... 44 
Systematic review .................................................................................................... 44 
MRI acquisition ....................................................................................................... 45 
Preprocessing of diffusion images ........................................................................... 45 
Correction of image artefacts ............................................................................... 45 
MRI analysis ............................................................................................................ 48 
WM analysis ........................................................................................................ 48 
Region of interest (ROI) .................................................................................. 48 
TBSS ................................................................................................................ 49 
GM analysis using Voxel–based morphometry (VBM) ...................................... 49 
Statistical analysis for TBSS and VBM ................................................................... 50 
Chapter 4: White matter tracts shared in ALS and FTD using DTI ................................ 52 
Introduction: ............................................................................................................. 53 
Methods: .................................................................................................................. 54 
Search strategy and key words ............................................................................. 54 
Selection criteria: ................................................................................................. 55 
Assessment of methodological quality ................................................................ 56 
Data extraction ..................................................................................................... 56 
Selection of tracts for inclusion in figures ........................................................... 56 
Results ...................................................................................................................... 56 
Overall summary and participant characteristics ................................................. 56 
DTI in ALS: ..................................................................................................... 59 
Whole brain analysis .................................................................................... 61 
ROI and Tractography analysis ................................................................... 61 
12  Alruwaili thesis 2016 
 
Projection Fibers ...................................................................................... 61 
Association Fibers .................................................................................... 66 
Subcortical WM (Limbic tracts) .............................................................. 70 
Commissural fibers .................................................................................. 73 
Brain stem tracts ...................................................................................... 75 
DTI in FTD ...................................................................................................... 77 
Whole brain analysis .................................................................................... 77 
ROI and Tractography analysis ................................................................... 78 
Projection Fibers ...................................................................................... 78 
Association Fibers .................................................................................... 79 
Subcortical WM (Limbic tracts) .............................................................. 80 
Commissural fibers .................................................................................. 80 
Brain stem tracts ...................................................................................... 81 
Overlap between ALS and FTD ...................................................................... 82 
Discussion ................................................................................................................ 84 
ALS studies .......................................................................................................... 85 
FTD studies .......................................................................................................... 86 
Overlap between ALS and FTD .......................................................................... 87 
Chapter 5: Baseline scan evaluating whole brain gray and white matter in ALS subgroups 
based on cognitive testing ..................................................................................................... 89 
Introduction .............................................................................................................. 90 
Materials and methods ......................................................................................... 93 
Subjects and recruitment .................................................................................. 93 
Clinical Evaluation........................................................................................... 94 
Motor function ............................................................................................. 94 
Cognitive and behavioral testing ................................................................. 95 
MRI acquisition ................................................................................................... 95 
13  Alruwaili thesis 2016 
 
Diffusion processing ........................................................................................ 95 
Tract based spatial statistics (TBSS) analysis .................................................. 96 
Voxel-based Morphometry Analysis (VBM) .................................................. 96 
Statistical tests ...................................................................................................... 97 
Results .................................................................................................................. 97 
Patient groups................................................................................................... 97 
DTI studies of white matter (TBSS) ................................................................ 98 
Mean Diffusivity (MD) ................................................................................ 99 
Fractional anisotropy (FA) ......................................................................... 100 
Axial diffusivity (AD)................................................................................ 101 
Radial diffusivity (RD) .............................................................................. 101 
VBM .............................................................................................................. 105 
Discussion .............................................................................................................. 108 
Chapter 6: Two scans evaluation of motor and extra-motor pathways ......................... 113 
Introduction ............................................................................................................ 114 
Methods.................................................................................................................. 115 
Participants ......................................................................................................... 115 
Clinical assessment ............................................................................................ 115 
Image acquisition ............................................................................................... 115 
Diffusion processing .......................................................................................... 116 
Region of interest (ROI) analysis ...................................................................... 116 
Tract-based spatial statistics (TBSS) ................................................................. 119 
Statistical analysis .............................................................................................. 119 
Results .................................................................................................................... 120 
Subjects .............................................................................................................. 120 
TBSS .................................................................................................................. 122 
FA and MD changes in motor pathways............................................................ 122 
14  Alruwaili thesis 2016 
 
FA and MD changes in extra-motor pathways .................................................. 127 
Correlation between DTI and ALSFRS-R ......................................................... 128 
DTI correlation with disease duration................................................................ 131 
Correlation between change in FA and change in ALSFRS-R .......................... 131 
Discussion .............................................................................................................. 133 
Chapter 7: 12–month follow-up DTI evaluating whole brain and corticospinal tract using 
TBSS and ROI approaches ................................................................................................. 138 
Introduction ............................................................................................................ 139 
Methods.................................................................................................................. 140 
Subjects: ............................................................................................................. 140 
MRI acquisition and pre–processing of HARDI ............................................... 142 
TBSS analysis .................................................................................................... 142 
Automated ROI analysis methods ..................................................................... 143 
Manual ROI methods ......................................................................................... 145 
Statistical analysis .............................................................................................. 146 
Results .................................................................................................................... 147 
TBSS results....................................................................................................... 147 
ROI results ......................................................................................................... 150 
FA results at each time-point ......................................................................... 150 
Atlas-based ROI ......................................................................................... 150 
Manual ROI ............................................................................................... 150 
Average FA for each atlas based and manual ROI methods ..................... 151 
Correlation of mROI with aROI ................................................................ 155 
Slope of the curve of FA at each time-point .............................................. 157 
Correlation of rate of loss of FA with clinical features ............................. 159 
Reproducibility of manual ROI ................................................................. 161 
Discussion .............................................................................................................. 162 
15  Alruwaili thesis 2016 
 
Chapter 8: Discussion ......................................................................................................... 165 
Systematic Review of DTI in ALS and FTD ......................................................... 165 
Differences between ALS patients with and without cognitive impairment ......... 167 
Serial MRI studies.................................................................................................. 169 
Limitations and future directions ........................................................................... 173 
Conclusion ............................................................................................................. 174 
Bibliography......................................................................................................................... 176 
Appendix .............................................................................................................................. 217 
  
16  Alruwaili thesis 2016 
 
List of Figures  
Chapter 2 
Figure 2.1: Diffusion maps.  
Figure 2.2: Visual representation of a diffusion tensor with the 3 main axes. 
Chapter 3 
Figure 3.1: Preprocessing pipeline of diffusion raw data. 
Chapter 4 
Figure 4.1: Inclusion of studies. 
Figure 4.2: Visual representation of WM tracts that were found significant in ALS 
studies. 
Figure 4.3: Visual representation of WM tracts that were found significant in FTD 
studies. 
Figure 4.4: Visual representation of WM tracts that are found to be significant and 
shared in both ALS and FTD studies. 
Chapter 5 
Figure 5.1: WM TBSS analysis of DTI metrics highlighting differences between 
ALScog and ALSnon-cog compared to healthy controls.  
Figure 5.2: TBSS comparison of ALSnon-cog and ALScog patients.  
Figure 5.3: Clusters of significant GM density differences in VBM analysis when 
comparing all ALS subjects and controls. 
Figure 5.4: Clusters of significant GM signal differences in VBM analysis when 
comparing ALS subgroups with healthy controls 
Chapter 6 
Figure 6.1: Regions of interest (ROIs) used in the analysis. 
Figure 6.2: Individual FA plot at two time-points in the motor pathways and callosal 
tracts.  
Figure 6.3: The individual FA plot at two time-points in the extra-motor pathways. 
Figure 6.4: The individual FA plot at two time-points in the in the association tracts. 
  
17  Alruwaili thesis 2016 
 
Chapter 7 
Figure 7.1: Atlas-based ROI of the CST at the pons.  
Figure 7.2: Atlas-based ROI of the PLIC.  
Figure 7.3: manual ROI of the CST at the pons and PLIC.  
Figure 7.4: TBSS results of three time-points for ALS subjects compared to controls. 
Figure 7.5: Atlas-based ROI FA measurement for individual patients at three time–
points in PLIC and CST in the pons.  
Figure 7.6: Manual ROI FA measurement for individual patients of three time-points 
for the CST at pons and PLIC. 
Figure 7.7: Estimated marginal means for every ROI in both methods. 
Figure 7.8: The mean and median differences for each ROI in every time-point using 
both methods. 
Figure 7.9: Regression results for FA values for all scans in every ROI comparing 
mROI and aROI. 
Figure 7.10: FA slope using both ROI analyses. 
  
18  Alruwaili thesis 2016 
 
List of Tables 
 
Chapter 3 
Table 3.1: Details of subjects. 
Chapter 4 
Table 4.1: Details of subjects. 
Table 4.2: Summary of WM analysis. 
Table 4.3: Numbers of FA studies with significant results. 
Table 4.4: Studies of FA in the projection fibers. 
Table 4.5: Studies of FA in the association fibers. 
Table 4.6: Studies of FA in the subcortical (limbic) tracts. 
Table 4.7: Studies of FA in the callosal radiation.  
Table 4.8: Studies of FA in the brain stem tracts.  
Chapter 5 
Table 5.2: Details of participants.  
Table 5.3: ACE-III results for all domain comparing ALSnon-cog and ALScog. 
Table 5.4: DTI and MRI changes in ALS patients. 
Chapter 6 
Table 6.5: List of regions–of–interest investigated in this study. 
Table 6.2: Clinical features for individual ALS participants. 
Table 6.3: Summary of clinical data. 
Table 6.4: The mean of the FA and MD differences between two scans. 
Table 6.5: Comparison of FA at first and second scans. 
Table 6.6: The correlations of FA with clinical measures at the first scan. 
Table 6.7: The correlations of FA with clinical measures at the second scan. 
Table 6.8: The correlations of MD with clinical measures at the first scan. 
Table 6.9: The correlations of MD with clinical measures at the second scan. 
Table 6.10: Correlation between the change in FA and the change in ALSFRS–R. 
Table 6.11: Our findings of significant ROIs compared to previous studies.  
 
19  Alruwaili thesis 2016 
 
Chapter 7 
Table 7.6: Subject details and clinical measures. 
Table 7.7: Comparisons that were examined with TBSS. 
Table 7.8: Means (SD) for FA at three Time-points using atlas-based ROI and manual 
ROI. 
Table 7.4: FA averaged mean of ROIs in both methods. 
Table 7.5: Correlation of FA in both methods. 
Table 7.6: Slope of the FA curve in manually drawn ROI. 
Table 7.7: Slope of the FA curve in manually drawn ROI. 
Table 7.8: FA slope correlation with survival from onset to death or censoring using 
Spearman’s correlation. 
Table 7.9: FA slope correlation with survival from onset to death or censoring using 
Pearson correlation. 
Table 7.10: FA slope correlation with survival from last scan to death or censoring 
using Pearson correlation. 
Table 7.11: FA slope correlation with survival from last scan to death or censoring 
using Spearman’s correlation. 
 
  
20  Alruwaili thesis 2016 
 
List of Tables in Appendix 
Chapter 4 
List of supplementary tables 
Supp Table 4.1: Full details of extracted data. 
Supp Table 4.2: FA correlations in ALS. 
Supp Table 4.3: MD correlations in ALS. 
Supp Table 4.4: RD correlations in ALS. 
Supp Table 4.5: AD correlations in ALS. 
Supp Table 4.6: FA correlations in FTD. 
  
21  Alruwaili thesis 2016 
 
List of Abbreviations  
AD – Axial diffusivity  
ALIC – Anterior limb of IC  
ALS – Amyotrophic Lateral Sclerosis  
ALScog – ALS subjects with cognitive impairment  
ALSFRS-R – Revised Amyotrophic Lateral Sclerosis Functional Rating Scale  
ALS-FTD-Q – ALS-FTD-Questionnaire  
ALSnon-cog – ALS subjects without cognitive impairment  
aTR – Anterior thalamic radiation  
CBS – Cognitive Behavioral Screen  
CC – Corpus callosum  
Cg – Cingulum  
CST – Corticospinal tract  
ECAS – Edinburgh Cognitive and Behavioral Amyotrophic Lateral Sclerosis Screen  
FA – Fractional anisotropy  
FAB – Frontal Assessment Battery  
FTD – Frontotemporal dementia  
GM – Gray matter  
Hpc – Hippocampal network  
ILF – The inferior longitudinal fasciculus  
IFOF – The inferior fronto-occipital fasciculus  
IC – Internal capsule 
MD – Mean diffusivity  
PLIC – Posterior limb of IC  
ROI – Region–of–interest  
RD – Radial diffusivity  
SLF – Superior longitudinal fasciculus  
TBSS – Tract-based spatial statistics 
TOI – tract of interest  
UncF –uncinated fasciculus  
VBM – Voxel-based morphometry  
22  Alruwaili thesis 2016 
 
WM – White matter  
23  Alruwaili thesis 2016 
 
Thesis  
24  Alruwaili thesis 2016 
 
Chapter 1: Introduction 
Amyotrophic lateral sclerosis 
Amyotrophic lateral sclerosis (ALS) is a devastating neurological disease characterized 
by the loss of upper motor neurons of the brain and lower motor neurons of the spinal 
cord (Kiernan, Vucic et al. 2011). Motor neurons control the muscles in the legs, arms, 
or those used for speech, swallowing or breathing. The clinical features of ALS result 
from the loss of these motor neurons (Zarei, Carr et al. 2015). The term Amyotrophic 
Lateral Sclerosis is used in some parts of the world for this disease, while the term 
motor neuron disease is often used in Australia and United Kingdom. The term “motor 
neuron disease“ can also be used to encompass a number of other diseases such as 
spinal muscular atrophy and post-poliomyelitis syndrome, that do not fulfill the criteria 
for diagnosis of ALS (Miller, Gelinas et al. 2005). In France, ALS is sometimes called 
Charcot’s disease (Maladie de Charcot), as the disease was first described by the French 
neurologist Jean-Martin Charcot (Charcot 1865, Rowland 2001).  
 
The anatomical pathology of ALS involves loss of upper and lower motor neurons. 
However, the microscopic pathology of ALS includes the presence of Bunina bodies, 
which are eosinophilic inclusions. These are considered to be the pathological hallmark 
of ALS (Okamoto, Mizuno et al. 2008), along with the accumulation of insoluble 
protein aggregates (Peters, Ghasemi et al. , Leigh, Anderton et al. 1988, Okamoto, 
Mizuno et al. 2008). The pathological protein aggregations vary among patients and 
can be categorized into TAR DNA-binding protein (Tdp-43) pathology, Tdp-with 
C9orf72 pathology, FUS pathology, and superoxide dismutase gene (SOD1) pathology 
(Saberi, Stauffer et al. 2015). 
 
The possibility of genetic factors being involved in ALS was first suggested in 1850 
with reports of cases with a family history (Strong, Hudson et al. 1991). It is now found 
that approximately 10% of ALS is inherited, which is referred to as familial ALS 
(fALS) (Camu, Khoris et al. 1999). In all patients, ALS is thought to arise from a 
combination of genetic susceptibility (Renton, Chio et al. 2014, Marangi and Traynor 
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2015), and environmental exposure (Fang, Kamel et al. 2009), and may be due to a 
multi-stage process (Al-Chalabi, Calvo et al. 2014). Causative genes have been 
identified in fALS, with some of these genetic mutations also found in patients with 
sporadic ALS (sALS) (Lattante, Conte et al. 2012). It has been estimated that 61% of 
the variance in risk of developing sALS is due to genetic factors (Al-Chalabi, Fang et 
al. 2010). The known causative genes usually encode for the proteins that accumulate 
within cells or are involved in the metabolism of protein aggregates (Chen, Sayana et 
al. 2013, Renton, Chio et al. 2014). 
 
The environmental factors that contribute to ALS are less well understood. 
Epidemiological studies have implicated smoking, dietary factors, and pesticide 
exposure as risk factors for ALS (Okamoto, Mizuno et al. 2008). Environmental 
neurotoxins have also been implicated in the development of ALS. These include ß-
methylaminoalanine (BMAA) and formaldehyde (Juntas-Morales, Pageot et al. 2014, 
Roberts, Johnson et al. 2015). It is possible that these environmental factors act through 
direct toxicity on neurons, but an epigenetic effect on gene expression is also possible 
(Kiernan, Vucic et al. 2011, Martin and Wong 2013, Lam, Chin et al. 2016). 
 
Although ALS was described over 100 years ago, the understanding of the etiology of 
this disease is still limited. There is disagreement over whether the degeneration and 
death of the upper motor neurons (UMN) is a consequence of death of lower motor 
neurons (LMN) or vice versa (Dadon-Nachum, Melamed et al. 2011). Theories of 
pathogenesis of ALS include excitotoxicity, hyperexcitability, the effects of 
aggregation of proteins and abnormalities in dealing with misfolded proteins (Peters, 
Ghasemi et al. , Rothstein 2009).  
 
The incidence of ALS is 1.5–2 per 100,000 people per year (Mitchell and Borasio). The 
prevalence of ALS is 5–6 subjects per 100,000 (Kurtzke 1981). In an epidemiological 
analysis combining global ALS studies, the average age of onset was 61.8 years (Chiò, 
Logroscino et al. 2013), typically between the ages of 50 and 70 years (Al-Chalabi, 
Calvo et al. 2014). Onset of ALS is rare before age 40 and both the incidence 
(Durrleman and Alperovitch 1989) and mortality rates (Hudson, Davenport et al. 1986) 
have been found to increase with age. Men are 1.5 times more likely to develop sporadic 
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ALS than women (McCombe and Henderson 2010); however, men and women are 
equally likely to develop familial ALS (fALS) (Camu, Khoris et al. 1999). The mean 
age at onset is younger in men than in women (Miller, Gelinas et al. 2005, Sabatelli, 
Madia et al. 2008). There is no cure for ALS. Studies have shown that Riluzole, a 
neuroprotective and anticonvulsant compound which inhibits the release of glutamic 
acid from neurons, prolongs the average survival in ALS patients by several months 
(Amyotrophic Lateral Sclerosis/Riluzole Study, Lacomblez et al. 1996). 
 
Requirements for the diagnosis of motor neuron disease include: (a) the presence of 
UMN and LMN signs in different body regions, (b) evidence of disease progression 
with spread of weakness (c) the absence of other underlying pathological conditions. 
Currently, the diagnosis of ALS is grounded in the clinical assessment of disease 
features by an experienced neurologist. The criteria for the diagnosis of ALS are the 
revised El Escorial criteria (Brooks, Miller et al. 2000). These criteria require the 
combination of upper and lower motor neuron signs (Lomen-Hoerth 2008). There are 
also neurophysiological criteria for diagnosis (de Carvalho, Dengler et al. 2008). 
 
The majority of patients die from respiratory failure within 3 to 5 years following 
symptom onset (Bruijn, Miller et al. 2004). However, some patients have longer 
survival and live beyond five years (Turner, Parton et al. 2003, Mateen, Carone et al. 
2010, Pupillo, Messina et al. 2014). Factors that are associated with poor prognosis are 
older age, bulbar onset, shorter time from onset to diagnosis (del Aguila, Longstreth et 
al. 2003) and site of onset (Louwerse, Visser et al. 1997). 
 
Clinical heterogeneity in the site of onset, disease progression and pattern of 
progression is a characteristic yet poorly understood feature of ALS (Baumann, 
Henderson et al. 2012). Patients can vary in terms of the degree of upper motor neuron 
and lower motor neuron weakness, but the most obvious difference between patients is 
the site of onset of weakness and the rate of progression (Beghi, Chiò et al. 2011). 
Patients with ALS also vary in the presence of extra-motor features, including the 
presence of cognitive change, as discussed below. 
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Cognition in ALS 
 Prevalence of cognitive disturbance in ALS 
One of the important causes of heterogeneity in ALS is the presence or absence of 
cognitive abnormalities. In Charcot’s first description of ALS, there was no mention of 
mental symptoms (Charcot 1865). A clinicopathologic study, published in 1932, was 
the first study to suggest that psychological abnormalities can occur in ALS (Wechsler 
and Davison 1932). Studies of the prevalence of cognitive dysfunction in ALS clinics, 
where most patients have sporadic ALS, indicate a prevalence of cognitive impairment 
ranging from 21% to 53% (Massman, Sims et al. 1996, Abrahams, Leigh et al. 2005, 
Ringholz, Appel et al. 2005, Rippon, Scarmeas et al. 2006, Gordon, Goetz et al. 2010, 
Phukan, Elamin et al. 2012, Oh, Park et al. 2014, Cui, Cui et al. 2015).  
  
Frontotemporal dementia (FTD) is a form of dementia with pathology in the frontal and 
temporal parts of the brain (van der Zee and Van Broeckhoven 2014). Changes of 
personality, such as changes in sleep and eating patterns, social functioning and lack of 
judgment are the common symptoms of FTD. Some patients experience disinhibition 
and repetitive compulsive behavior and decreased attention (Ferrari, Kapogiannis et al. 
2011).  
 
Some patients have both ALS and frontotemporal dementia (FTD) (Burrell, Kiernan et 
al. 2011, Kiernan 2012). ALS patients with co–existent FTD have a poor prognosis 
(Mathuranath, Nestor et al. 2000, Ratnavalli, Brayne et al. 2002, Hodges, Davies et al. 
2003). Language changes and abnormalities of comprehension are also found in ALS 
(Bak and Hodges 2004). It is accepted that some symptoms of FTD can be detected in 
up to 50% of ALS patients (Lomen-Hoerth, Anderson et al. 2002, Liscic, Grinberg et 
al. 2008, Strong 2008). Conversely, one study of FTD patients found that 14% had 
definite ALS, while 36% met the criteria for possible ALS (Lomen-Hoerth, Anderson 
et al. 2002). A number of recent studies emphasize the need to assess the motor 
dysfunction in FTD patients along with investigating cognition in ALS patients (Irwin, 
Lippa et al. 2007).  
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The continuum of the ALS with FTD has gained growing recognition based on 
epidemiological data and genetic studies (Renton, Majounie et al. 2011). Recent studies 
have established a genetic link between ALS and FTD by the discovery of the 
hexanucleotide repeat expansion of GGGGCC in the C90RF72 gene, which is 
associated with both ALS and FTD (DeJesus-Hernandez, Mackenzie et al. 2011, 
Renton, Majounie et al. 2011). These cognitive changes may have consequences for the 
planning of symptomatic care and the design and analysis of therapeutic trials. 
 
Clinic based tools to measure cognition in ALS 
Thorough assessment of cognition in ALS requires a full neuropsychological 
assessment. This is, however, not within the scope of routine clinical practice. 
Therefore, there is a need for a screening test that provides a measure for cognitive 
evaluation, which can be administered in the clinic in a relatively short time. The most 
widely used tests are the Mini mental state examination (MMSE), the revised 
Addenbrooke’s Cognitive Examination (ACE-R) (Davies and Larner 2013), and the 
Frontal Assessment Battery (FAB) (Strong, Grace et al. 2009). More recently, the 
Edinburgh Cognitive and Behavioral ALS Screen (ECAS) and the ALS cognitive 
behavioral screen (ALS-CBS™) were developed. The ECAS aims to determine 
cognitive and behavioral changes of ALS patients (Abrahams and Bak 2013), while the 
ALS-CBS™ also aims to detect frontal lobe-mediated cognitive and behavioral 
changes (Woolley, York et al. 2010). Neither of these tests was available at the start of 
this project and could not be used here. 
 
The Mini-Mental State Examination (MMSE) is a screening test that provides a brief 
and objective measure of cognitive function that is used to evaluate memory and 
cognition in clinical practice to diagnose dementia. Despite the vast literature on 
MMSE, there are certain limitations, such as (a) poor sensitivity to the early stages of 
Alzheimer’s Disease when it is confined to amnestic syndrome (Feher, Mahurin et al. 
1992), (b) inability to differentiate the type of dementia (Mathuranath, Nestor et al. 
2000), and (c) inability to isolate linguistic or frontal deficits in early FTD that are 
critically dependent on executive ability measures, also it fails to detect deficits in 
memory and language tasks until the deficit is progressed (Hodges, Patterson et al. 
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1999). It is not effective in evaluating behavior or assessing the executive dysfunction 
that is common to ALS (Strong, Grace et al. 2009).  
 
The Addenbrooke’s Cognitive Examination (ACE) was designed to survey key 
domains of cognitive function without the need for specialized equipment, and to be 
sensitive to early stages of Alzheimer’s disease and FTD. Sub-scores of the ACE are 
suggested to differentiate the diagnosis between FTD and Alzheimer’s disease 
(Mathuranath, Nestor et al. 2000, Davies and Larner 2013). The ACE incorporates the 
Mini-Mental State Examination, which can be derived from the scores generated. 
Compared to the MMSE, naming in ACE is more difficult. Components such as verbal 
fluency and visuospatial function (copying a 3-D cube and drawing a clock face) have 
been added to ACE to detect the impaired constructional ability. Compared to the 
MMSE, the ACE has expanded memory and language tasks to reflect the impairment 
of episodic memory in early detection of Alzheimer’s disease whereas the letter-based 
fluency is sensitive to FTD. ACE also incorporates the delayed recall test for the name 
and address which appears to be a sensitive measure in Alzheimer’s disease 
(Mathuranath, Nestor et al. 2000). The performance of FTD patients in orientation tasks 
and episodic memory tasks is better than that of Alzheimer’s disease patients. However, 
the latter perform better on verbal fluency and language components (Mathuranath, 
Nestor et al. 2000). 
 
The Addenbrooke’s Cognitive Examination Revised (ACE-R) is the revised version of 
ACE which incorporates the MMSE with the total possible score of 100 (Mioshi, 
Dawson et al. 2006). The revised version aimed to be quick to administer and readily 
acceptable to patients. The authors created three alternative versions of the name and 
address recall test, thereby preventing recalling from previous clinical visits. ACE-III 
was subsequently developed to omit the MMSE items due to copy-right restrictions. 
Modification to ACE is explained further in the methodology section. 
 
The Frontal Assessment Battery (FAB) was designed to assess frontal lobe processes 
and identify the presence and severity of the dysexecutive syndrome that affects both 
motor behavior and cognitive function in several neurodegenerative diseases (Dubois, 
Slachevsky et al. 2000). A global agreement amongst researchers accepted the FAB as 
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a short and easy bedside battery to measures dysexecutive function and that can follow 
this dysfunction as the disease progresses (Slachevsky A 2004, Maeshima, Tanemura 
et al. 2006).  
 Biomarkers in ALS 
The WHO has defined biomarkers as “almost any measurement reflecting an 
interaction between a biological system and a potential hazard, which may be chemical, 
physical, or biological. The measured response may be functional and physiological, 
biochemical at the cellular level, or a molecular interaction” (WHO 1993). 
 
A delay of about 12–18 months from onset of ALS symptoms to diagnosis prevents 
early treatment with a disease-modifying drug (Zoccolella, Beghi et al. 2006). It has 
been suggested that the effects of motor neuron loss may be masked by the 
compensatory mechanism; in which neuronal damage might stimulate neural stem cell 
activity (Kuhn, Palmer et al. 2001), before the onset of clinical symptoms (Swash and 
Ingram 1988). Thus, there is a need for sensitive and specific biomarkers to assist with 
early diagnosis, to test a drug, to monitor progression, and as a surrogate endpoint in 
clinical trials.  
 
Biomarkers can be relevant to phenotype, disability, or progression with diagnostic 
value. In ALS, these biomarkers can be from blood, body fluids such as cerebrospinal 
fluid (CSF), or imaging. 
 
Clinical biomarkers 
The ALS Functional Rating Scale (ALSFRS-R) is used to determine the capability and 
independence of ALS patients in functional activities relevant to their daily routine 
(Cedarbaum, Stambler et al. 1999). It is widely used to monitor progression of disease.  
 
The extent of respiratory involvement has been reported to be a major prognostic factor 
in ALS (Haverkamp, Appel et al. 1995). Therefore, studies have moved towards the 
measurements of respiratory muscle strength such as measurement of the sniff nasal 
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inspiratory pressure (SNIP), which is a measure of diaphragmatic strength. It has been 
suggested that SNIP is more accurate than forced vital capacity (FVC) (Wijesekera 
2009) because FVC assesses inspiratory muscle strength but not the expiratory muscles. 
Supine measurements can be used and were found to predict outcome (Baumann, 
Henderson et al. 2010). 
 
Motor unit number estimation (MUNE) is an electrophysiological technique that 
assesses loss of lower motor neurons by estimating the number of active motor neurons 
innervating muscles (Felice 1997). MUNE would be expected to be a useful tool to 
follow the progression of ALS, but there are technical difficulties in the methods and 
limitation concerning the estimation of surface motor unit potential (SMUP) (Bromberg 
2007).  
Body fluid biomarkers 
It has been suggested that plasma or serum would be the best source of biomarkers in 
ALS (Turner, Kiernan et al. 2009). Amino acid concentrations have been investigated, 
with increased levels of tyrosine (Patten, Harati et al. 1978) and glutamate (Iłżecka, 
Stelmasiak et al. 2003) being found in ALS patients compared to healthy controls. 
Moreover, blood studies have led researchers to investigate connective tissue in ALS 
patients and found that lower levels of fibronectin correlated with disease duration 
(Ono, Imai et al. 2000). Immune biomarkers were the focus of other researchers who 
found raised concentrations of T-cells that correlated negatively with ALSFRS-R and 
positively with the rate of disease progression (Shi, Kawano et al. 2007). Finally, levels 
of growth factors (Houi, Kobayashi et al. 2002) and lipoprotein (Dupuis, Corcia et al. 
2008) have been found to affect progression and survival in ALS.  
 
CSF biomarkers such as higher concentration of neurofilament have been implicated in 
the pathogenesis of motor neuron degeneration and indicated shorter survival (Beghi, 
Logroscino et al. 2006, Brettschneider, Petzold et al. 2006). Lower concentrations of 
vascular endothelial growth factor were found in ALS patients when compared to 
controls (Moreau, Devos et al. 2006, Xu, Henderson et al. 2016). 
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Imaging biomarkers 
In this study the use of MRI as a biomarker will be the main aim. MRI gives an insight 
in the understanding of disease pathology and the possible progression of disease to 
other body regions (Keil, Prell et al. 2012). Since MRI is a non-invasive imaging 
technique, it has been extensively applied in neuroscience and neurological diseases 
and has the potential to be a useful biomarker for progression of ALS. The role of MRI 
in ALS will be discussed in detail in the next chapter. 
Aims and hypotheses of this study 
In this project I aim to provide more insight not only into the usefulness of diffusion 
MRI in ALS but also the structural changes associated with cognitive involvement in 
ALS. The study will concentrate on diffusion tensor imaging (DTI), which is thought 
to be a promising tool for prognostic, diagnostic or/and monitoring purposes in ALS 
(Rose, Pannek et al. 2012). 
My aims were: 
• To review the evidence of WM alterations in both ALS and FTD. Thus, I 
performed a thorough review of the literature on DTI in these diseases. If 
10-15% of ALS patients meet the criteria for FTD, then I hypothesize that 
both conditions will share similar structural changes in the brain and that 
this will be evident in the published literature. 
• To identify brain regions involved in ALS patients with and without 
cognitive impairment compared to controls. I used whole brain voxel-wise 
analyses to investigate the microstructural and macrostructural changes 
using both DTI and structural MRI data. ALS patients with cognitive 
impairment will be expected to show more extensive changes in the brain 
on MRI than those without cognitive impairment due to the involvement of 
brain regions that play role in cognition. I hypothesized that ALS patients 
with cognitive impairment would show more widespread alterations in both 
brain microstructure and macrostructure, particularly in extra-motor 
regions. 
• To determine whether there are WM microstructural changes, either in 
motor or extra-motor pathways, over 6 months. I performed this analysis 
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using whole-brain voxel-wise analysis and ROI analysis of DTI. I 
hypothesize that there would be changes in a wide range of WM tracts over 
6 months. 
• To investigate the DTI changes of the CST over 12 months to determine if 
there are significant changes over time and whether the rate of change of 
DTI over 12 months correlates with clinical progression. This was 
performed using whole brain and ROI analyses. I hypothesize that the motor 
pathways will show changes over 12 months with changes in the distal CST, 
due to dying back of fibers. 
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Chapter 2: Diffusion MRI and imaging in 
ALS 
 History of MRI 
The phenomenon of nuclear magnetic resonance (NMR) was first described by Rabi in 1938 
(Ai, Morelli et al. 2012). In the ground state, the atomic nuclei have non-zero spin momentum 
and a dipolar momentum. These moments give the rise to nuclear magnetism (Abragam 1961). 
The idea behind the use of NMR for imaging was proposed by Damadian in 1971: he found 
that tissue relaxation times during MR acquisition can discriminate between benign and 
malignant neoplasms, and concluded that a point-by-point assessment of relaxation times in 
the body could be used to detect cancerous tissues (Damadian 1971). The first MR images were 
acquired in 1973 by Lauterbur who reconstructed 2–D images of two tubes in water (Lauterbur 
1973). In 1974, Mansfield devised a faster pulsed-sequence method (Mansfield 1977). The first 
human MRI scans were performed in 1977 by Damadian together with Goldsmith and Minkoff 
(Damadian, Goldsmith et al. 1977). Since then, different MR techniques, methods of 
acquisition, and image analysis have been developed to reduce the scan times and to improve 
image quality. In 1981, ultrafast MR imaging was first used to obtain real-time images 
(Ordidge, Mansfield et al. 1982).  
 
Diffusion weighted imaging (DWI) 
Diffusion refers to the Brownian displacement of molecules, which was initially thought to be 
due to concentration or thermal gradient. However, microscopic observations by Robert Brown 
made it clear that diffusion continues even in the absence of concentration or thermal gradients 
(Brown 1828).  
 
In MRI, diffusion usually considers the movement of water molecules. Diffusion of water 
molecules can be isotropic, when the diffusion of water molecule is the same in all directions, 
or anisotropic, when the diffusion of water molecule is hindered or restricted. In the human 
brain, the presence of macromolecules and cellular membrane cause the diffusion to be 
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hindered (Gaussian) within the extra-axonal space; and restricted (non-Gaussian) within intra-
axonal space. The idea of diffusion weighted MR imaging was introduced in 1986 (Bihan, 
Breton et al. 1986). To acquire DW sequences, two equal and opposing motion-probing 
gradients must be applied and this will reduce the signal of the voxel exponentially. The 
attenuation of the final MR signal occurs when the applied diffusion sensitizing gradient is 
along the same direction of the diffusion in voxels, i.e parallel to white matter tracts. The 
strength, duration, and time between the motion-probing gradients is summarized by the b-
value. Higher b-values allow better angular resolution of underlying crossing fibers, at the 
expense of a reduced signal to noise ratio. For diffusion tensor imaging (described below), b-
values between 700-1200 sec/mm2 provide the most robust measurements (Alexander and 
Barker 2005).  
 
Diffusion tensor imaging (DTI) is a promising tool used in diffusion MRI for characterizing 
the diffusion in brain white matter. The diffusion tensor is a 3 x 3 covariance matrix which 







where D is the diffusion tensor and Dxx, Dyy, Dzz, Dxy, Dxz, Dyz are the 6 independent elements 
of the tensor. The diffusion tensor can be represented as an ellipsoid-shape that is tilted in 
different directions, based on the local diffusion coefficients, see Figure 2.1. The diffusion 
tensor has three principal diffusion values (eigenvalues): 𝜆1, 𝜆2, and 𝜆3, and associated 
eigenvectors, which together determine the orientation and length of the axes of the ellipsoid. 
The first eigenvector is thought to correspond to the major diffusion direction and reflect the 
underlying fiber orientation. If the tissue is isotropic and water can diffuse freely, then 𝜆1 =𝜆2 = 
𝜆3 ; if the tissue is anisotropic with the convention that 𝜆1 is the largest diffusion coefficient, 
𝜆1 > 𝜆2 ≥ 𝜆3 (Taylor, Hsu et al. 2004), Figure 2.1. 
 
The diffusion tensor can be derived from at least seven measurements, including one b0 image 
and six diffusion weighted images acquired along non-collinear directions (Jones, Horsfield et 
al. 1999, Hasan, Parker et al. 2001). Ideally, at least 30 diffusion weighted images should be 
acquired (Jones, Horsfield et al. 1999). 
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A number of rotationally invariant scalar metrics can be calculated from the diffusion tensor. 
The most frequently used DTI metric is the fractional anisotropy (FA), which is an index 
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Where 𝜆1, 𝜆2, 𝜆3, are the eigenvalues of the diffusion tensor as mentioned above, and 𝜆 is the 
average of the three eigenvalues. FA is high when the diffusion is constrained along the tract 
such as within the WM and low when the diffusion is less restricted such as GM or 
cerebrospinal fluid (CSF). Another measure is the mean diffusivity (MD), sometimes also 
referred to as apparent diffusion coefficient (ADC) (Pyra, Hui et al. 2010). The third of the 




(𝜆1 + 𝜆2 + 𝜆3) 
Further diffusion tensor metrics include axial diffusivity (AD), which represents the water 
diffusivity parallel to the axonal fibers. Diffusion perpendicular to axonal fibers is referred to 
as radial diffusivity (RD). Both AD and RD can serve as a surrogate markers for the detection 
of myelin and axonal abnormalities (Song, Yoshino et al. 2005, Klawiter, Schmidt et al. 2011), 
Figure 2.1. All DTI metrics have been found to reflect microstructural pathology, which is 
discussed in the next section. 
 
In addition to the abovementioned scalar metrics, the principal direction of diffusion can be 
determined from the first eigenvector of the diffusion tensor. This principal direction of 
diffusion can be encoded into a color scheme in which every color is assigned to the major 
direction– red: left-right, green: anterior-posterior, and blue: superior-inferior (Taber, Pierpaoli 
et al. 2002). Direction based color coding is an approach for visualization in DT images where 
the brightness of the image represents the diffusion anisotropy (FA) while the red-green-blue 
(RGB) color scheme indicates the orientation of the fiber tract (Wakana, Jiang et al. 2004), 
Figure 2.2. Although the information provided by RGB-color scheme is complex and requires 
knowledge of 3D architecture of WM, it has proven to be useful in many neurodegenerative 
disease (Hoon, Lawrie et al. 2002, Canu, Agosta et al. 2011).   




Some tissues that have gross motion may show artificial increased diffusivity due to loss of 
signal in diffusion weighted image which can be avoided by reducing the scan time and the use 
of fast acquisition techniques such as echo-planar imaging (EPI) (Turner, Le Bihan et al. 1991). 
One would expect artifacts as a result of head motion, physiological noise or even eddy currents 
and susceptibility effects when applying DTI in scanning patients with neurodegenerative 
disease. Therefore, to perform DTI analysis, extensive pre-processing (Pannek, Raffelt et al. 
2012) is required to deal with these issues. 
 
Figure 2.1: Visual -representation of a diffusion tensor 
with the 3 main axes: the longest axis stands for the 
primary eigenvector (𝜆1), reflecting the diffusion parallel 
to the fibers; the two shorter axes represent the second (𝜆2) 
and third (𝜆3) eigenvectors, whose average provides a 
measure of diffusivity perpendicular to the fibers. 
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Figure 2.2: Diffusion maps. From left to right: Mean diffusivity (MD) measures the 
overall speed of diffusion with high MD (brighter) in the cerebrospinal fluid. Axial 
diffusivity (AD) measure the speed of diffusion along the principal eigenvector, while 
radial diffusivity (RD) represents the speed of diffusion perpendicular to the principal 
eigenvector. Fractional anisotropy (FA) is the measure of the local anisotropic diffusion; 
higher values (closer to 1) represents anisotropic diffusion. FA is high in WM and low in 
GM and CSF. Directionally encoded color FA maps (decFA) represent the orientation of 
the principal eigenvector in a red-green-blue (RGB) color scheme. 
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Radiological pathological correlation of diffusion images 
The theoretical basis of diffusion imaging is that it reflects the constraints on the diffusion of 
water. There have been studies that have investigated the correlation between the DTI 
appearances and the underlying pathology (Tu, Williams et al. 2016). Alteration of diffusivity 
occurs as a result of changes in microstructural tissue and fiber organization. Microstructural 
architecture and increased cellularity were postulated to correlate with gliosis in fractional 
anisotropy (FA) and mean diffusivity (MD) (Tu, Williams et al. 2016). Quantitative FA 
measures are believed to reflect changes in the myelination, fiber density and packing (Mädler, 
Drabycz et al. 2008). Generally speaking, decreased diffusivity and increased diffusion 
anisotropy reflects more structural organization and better WM structural integrity (Pannek, 
Guzzetta et al. 2012). What we know about DTI metrics is largely based upon empirical studies 
that investigate how these measures correlate with the underlying pathology. Evidence suggests 
that FA is sensitive to the WM integrity but is not very specific and cannot distinguish between 
different pathological processes (Filippi, Iannucci et al. 2000, Assaf and Pasternak 2008, 
Sbardella, Tona et al. 2013). MD is suggested to be influenced by free water diffusion in 
cellular space, such as oedema, which is increased in neurodegenerative diseases (Filippi, 
Iannucci et al. 2000). Axial diffusivity (AD) is thought to reflect demyelination in white matter 
tracts. Axial integrity of axons and can be reflected as either increased or decreased AD when 
WM is destroyed by any other process (Mayer, Ling et al. 2010). It has not yet been well-
defined whether RD is specific to demyelination and could also be related to be due to; the 
occurrence of inflammation, or to axonal damage. RD was found to be high in 
neurodegenerative disease (Sun, Liang et al. 2006). Radial diffusivity (RD) has been shown to 
correlate with demyelination and dysmyelination in several pathological models (Song, Sun et 
al. 2002, Fink, Klein et al. 2010).  
 
Wallerian degeneration (WD) is a pathological event that begins with physical fragmentation 
of axons within days after injury, followed by breaking down of myelin sheath due to 
infiltration of macrophages (Thomalla, Glauche et al. 2004). This results in a distal 
degeneration of the nerve fiber and fibrosis and atrophy (Sawlani, Gupta et al. 1997). This is 
slower in the central nervous system (CNS) than in the peripheral nervous system (PNS) 
(Koeppen 2004). MRI can detect Wallerian degeneration in human brain secondary to an insult 
that correlates to functional disability (Mazumdar, Mukherjee et al. 2003, Grassel, Ringer et 
al. 2010). Degeneration of neuronal cell bodies and axonal degeneration are separate and 
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independent processes, and are found to have differing appearances in diffusion studies (Finn, 
Weil et al. 2000).  
 
Non-conventional MRI techniques are those that are mainly used in the research fields to help 
in the early diagnosis or as a tool to monitor disease progression and drug trials. One is the 
diffusion weighted imaging (DWI), which became an established tool for WM integrity and 
fiber tracking in neurodegenerative diseases.  
Role of MRI in ALS 
Corticospinal tract degeneration is the hallmark of ALS pathology. Different structural MR 
imaging modalities can show the changes in CST (Hecht, Fellner et al. 2002, Lee, Markus et 
al. 2003, da Rocha, Oliveira et al. 2004, Kwan, Jeong et al. 2012). On fluid-attenuated inversion 
recovery (FLAIR) imaging, signal hyperintensities along the CST were more significant 
compared to other MR sequences (Hecht, Fellner et al. 2001). Using DTI in ALS, several 
studies have reported a decrease in the FA in CST earlier than other MR techniques (Pierpaoli, 
Barnett et al. 2001). In ALS, there is evidence of Wallerian degeneration and atrophy of the 
myelinated fibers in the CST (Delisle and Carpenter 1984). 
 
DTI in ALS demonstrated abnormalities of the CST at different levels from its origin in the 
motor cortex to the upper spinal cord (Eisen and Weber 2001). All DTI metrics are found to be 
increased, except FA, which is reduced (Metwalli, Benatar et al. 2010, Douaud, Filippini et al. 
2011, Sarro, Agosta et al. 2011). In ALS, Ellis et al not only demonstrated a positive correlation 
between the disease duration and the MD but also found a correlation between reduced FA 
values and the disease severity (Ellis, Simmons et al. 1999). 
 
Many DTI studies have been carried out to compare DTI parameters in different groups and 
correlate these variables with clinical measures. Since the 20th century, there have been reports 
suggesting the correlation between reduction in FA values and neuronal damage in 
neurodegenerative diseases including ALS (Ellis, Simmons et al. 1999, Uluğ, Moore et al. 
1999). The DTI changes along corticospinal tract (CST) have been studied in ALS (Cosottini, 
Giannelli et al. 2005, Wong, Concha et al. 2007, Bartels, Mertens et al. 2008). Other ALS 
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studies have detected changes on brain stem (BS) and corpus callosum (CC) (Hong, Lee et al. 
2004, Ciccarelli, Behrens et al. 2009).  
 
This project used DTI to investigate changes in WM microstructure in patients with or without 
cognitive impairment, as well as serially. A systematic review of the literature on DTI in ALS 
is provided in Chapter 4. The image processing and analysis approaches used in this project 
are described in the following chapter.  
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Chapter 3: Methods 
This chapter describes in detail the methods that were used in the project. The specific 
analyses used are given in the chapters about each study. 
Participants 
All participants provided written informed consent for this study. This study was 
approved by the Human Research Ethics Committee (HREC) at the Royal Brisbane 
Women’s Hospital (RBWH) protocol number 2008/98. 
 
ALS patients 
Patients with clinically probable or definite ALS as defined by the revised El Escorial 
criteria (Brooks, Miller et al. 2000) were recruited for this project from the motor 
neuron disease (MND) Clinic at the Royal Brisbane and Women’s Hospital (RBWH).  
 
Patients were classified according to the site of onset of disease (Limb-onset or bulbar-
onset) as well as handedness. The disease duration since onset of symptoms was also 
recorded. Disease severity was assessed every three months by the Revised ALS 
Functional Rating Scale (ALSFRS-R) (Cedarbaum, Stambler et al. 1999). MRI was 
performed at baseline, 6 months, and 12 months. Of 30 recruited patients, 30 
successfully underwent baseline MRI. Of these, 23 returned for 6-month follow-up, and 
15 returned for 12-month follow-up. Demographics are presented in Table 3.1. 
Cognitive examination (ACE-III and FAB) was administered every 6 months on the 
same day as the MRI. 
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Healthy controls 
Nineteen neurologically normal subjects with no current or previous history of 
neurological, medical or surgical conditions were recruited from the patients’ relatives 
and from the The university of Queensland Centre for clinical research (UQ-CCR) 
volunteer scheme. Controls had only a single MRI. 
Clinical Measures 
Amyotrophic Lateral Sclerosis Functional Rating (ALSRFS-R) 
Motor function was assessed with the revised Amyotrophic Lateral Sclerosis 
Functional Rating (ALSRFS-R) (Cedarbaum, Stambler et al. 1999). ALSFRS-R a 12-
item scale evaluating motor skills of ALS patients, including speech, breathing, 
swallowing, and walking and so on) (Cedarbaum, Stambler et al. 1999). Each item is 
scored from 0 to 4 (worst to best respectively). 
Addenbrooke’s Cognitive Examination (ACE)  
Addenbrooke’s Cognitive Examination (ACE), discussed in Chapter 1, was designed 
to survey key domains of cognitive function without the need for specialized equipment 
and to be sensitive to early stages of Alzheimer’s disease and FTD. It has been proven 
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that it detects cognitive impairment that causes cognitive decline. The sub scores are 
suggested to differentiate diagnosis between FTD and AD (Mathuranath, Nestor et al. 
2000, Davies and Larner 2013).  
 
Addenbrooke’s Cognitive Examination Revised (ACE-R) is the revised version of ACE 
which incorporates the MMSE and is intended to be quick to administer and acceptable 
to subjects. The overall score is 100 (Mioshi, Dawson et al. 2006). The authors created 
three different alternative versions of the name and address recall preventing recalling 
from previous clinical visits. However, ACE-III was developed to omit the MMSE 
items due to copy rights restrictions and modification is explained further in the 
methodology section. 
Frontal Assessment Battery (FAB) 
FAB is a test that was designed mainly to assess frontal lobe processes and identify the 
presence and severity of dysexecutive syndrome that affect both motor behaviour and 
cognitive function in several neurodegenerative diseases (Dubois, Slachevsky et al. 
2000). A global agreement amongst researchers validated FAB as a fast, short, and easy 
bedside battery that measure dysexecustive function (Slachevsky, Villalpando et al. 
2004, Maeshima, Tanemura et al. 2006).  
Systematic review 
A systematic review is a high level of evidence designed to summarizes the results of 
the available studies in the literature to provide judgments and recommendations for 
healthcare and research (Collaboration 1996). In this study, a research question was 
developed to investigate the WM tracts that were studies in ALS and FTD and pool the 
significant findings using DTI to report the shared tracts in both ALS and FTD. 
Therefore, a thorough search of the literature from five databases was performed on 
Dec 2015 with search terms that are discussed in detail in Chapter 4. The result papers 
were evaluated for inclusion criteria and eligibility by two raters (A.A and M.D) who 
also extracted the data.   
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MRI acquisition 
MRI data were acquired using a 3 T Siemens TimTrio, using the commercial sequences 
from VB17 Neuro application and Diffusion Tensor Imaging (DTI) and a 12–channel 
head coil. Along with a number of clinical radiological sequences, (a) a high resolution 
structural image using 0.44 mm3 isotropic 3D T1 MPRAGE ( TR=1900 ms, TE= 2.4 
ms, TI= 900 ms, FOV 24 × 25.6 × 17.6 cm, flip angle=9º), (b) diffusion images using 
the following parameters: 60 axial slices, TR=3200ms, TE=91ms, FOV 30x30 cm, 
acquisition matrix 128x128 with in-plane resolution=2.3 mm, slice thickness=2.5 mm, 
acceleration factor of 2 employing GRAPPA (Griswold, Jakob et al. 2002) were also 
acquired. Sixty-four non-collinear diffusion weighted images were acquired at b=3000 
s mm-2, along with one non-diffusion weighted image, and c) a field map was acquired 
using two 2D gradient-recalled echo images with TE1/TE2=4.92/7.3 and TR= 488 ms 
to assist in the correction of geometric distortions. The total scan time was 30–40 
minutes while subjects lie comfortably in supine position with supporting cushions and 
knee rest. The b value was chosen to allow detection of the crossing fibres. These 
parameters have been used in our previous DTI studies of MND (Rose, Pannek et al. 
2012).  
Preprocessing of diffusion images 
To obtain accurate diffusion results, adequate pre-processing steps for diffusion data is 
required. Figure 3.1 summarizes the workflow for diffusion data pre-processing 
suggested by Pannek et al (Pannek, Guzzetta et al. 2012), which was followed in this 
study. While this pre-processing workflow was initially developed for use with 
neonates, the same approach was followed here because motion artefacts are frequently 
observed in ALS patients who are often restless, due to their disease symptoms. 
 
Correction of image artefacts  
The following issues were considered and resolved: 
a) Quality of raw diffusion images was assessed visually. 
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b) Misalignment of the odd and even sub–volumes was detected using the 
discontinuity index (Nam and Park 2011). Affected volumes were removed 
from further analysis.  
c) Intensity inhomogeneity caused by magnetic field inhomogeneity in the static 
magnetic field B0 and the radiofrequency (RF) field B1 was corrected. The bias 
field was calculated from the non-diffusion weighted images using N3 and 
applied to unregistered diffusion images (Vovk, Pernus et al. 2007).  
d) Susceptibility distortions, which occur in echo planar imaging (EPI), were 
reduced using parallel imaging (GRAPPA). Residual distortions were corrected 
using a field map (http://www.fmrib.ox.ac.uk/fsl) (Jenkinson 2004, Wu, Chang 
et al. 2008).  
e) Misalignments due to physical motion were corrected by employing a rigid-
body registration using the fit model to all measurements (FMAM) method (Bai 
and Alexander 2008). The b-matrix was rotated to account for head motion 
(Leemans and Jones 2009).  
f) Outliers caused by bulk head motion and cardiac pulsation were corrected using 
a combination of higher order model outlier rejection (HOMOR) (Tournier, 
Calamante et al. 2012) and detection and replacement of outliers prior to 
resampling (DROP-R) (Morris, Nossin-Manor et al. 2011). 
g) The diffusion tensor was fit to the corrected diffusion images, and maps of 
FA, MD, AD, and RD were calculated.   




Figure 3.1: Preprocessing pipeline of diffusion data  
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MRI analysis 
 WM analysis 
Region of interest (ROI) 
Region of interest (ROI) analysis involves defining an area the WM which is used to 
obtain DTI measurements for this specific site. Typically, the structure in question is 
outlined manually. ROIs are usually defined on the colored FA maps or structural MR 
images and the structure is visualized to be at its thickest. Manual delineation of ROIs 
is operator-dependent, which can be time consuming in large cohort studies or when a 
large number of regions is examined. For reproducibility of results, the ROIs have to 
be drawn several times by the same operator, and ideally also by an independent 
operator.  
 
The placement of the ROI can have a significant effect on the results. Thus, one has to 
understand that ROI has several drawbacks which can be due to user bias and the low 
resolution. Moreover, there is significant variability in the diffusion measurements as a 
result of orientation of the plane and the positions of the slices in small structures 
(Snook, Plewes et al. 2007). It has been suggested that ROIs drawn following the shape 
of the structure (Schneider, Il’yasov et al. 2004, Snook, Paulson et al. 2005) may be 
preferred to placing circles or squares over ROI, especially when the area is large 
(Shimony, McKinstry et al. 1999, Abe, Aoki et al. 2002, Suzuki, Matsuzawa et al. 2003, 
Yoshiura, Mihara et al. 2005). The major limitation of ROI is the practicality of 
measuring many ROIs of the brain which introduces time constraints. Although 
previous studies suggest that voxel placement differs by less than a voxel (Ciccarelli, 
Parker et al. 2003), the manual method still suffer variability in the placement of ROIs. 
ROI placement relies on the operator’s level of anatomical knowledge and judgment 
which can be a concern about the intra- and inter-operator reproducibility (Heiervang, 
Behrens et al. 2006). To overcome this limitation, the automated ROI approach can be 
employed. Atlas-based ROI demonstrates a significant time savings with minimal 
difference in reproducibility over manual methods (Chow, Takeshita et al. 2007, Zhang, 
Zhang et al. 2010). In this study we used both manually outlined ROIs and atlas-based 
ROIs. 
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TBSS 
Tract-based spatial statistics (TBSS) (Smith, Jenkinson et al. 2006) is a “whole-brain” 
analysis method that was introduced by Smith et al as part of the FSL package. TBSS 
has gained interest due to the simplicity and user-friendly input. In contrast to typical 
voxel-based analyses, TBSS does not require smoothing of the data to improve signal 
to noise ratio, which can lead to arbitrariness. TBSS creates a skeleton which represents 
the center of the WM. This step allows any residual misalignment to be removed, which 
adds the advantage that TBSS does not require perfect registration. TBSS has been 
shown to enhance specificity (Bach, Laun et al. 2014). 
  
The steps required for running TBSS can be found at 
(http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/TBSS/UserGuide). Briefly, following 
preprocessing of diffusion images, all individual FA maps are aligned to the FMRIB58 
FA template. Registration accuracy is assessed visually. An FA “skeleton”, 
representing the centers of the WM tracts common to all subjects, is created. In this 
study, we employed an FA threshold of 0.2 for the skeletonisation, which is also the 
threshold recommended in the User Guide. FA values from all subjects are then 
projected onto this skeleton for statistical analysis. Although the skeleton is derived 
from FA values, other DTI measures such as MD, AD and RD can still be employed in 
the statistical analysis by applying the projection calculated for FA maps. 
 
Statistical analyses are performed for each voxel of the skeleton, with appropriate 
correction for multiple comparisons across space as described below (Winkler, 
Ridgway et al. 2014).  
 
GM analysis using Voxel–based morphometry (VBM) 
Voxel-based morphometry (VBM) is an automated method for analyzing structural MR 
images. VBM allows whole brain analysis without a priori hypothesis regarding the 
brain regions involved (Douaud, Smith et al. 2007). This standard approach was 
developed by Ashburner and Friston to compare GM volumes between two groups 
(Ashburner and Friston 2000). It has high sensitivity to GM atrophy and is available in 
different image analysis packages.  
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In this study, VBM is performed on T1–weighted images using the FSL–VBM toolbox 
(http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FSLVBM). Briefly, brain was extracted from all 
subjects’ data to exclude all non-brain tissue followed by a visual check of the 
extraction for every subject. GM was segmented before applying non-linear registration 
to the MNI 152 standard space which results in study-specific GM template in standard 
space (Andersson, Jenkinson et al. 2007). GM maps were averaged and flipped along 
the x-axis to create a left-right symmetric GM template. All native grey matter images 
were non-linearly registered to this study-specific template and "modulated" to correct 
for contraction or expansion. The normalized GM images were then smoothed with an 
isotropic Gaussian kernel which is developed to reduce Type 1 error (Worsley, Evans 
et al. 1992). VBM makes a simple and relatively fast approach to assessing small 
structural differences that is within the capabilities of most research units.  
 
Statistical analysis for TBSS and VBM 
To identify group differences in diffusion metrics using TBSS and VBM, we used the 
“randomise” tool of FSL (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/Randomise/UserGuide). 
With the assumption that each voxel represents the same anatomic location between 
subjects, VBM and TBSS perform a voxel-wise general linear model (GLM) statistical 
analysis across space is performed using permutation-based non-parametric testing. 
Correction for multiple comparisons to localize and make inferences about group 
differences was performed using threshold-free cluster enhancement (TFCE, (Smith 
and Nichols 2009)). TFCE is an approach to avoid the problem of thresholding selection 
in the context of cluster-based statistics. P-values were determined using 5000 random 
permutations (Nichols and Holmes 2002). Results were considered significant at 
p<0.05, corrected for multiple comparisons using TFCE. The end result shows regions 















The following chapters are written following the “paper-style”. Most of the chapters 
are either submitted and under review (Chapter 5), or manuscripts ready for submission 
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Chapter 4: White matter tracts shared 




This chapter consist of a manuscript titled “A Systematic Review of diffusion tensor 
imaging in amyotrophic lateral sclerosis and frontotemporal dementia: a study of white 
matter tracts”. Here, I address the first aim of this thesis, which is to determine the 
evidence of WM alterations in both ALS and FTD. Thus, the steps included developing 
the research question, setting the inclusion and exclusion criteria. Next, designing the 
searches of the databases, screening all titles and abstracts, and inspecting eligibility of 
the papers. Then extracted the required data and systematically summarized, interpreted 
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A Systematic Review of diffusion tensor imaging in 
amyotrophic lateral sclerosis and frontotemporal 
dementia  
Introduction: 
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized 
by the progressive death of upper and lower motor neurons. ALS is thought to arise 
from a combination of genetic susceptibility and environmental exposure (Fang, Kamel 
et al. 2009, Sutedja, Veldink et al. 2009). Patients with ALS develop weakness of the 
limbs, the bulbar muscles and the diaphragm (Kiernan, Vucic et al. 2011). There are 
clinical signs of dysfunction of both upper motor neurons (UMN) and lower motor 
neurons (LMN) (Miller, Gelinas et al. 2005).  
 
Frontotemporal dementia (FTD) is the term for progressive dementias characterized by 
cognitive and behavioral difficulties, with degeneration of the frontal and temporal 
lobes. FTD can be divided into behavioral variant, primary progressive aphasia and 
semantic dementia (Warren, Rohrer et al. 2013). Pathological studies allow the division 
of FTD into tauopathy and ubiquinopathy (Kertesz and McMonagle 2011) . 
 
A proportion of patients with ALS show cognitive impairment with subtle executive 
function deficits (Raaphorst, De Visser et al. 2010, Phukan, Elamin et al. 2012) and 10-
15% fulfill the criteria for diagnosis of frontotemporal dementia (FTD) (Ringholz, 
Appel et al. 2005). It is now considered that ALS and FTD lie on a pathological and 
clinical spectrum (Von Braunmühl 1932). Some causative genes are found in both ALS 
and FTD (Siddique and Deng 1996, Al-Chalabi, Jones et al. 2012, Pan and Chen 2013), 
with the most important so far identified being C9orf72 (Mori, Weng et al. 2013). Some 
pathological features are common to FTD, ALS-FTD and ALS (Ferrari, Kapogiannis 
et al. 2011), particularly TDP-43 pathology and possibly dipeptide repeats (Al-Chalabi 
and Hardiman 2013), which are found in many patients with ALS and patients with 
FTD with ubiquinopathy. An anatomical study has shown that behavioural disturbance 
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in patients with ALS is significantly associated with frontal lobe involvement 
(Tsujimoto, Senda et al. 2011).  
 
Pathological studies on autopsy material are done at the end stage of disease, whereas 
imaging studies allow the assessment of earlier stages of disease. Various neuroimaging 
modalities have been used to study ALS and FTD (Wang, Poptani et al. 2006) including 
diffusion tensor imaging (DTI), which is able to detect microstructural changes in fiber 
tracts(Uluğ, Moore et al. 1999, Hong, Lee et al. 2004). DTI is increasingly being used 
to show changes in fiber tracts in neurodegenerative diseases. Generally speaking, 
decreased diffusivity and increased diffusion anisotropy reflect greater structural 
organization and white matter (WM) structural integrity (Pannek, Guzzetta et al. 2012).  
 
There have been previous meta-analyses of DTI abnormalities in ALS. One study 
reported a voxel based meta-analysis of FA of 143 non-demented ALS patients from 7 
studies (Li, Pan et al. 2012). Another reported 170 patients from 9 studies, to determine 
a threshold for FA abnormality in the corticospinal tract (Rosskopf, Müller et al. 2015).  
 
Because some patients with ALS also have FTD or less severe cognitive defects, we 
expect there will be overlap of pathology (Yamada, Sakai et al. 2009). Brain regions 
that show abnormal DTI changes in both ALS and FTD may provide clues to 
elucidating the pathogenesis of ALS-FTD overlap. Here I aim to review the literature 
regarding the location and extent of white matter tract degeneration in ALS patients 
with and without FTD, and patients with pure FTD, to determine if there is overlap of 
the fiber tract involvement in these conditions. The studies in this review use various 
MRI measures making a meta-analysis impossible. This systematic review is a 
therefore a descriptive study. We also review the correlations of DTI measures with 
clinical status. 
Methods: 
Search strategy and key words 
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In December 2015, a systematic search was conducted of the databases; Pubmed 
Embase, CINAHL, Scopus and Web of Science.  
The search strategy used the medical subject heading (MeSH) terms and the keywords: 
“amyotrophic lateral sclerosis”, “ALS”, “frontotemporal dementia”, “FTD”, “cognitive 
impairment”, “diffusion tensor imaging”, “DTI”, “tractography”, and “white matter 
tracts”. These were then combined to limit the findings: [“amyotrophic lateral sclerosis” 
AND diffusion tensor imaging], [“Frontotemporal dementia” AND diffusion tensor 
imaging], [amyotrophic lateral sclerosis” AND tractography], [“Frontotemporal 
dementia” AND tractography], [“Frontotemporal dementia” AND white matter tracts], 
[amyotrophic lateral sclerosis” AND white matter tracts]. 
Selection criteria:  
Inclusion criteria: 1) studies were carried out in human subjects equal to or older than 
18 years of age; 2) subjects diagnosed with amyotrophic lateral sclerosis met the 
accepted El Escorial diagnostic criteria (Brooks, Miller et al. 2000); 3) subjects 
diagnosed with ALS-FTD or FTD fulfilled the Neary criteria for diagnosis of 
frontotemporal dementia (Neary, Snowden et al. 1998); 4) studies provided an adequate 
descriptions of the patient sample such as male: female ratio, age and whether the 
subjects had other neurological disorders or disease; 5) studies used diffusion tensor 
imaging (DTI) region of interest (ROI), tractography, or voxel-based analysis to assess 
white matter tracts by comparing DTI measures between patients and healthy controls; 
6) studies provided adequate description of the imaging protocol (MR sequence, b-
value, diffusion directions, threshold) and statistical data such as mean, and SD; 7) 
studies measured DTI metrics in specific white matter regions with defined coordinates.  
 
Exclusion criteria: 1) studies which included children and adolescents younger than 18 
years; 2) subjects who had associated neurological disorders or pathologic changes such 
as brain tumor, epilepsy or brain injury; 3) studies with fewer than 7 participants, 4) 
studies without healthy controls participants; 5) studies not published in English. 6) 
studies with missing data such as details about participants or imaging sequence. 7) 
studies assessed as low quality studies. 
Two independent raters (A.A and M.D) assessed eligibility based on the title and 
abstract of each study. Then a full screening of references was performed for inclusion. 
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Assessment of methodological quality  
Two raters (Ashwag Alruwaili, Mathew Devine) independently assessed the quality of 
each study according to the quality of diagnostic accuracy studies (QUADAS) criteria 
(Whiting, Rutjes et al. 2003). Each criterion was scored “yes”, “no” or “unclear”. A 
score of 7-10 of 14 is considered to be a high quality study. 
Data extraction   
The details of data extracted from all eligible studies included: a) total number of 
participants, 2) the imaging sequences (field strength, b-value, number of directions, 
smoothing and FA threshold), 3) WM analysis type (ROI, VBA, tractography), 4) DTI 
metrics (FA, MD, AD, RD) and, 5) the brain regions studied. 
 Selection of tracts for inclusion in figures 
To create a visual representation of the tracts that are abnormal in ALS and FTD, we 
selected tracts that were reported as being significantly abnormal in more than 66% of 
the studies that assessed them. These are the tracts for which the evidence is strongest. 
Selection of these tracts was based on results of FA, because this measure was used 
most consistently across the different studies. 
 Results  
 Overall summary and participant characteristics 
 
As shown in Figure 4.1, of 233 papers, a total of 64 studies met the criteria for full 
review. These papers reported on a total 1674 patients (ALS N=1192, FTD N=458 and 
ALS-FTD N=24) and 1411 healthy controls. The extracted data are given in Supp Table 
4.1. Table 4.1 summarizes the information about the number of participants in each 
clinical category. For the studies of ALS, the total patient number was 1192, with 991 
controls. For the studies of FTD there were 458 subjects and 420 controls. In addition, 
two paper studied ALS with FTD (n=24). 
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Table 4.2 summarizes the use of different techniques to analyze white matter changes 
in ALS, FTD and ALS-FTD. These were regions of interest (ROI, n=23), tractography 
(n=15), tract-based spatial statistics (TBSS, n=22), and tract of interest (TOI, n=2). 
There were also studies that used mixed analysis (n=14). 
 
Table 4.1: Details of participants. 
Disease studied No of papers No of patients No of controls 
ALS 43 1192 991 
FTD 20** 458 420 
ALS and FTD 2 24 * 
* Controls included in the main ALS studies controls column. 
** Three ALS papers have included ALS-FTD subjects (so total of 23 studies). 
 
Table 4.2: Summary of WM analysis. 
Disease 
studied 
No. of studies using each technique  
 ROI Tractography TBSS TOI Mixed 
ALS 16 12 15 1 11* 
FTD 7 3 6 1 3** 
ALS and FTD - - 1 - - 
*1 ROI+TBSS+ Tractography, 3 ROI+TBSS, 3 TBSS+Tractography, 1 ROI + Tractography, 1TOI+ROI 
** 1 TOI+VWA, 1 canonical correlation analysis, 1 ROI+TBSS  







Total search of 5 databases (Sep 2014) 
Duplicate deleted. 




2 non English 
2 Less than 7 patients 
12 irrelevant 
12 conference, or poster paper 
N=64  Included full text Articles 
 Figure 4.1: Pipeline of inclusion of studies. 
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DTI in ALS: 
A summary of the number of papers that studied each tract, and the number of these 
papers that found significant abnormalities in each tract using FA is provided in Table 
4.3. The full details of the extracted data are presented in Supp Table 4.1. In the 
following sections, we mostly describe the studies that found significant results from 
DTI measures. The non-significant findings are presented in each table but not within 
the text. The full details of the studies with both positive and negative results, for each 
class of white matter fibers, are presented in Tables 4.4–4.7. A visual summary of the 
WM tracts that were found to be significant in ALS studies is presented in Figure 4.2. 
The details of the clinical correlations of the DTI results for each MRI metric are given 
in Supp Tables (4.2–4.6). 
  
Figure 4.2: Visual representation of WM tracts that were found significant in 
ALS studies. 
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Whole brain analysis 
Six studies performed whole brain analysis (Lillo, Mioshi et al. 2012, McMillan, Brun 
et al. 2012, Pettit, Bastin et al. 2012, Prudlo, Bissbort et al. 2012, Sarica, Cerasa et al. 
2014, Trojsi, Caiazzo et al. 2015). Whole brain TBSS found significant changes in FA 
and MD in the SLF bilaterally (Sarica, Cerasa et al. 2014, Trojsi, Caiazzo et al. 2015). 
Based on the clinical staging system for ALS, proposed by Roche et al. (Roche, Rojas-
Garcia et al. 2012) (refer to appendix for details), a longitudinal study revealed that the 
body of CC shows reduced FA in stage 2A, and reduced FA and increased MD and RD 
in stage 3, compared to controls (Trojsi, Caiazzo et al. 2015). A different study found 
that the FA in the SLF, ILF and IFOF was reduced in ALS patients compared to controls 
(Prudlo, Bissbort et al. 2012). In both bulbar and limb onset ALS compared to controls, 
CST showed reduced FA along the tract (Cardenas-Blanco, Machts et al. 2014). One 
study reported that ALS patients showed more degeneration in the CST than in callosal 
and association tracts compared to controls (Lillo, Mioshi et al. 2012). While this was 
not the case when the same ALS subjects were compared to FTD and ALS-FTD 
patients, TBSS results shows less CST involvement than extra-motor tracts (Lillo, 
Mioshi et al. 2012).  
ROI and Tractography analysis 
Projection Fibers 
Corticospinal tract (CST) degeneration is a hallmark of ALS and hence the CST was 
studied in ALS frequently. The studies that found significant and non-significant results 
are given in Table 4.4 and a summary in Figure 4.2. 
 
Apart from the study of Grapperon et al who reported an increase in FA (Grapperon, 
Verschueren et al. 2014), all other studies found reduction of the average FA over the 
entire CST(Abe, Yamada et al. 2004, Karlsborg, Rosenbaum et al. 2004, Iwata, Aoki 
et al. 2008, Sarro, Agosta et al. 2011, Tsujimoto, Senda et al. 2011, Lillo, Mioshi et al. 
2012, Pettit, Bastin et al. 2012, Prudlo, Bissbort et al. 2012, Agosta, Caso et al. 2013, 
Bastin, Pettit et al. 2013, Rajagopalan, Yue et al. 2013, Trojsi, Corbo et al. 2013, Crespi, 
Cerami et al. 2014, Floeter, Katipally et al. 2014, Kassubek, Müller et al. 2014, 
Prokscha, Guo et al. 2014) as well as at different levels along the tract (Toosy, Werring 
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et al. 2003, Karlsborg, Rosenbaum et al. 2004, Mitsumoto, Ulug et al. 2007, 
Rajagopalan, Yue et al. 2013, Hübers, Müller et al. 2015). This was more apparent in 
the right CST (Sarica, Cerasa et al. 2014) with RD increase (Zhang, Schuff et al. 2009), 
superiorly (Bede, Bokde et al. 2013) caudally (Zhang, Yin et al. 2014, Hübers, Müller 
et al. 2015) and rostrally (Filippini, Douaud et al. 2010) and with MD increases (Toosy, 
Werring et al. 2003, Prudlo, Bissbort et al. 2012, Floeter, Katipally et al. 2014) at the 
level of the internal capsule (Sach, Winkler et al. 2004). One study found changes in 
CST in familial ALS (fALS) but not in sporadic ALS when compared to controls 
(Mitsumoto, Ulug et al. 2007). In both bulbar and limb onset ALS compared to controls, 
CST showed reduced FA and exhibited in higher RD and MD when using ROI 
(Cardenas-Blanco, Machts et al. 2014). Some other groups reported significant changes 
in RD (Menke, Körner et al. 2014, Zimmerman‐Moreno, Ben Bashat et al. 2015, 
Vora, Kumar et al. 2016) and AD (Menke, Körner et al. 2014) along the CST 
(Kassubek, Müller et al. 2014, Menke, Körner et al. 2014). Steinbach et al found 
connectivity indices1 to be significantly reduced along the tract (Steinbach, Loewe et 
al. 2015). The motor pathway was also studied at the level of internal capsule (PLIC) 
(Kasper, Schuster et al. 2014, Vora, Kumar et al. 2016) and corona radiata where it was 
found to have significantly reduced FA (Agosta, Caso et al. 2013, Agosta, Galantucci 
et al. 2015) and increased RD (Sarica, Cerasa et al. 2014) and MD (Pettit, Bastin et al. 
2012, Sarica, Cerasa et al. 2014, Agosta, Galantucci et al. 2015). Some studies 
investigated the CST at the level of pons (Toosy, Werring et al. 2003, Iwata, Aoki et 
al. 2008, Sheelakumari, Madhusoodanan et al. 2015) and found significantly reduced 
FA and increased MD. In the CST, Romano et al found significantly reduced FA and 
increased MD and RD, but no changes in AD (Romano, Guo et al. 2014). Another 
group classified ALS participants based on a staging system (Roche, Rojas-Garcia et 
al. 2012) and found reduced FA in left rostral CST in stages 2A; at diagnosis, and 3; 
when a third body region was involved (Trojsi, Caiazzo et al. 2015). The changes in 
the latter stage involved more DTI metrics such as higher MD and RD (Trojsi, Caiazzo 
et al. 2015). 
                                                 
1 Index of structural connectivity (CI) is the proportion of plausible paths connecting two ROIs, 
averaged across tractography directions. 
 
63  Alruwaili thesis 2016 
 
 
The correlations of DTI measures with quantitative clinical measures are shown in Supp 
Tables 4.2–4.6. In ALS, increased AD (Menke, Körner et al. 2014), MD (Menke, 
Körner et al. 2014) and RD (Menke, Körner et al. 2014) and decreased FA along the 
CST were associated with higher UMN scores (Abe, Yamada et al. 2004, Iwata, Aoki 
et al. 2008, Filippini, Douaud et al. 2010, Trojsi, Corbo et al. 2013, Menke, Körner et 
al. 2014, Woo, Wang et al. 2014). Longer disease duration correlated with increased 
FA (Filippini, Douaud et al. 2010) and AD (Rajagopalan, Yue et al. 2013). Reduced 
FA along the CST correlated positively with delayed central motor conduction time 
(CMCT) and cortical-brainstem conduction time (CTX-BS) (Iwata, Aoki et al. 2008), 
but negatively with disease progression (Bastin, Pettit et al. 2013). Disease progression 
correlated with increased RD when using ROI (Menke, Körner et al. 2014) and 
correlated negatively with reduced connectivity indices (Steinbach, Loewe et al. 2015). 
In many studies (Furtula, Johnsen et al. 2013, Grapperon, Verschueren et al. 2014, 
Woo, Wang et al. 2014) there was no significant correlation between DTI metrics and 
clinical features such as forced vital capacity (FVC) and site of onset (Pettit, Bastin et 
al. 2012). Changes in FA (Woo, Wang et al. 2014), RD and MD were negatively 
correlated with ALSFRS-R (Sarica, Cerasa et al. 2014) in the right CST. The latter 
study found that there was a trend towards significant correlation between ALSFRS-R 
scores and FA (Sarica, Cerasa et al. 2014). Other studies found no correlation between 
FA and ALSFRS-R and disease duration (Furtula, Johnsen et al. 2013, Woo, Wang et 
al. 2014) or disease progression (Trojsi, Corbo et al. 2013). 
 
When using cognitive examination, it was found that reduced FA correlated with 
reduced letter fluency (Pettit, Bastin et al. 2012) and negatively with frontal system 
behavior scale (FrSBe) score at the level of pontomesencephalic junction (Trojsi, Corbo 
et al. 2013). Reduced FA along CST correlated with Trail-making test scores (Sarro, 
Agosta et al. 2011) and Stroop test scores (Sarro, Agosta et al. 2011). 
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Association Fibers 
Studies finding both significant and non-significant results for each of the association 
fiber tracts in ALS are presented in Table 4.5 and Figure 4.2.  
 
There were widespread changes in the association fibers in ALS. Sarro et al found 
increased MD, AD and RD bilaterally in the SLF but no changes in FA (Sarro, Agosta 
et al. 2011). ROI analysis revealed changes in DTI metrics such as MD in the uncF and 
decreased FA in ILF (Pettit, Bastin et al. 2012) and right SLF with increased RD and 
MD (Menke, Körner et al. 2014). Many studies found that reduced FA was greatest in 
SLF (Agosta, Caso et al. 2013) and IFOF (Borroni B and et al. 2007). When cognitively 
impaired ALS (ALSci) were compared to controls and non-impaired counterparts, 
increased RD and MD were observed in the SLF, IFOF and uncF bilaterally while 
reduced FA were seen only when ALSci were compared to controls (Kasper, Schuster 
et al. 2014). Tractography in ALS showed increased AD in uncF compared to controls 
(Christidi, Zalonis et al. 2014). In later stages of ALS, more association fibers were 
involved in DTI changes than in the early stages (Trojsi, Caiazzo et al. 2015).While 
one study found reduced generalized FA2 in the left SLF (Trojsi, Corbo et al. 2013), 
another study also studied the arcuate fasciculus but found no significant changes in 
FA, MD or RD (Bastin, Pettit et al. 2013). 
 
The correlations of DTI measures with quantitative clinical measure in ALS are 
summarized in Supp Tables 4.2–4.6. Using ROI, RD in the right SLF correlated with 
ALSFRS while both FA and RD correlated with disease progression (Menke, Körner 
et al. 2014). In regression analysis, reduced FA in bilateral IFOF and ILF was shown 
to negatively correlate with Trail-making test scores while the right IFOF and ILF 
associated with Stroop test scores (Sarro, Agosta et al. 2011). Negative correlation of 
DTI metrics with UMN scores and Frontal Systems Behavior Scale (FrSBe) was found 
in the SLF (Trojsi, Corbo et al. 2013). Crespi found an association between specific 
                                                 
2 The generalized fractional anisotropy (GFA) was calculated as GFA = std(ψ)/rms(ψ), where std is the 
standard deviation and rms is the root-mean-square. 
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emotional recognition and FA, MD and mode of anisotropy 3 along the right ILF and 
IFOF but positive correlation with the cumulative scores of single negative emotions 
(Crespi, Cerami et al. 2014). 
  
                                                 
3 Mode of anisotropy is a recently developed measure of anisotropy providing information about the 
shape of the tensor.  
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Subcortical WM (Limbic tracts) 
 
Studies showing significant and non-significant changes in DTI metrics in limbic tracts 
are presented in Table 4.6 and Figure 4.2. 
 
There were widespread changes in the limbic tracts in ALS. There was reduced FA in 
the thalamus (Pettit, Bastin et al. 2012, Heimrath, Gorges et al. 2014), more significant 
on the right side (Sach, Winkler et al. 2004) and anteriorly (Trojsi, Corbo et al. 2013, 
Sarica, Cerasa et al. 2014). The hippocampus, thalamus and anterior cingulum were 
found to have increased RD (Cardenas-Blanco, Machts et al. 2014) and MD 
(Barbagallo, Nicoletti et al. 2014) in ALS specifically when using ROI-based methods 
(Kasper, Schuster et al. 2014), which was found to be correlated with reverse digital 
span (Pettit, Bastin et al. 2012). The average FA of the fornix was also reported to be 
reduced (Trojsi, Corbo et al. 2013). The amygdala was found by one group to have 
increased MD, which was negatively correlated with ALSFRS-R (Barbagallo, Nicoletti 
et al. 2014). ROI analysis showed significant changes in FA and MD in the thalamic 
radiation in the frontal region (Pettit, Bastin et al. 2012). Agosta et al reported similar 
changes when comparing ALS versus primary lateral sclerosis (PLS) (Agosta, Caso et 
al. 2013). One study found widespread reduction in FA and increase in MD in WM 
subcortical structures (Floeter, Katipally et al. 2014). In ALS patients at stage 3, where 
a third body region is involved, DTI metrics showed significant changes in thalamic 
radiation (ThR) (Trojsi, Caiazzo et al. 2015). When comparing ALS with their 
counterparts who had cognitive impairment, increased RD and MD were seen in ThR 
and Cg in ALSci (Kasper, Schuster et al. 2014). 
 
The results of clinical correlation of DTI measures with clinical features of ALS in 
subcortical white matter tracts are summarized in Supp Tables 4.2–4.6. Modified Card 
Sorting Test (MSCT) and frontal assessment battery (FAB) scores were found to 
correlate with MD in WM tracts in caudate nucleus, amygdala and hippocampus in 
ALS (Barbagallo, Nicoletti et al. 2014). FA and MD in the fornix correlated with verbal 
learning and memory test scores (Filippi, Agosta et al. 2011). In the parahippocampal 
tract and the left thalamic radiation, increased FA correlated with increased apathy 
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score on Frontal Systems Behavior Scale (FrSBe) (Tsujimoto, Senda et al. 2011). MD 
in the thalamus correlated positively with disease duration and negatively with 
ALSFRS-R (Barbagallo, Nicoletti et al. 2014).  
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Studies showing both significant and non-significant changes in DTI metrics in 
commissural fiber tracts are presented in Table 4.7 and Figure 4.2. 
 
Widespread changes in commissural fibers were reported. Reduced FA in the CC was 
found when comparing ALS and ALS-FTD group with controls (Lillo, Mioshi et al. 
2012). Others reported the reduction in FA to be more dominant in the genu (Bastin, 
Pettit et al. 2013, Bede, Bokde et al. 2013) of the CC, forceps minor and major (Prudlo, 
Bissbort et al. 2012) but the body of the CC showed more changes when classic ALS 
patients were compared with controls (Prudlo, Bissbort et al. 2012, Agosta, Galantucci 
et al. 2015, Tang, Chen et al. 2015). Most studies found reduced FA in the CC (Sach, 
Winkler et al. 2004, Kasper, Schuster et al. 2014).  
 
Increased MD (Sarro, Agosta et al. 2011, Trojsi, Caiazzo et al. 2015, Vora, Kumar et 
al. 2016) and RD (Kasper, Schuster et al. 2014, Zimmerman‐Moreno, Ben Bashat et 
al. 2015) were reported in few studies. Prudle et al found that both forceps major and 
minor showed reduced FA in all ALS subtypes when using ROI analysis (Prudlo, 
Bissbort et al. 2012). When ROI is used, the genu and splenium of CC reflected 
significant reduction in the FA in ALS group (Vora, Kumar et al. 2016).  
 
When not corrected for multiple comparisons, reduced FA showed weaker correlation 
with ALSFRS-R, but higher RD correlated with clinical scores such as UMN scores 
and ALSFRS-R (Filippini, Douaud et al. 2010). No correlations was found in the CC 
with ALSFRS-R or UMN scores (Filippini, Douaud et al. 2010). Sarro et al found that 
the changes in FA and MD in the CC correlated with the results of neuropsychological 
tests such as the Trail-making test scores and Stroop test which also correlated with the 
FA in the CC (Sarro, Agosta et al. 2011).  
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Table 4.7: Studies of FA in the callosal radiation, which studied the callosal tracts. 
 
  Corpus callosum Forceps Minor Forceps major 
 Sig P None Sig P None Sig P None 




## Lillo (2012) -  Woo (2014) 
Sach (2004) ^ Pettit 
(2013) 
  Crespi 
(2014) 
-  Sarica(2014) 
Zhang (2014) * Iwata 
(2008) 
       
Kim (2014) * Sarro 
(2011) 
        
Trojsi (2013) *          
Bastin 
(2013)*** 
          
Agosta (2011) *          
Floeter (2014) *          
Agosta (2013) *M          
Crespi (2014) *          
Sarica(2014) *          
Bede (2013) *          
Filippini 
(2010) 
*          
Agosta (2015) *P          
 Kasper (2014) *        
FTD Lillo (2012) *A Chen 
(2009) 
Lillo (2012) * Hornberger 
(2011) 
 Irish et 
al (2014) 
*  
Zhang (2013)  Whitwell 
(2010) 
Irish et al (2014) *     
Zhang (2009) +A Bozzali 
(2013)  
 Tovar-Moll et 
al (2014) 
*      
Avants (2010)  *A Hornberger 
(2011) 
        
Borroni (2007) *          
Zhang (2011) ^^A          
McMillan 
(2012)  
$$$A          
Matsuo (2008) $$$          
Agosta (2015) *        
          
 p < 0.05, ** at p < 0.005 uncorrected, ***at p≤0.03, $p=0.07, #p=0.02, ##p≤0.001, ###p<0.04, $$p=0.002, $$$p≤0.01, 
^p<0.01 uncorrected, ^^p<0.001 uncorrected, +p<0.002, ++P<0.003, +++p<0.0001 
Rright, Lleft, Aanterior, Pposterior, Mmid 
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Brain stem tracts 
 
Studies showing significant and non-significant results in DTI metrics in brain stem 
tracts are presented in Table 4.8 and Figure 4.2. 
 
Significant changes in FA were found in most of brainstem tracts; medulla oblongata 
(MD but not FA) (Sheelakumari, Madhusoodanan et al. 2015), cerebral peduncle 
(Sheelakumari, Madhusoodanan et al. 2015, Tang, Chen et al. 2015), and basis pontis 
(Iwata, Aoki et al. 2008). Reduced FA was reported in the left medullary pyramid 
(Vora, Kumar et al. 2016) and bilaterally in cerebellar peduncle (CP) (Tang, Chen et 
al. 2015) in ALS compared to controls. Bede et al divided ALS subjects based on results 
of testing for C9orf72 hexanucleotide repeats (C9+ve and C9–ve) and found that WM 
exhibited changes in the cerebellar pathways in both groups (Bede, Bokde et al. 2013). 
In another study comparing ALS versus primary lateral sclerosis (PLS), increased MD 
was found in the bilateral middle CP (Sheelakumari, Madhusoodanan et al. 2015) and 
transverse pontine fibers (Floeter, Katipally et al. 2014). Reduced FA in the medulla 
oblongata correlated with higher UMN scores in ALS patients (Iwata, Aoki et al. 2008). 
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DTI in FTD 
A summary of the number of papers that studied each tract, and the number of these 
papers that found significant abnormalities in each tract using FA is provided in Table 
4.3. A visual summary of the WM tracts that found to be significant in FTD studies is 
presented in Figure 4.3.  
Whole brain analysis 
Nine whole-brain studies of FTD were included (Zhang, Schuff et al. 2009, Agosta, 
Scola et al. 2011, Hornberger, Geng et al. 2011, Lillo, Mioshi et al. 2012, Zhang, 
Tartaglia et al. 2013, Lam, Halliday et al. 2014, Tovar-Moll, de Oliveira-Souza et al. 
2014, Agosta, Galantucci et al. 2015, Downey, Mahoney et al. 2015). When FTD 
patients were compared to ALS and ALS-FTD patients, TBSS revealed significant 
changes involving the callosal tracts; the forceps minor, and ILF than in CST (Lillo, 
Mioshi et al. 2012). Reduced FA and increased MD were also found in CC, 
orbitofrontal, occipital and frontoparietal WM in behavioral variant FTD (bvFTD) 
subjects when compared to controls (Agosta, Scola et al. 2011, Agosta, Galantucci et 
al. 2015). The most pronounced white matter degeneration in FTD patients was seen in 
the anterior callosal region (Zhang, Schuff et al. 2009). Increases in RD and AD were 
similar and shown to be sharing the same regions when FTD were compared to controls. 
These regions included; anterior callosal region, fornix (Agosta, Scola et al. 2011) and 
bilateral uncF (Zhang, Schuff et al. 2009). Changes in FA and AD in uncF were found 
when comparing FTD versus healthy controls (Zhang, Schuff et al. 2009). It has been 
reported that FA changes were mostly dorsal and ventral when comparing bvFTD 
versus controls in voxel-wise analysis (Tovar-Moll, de Oliveira-Souza et al. 2014) and 
whole brain TBSS (Downey, Mahoney et al. 2015). Longitudinal study have 
documented that DTI changes involved the callosal, association and cingulate tracts in 
bvFTD and that WM changes overlap GM atrophy (Lam, Halliday et al. 2014). 
Reduced FA correlated negatively with Hayling task and neuropsychiatric inventory 
disinhibition in UncF (Hornberger, Geng et al. 2011). Abnormalities in CR and ALIC 
were also reported when using voxel-wise analysis (Tovar-Moll, de Oliveira-Souza et 
al. 2014). External capsule and IC were found to have reduced FA but increased RD 
(Agosta, Scola et al. 2011). Some studies reported that RD shows more regions than 
other DTI metrics in FTD group (Zhang, Schuff et al. 2009, Lam, Halliday et al. 2014).  
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ROI and Tractography analysis 
Projection Fibers 
Table 4.4 shows all the studies that involved projection fibers. Decreased FA bilaterally 
in the overall CST was reported in two studies (Lillo, Mioshi et al. 2012, McMillan, 
Brun et al. 2012), but more specifically in the left in one study (Borroni B and et al. 
2007). FA was found to be reduced at the level of both cerebral peduncles (CP) (Agosta, 
Scola et al. 2011, Mahoney, Beck et al. 2012) and corona radiata (CR) with increased 
AD (Borroni B and et al. 2007, Agosta, Scola et al. 2011) and RD on the right CST 
(Zhang, Schuff et al. 2009). However, other studies reported increased FA along the 





Figure 4.3: Visual representation of WM tracts that were found significant in 
FTD studies. (CST was removed for better visualization of other tracts). 
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Although severe degeneration across the motor system was found when comparing 
bvFTD with controls and ALS patients (Bae, Ferguson et al. 2016), another study 
reported the CST to be the least affected tract in bvFTD (Daianu, Mendez et al. 
2015).The only study that addressed DTI correlations showed that in FTD, reduced FA 
correlated with cortical thickness (Avants, Cook et al. 2010). 
Association Fibers 
Table 4.5 shows FTD studies that included association fibers. Reduced FA was reported 
in all papers that investigated the SLF (Borroni B and et al. 2007, Avants, Cook et al. 
2010, Whitwell, Avula et al. 2010, McMillan, Brun et al. 2012). This reduction in FA 
was associated with increased RD in both the SLF and ILF particularly in the anterior 
regions (Whitwell, Avula et al. 2010). Reduced FA was also reported in the right SLF 
in fontal variant FTD (fvFTD) and left SLF in temporal variant FTD (tvFTD), 
bilaterally in ILF and IFOF when compared to controls while changes were bilateral in 
the ILF and IFOF (Borroni, Brambati et al. 2007). Changes in uncF were mostly frontal 
and temporal when comparing bvFTD versus controls in ROI (Tovar-Moll, de Oliveira-
Souza et al. 2014). 
 
When comparing bvFTD versus controls, DTI revealed abnormalities in most of the 
association fibers bilaterally (Irish, Hornberger et al. 2014, Tovar-Moll, de Oliveira-
Souza et al. 2014, Daianu, Mendez et al. 2015). This was noted even with longitudinal 
studies that showed changes of DTI metrics at base line in regions of ILF, IFOF and 
uncF (Mahoney, Simpson et al. 2015). SLF and ILF had increased MD and AD after 
12 months (Lam, Halliday et al. 2014). Rate of changes4 in DTI metrics in uncF were 
significant when bvFTD compared to controls in a longitudinal study (Mahoney, 
Simpson et al. 2015).  
 
WM changes in the SLF, IFOF, uncF and ILF correlated with cortical thickness in FTD 
(Avants, Cook et al. 2010). A negative correlation was reported between FA in SLF 
and behavioural and neuropsychological examinations (Borroni, Brambati et al. 2007). 
                                                 
4 Was calculated based on the time from baseline scan in years, and interaction between disease group 
and time included to provide estimates of differences in the rate of change as a percentage per year. 
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Remote ABM retrieval correlated significantly with FA in the left uncF (Irish, 
Hornberger et al. 2014). DTI measures in the uncF correlated with NPI-aberrant motor 
behavior sub-score especially in the frontal part (MD and FA) and temporal part (FA) 
(Tovar-Moll, de Oliveira-Souza et al. 2014), Supp Table 6.  
 
Subcortical WM (Limbic tracts) 
All FTD studies that included limbic tracts are shown in Table 4.6. Reduced FA and 
increased MD were found in the frontotemporal subcortical WM structures such as 
fornix, anterior ThR (Irish, Hornberger et al. 2014) and cingulum (Floeter, Katipally et 
al. 2014, Irish, Hornberger et al. 2014, Tovar-Moll, de Oliveira-Souza et al. 2014), but 
significant changes in the latter were seen only in FA in the bvFTD group when 
compared to controls (Agosta, Scola et al. 2011).  
 
When using TOI, the fornix exhibited changes in FA, AD and MD (Zhang, Tartaglia et 
al. 2013). One study reported increased RD and AD in parahippocampal cingulum 
(Zhang, Tartaglia et al. 2013). Right parahippocampal cingulum showed changes in all 
assessed DTI metrics in a cross-sectional DTI study that compared bvFTD and controls 
(Mahoney, Simpson et al. 2015). MD was reported to be increased in ThR and Cg in 
bvFTD group compared to controls (Daianu, Mendez et al. 2015). At baseline, when 
comparing bvFTD and controls, all DTI measures reflected significant changes in the 
anterior ThR and Cg but this was not reported after 12 months (Lam, Halliday et al. 
2014). FA changes in the right anterior ThR and fornix had positive correlation with 
cognitive performance in bvFTD patients (Downey, Mahoney et al. 2015). In bvFTD, 
DTI changes in the posterior Cg, the parahippocampal part (paraHpc), correlated with 
NPI-apathy subscores (MD, p<0.01), and Mattis total scores (MD and FA, p<0.05) 
(Tovar-Moll, de Oliveira-Souza et al. 2014).  
 
Commissural fibers 
FTD studies that investigated commissural fibers are shown in Table 7. There was 
reduced FA in the CC (Matsuo, Mizuno et al. 2008, Avants, Cook et al. 2010, Whitwell, 
Avula et al. 2010, Lillo, Mioshi et al. 2012, McMillan, Brun et al. 2012) and more 
anteriorly when not corrected for multiple comparisons (Zhang, Schuff et al. 2011). 
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Increased MD was reported when comparing a small group of seven FTD subjects with 
controls (Chen, Lin et al. 2009). Changes in DTI metrics were found in the CC in most 
of the fronto-temporal lobar degeneration (FTLD) subgroups (Agosta, Scola et al. 
2011). However, in the bvFTD group, when compared to controls, there were changes 
in FA, MD and AD (Agosta, Scola et al. 2011). Reduced FA in left CC was reported in 
tvFTD when compared with healthy controls (Borroni, Brambati et al. 2007). At 
baseline, all DTI metrics exhibited significant changes in the genu of CC, while after 
12 months the significant changes in FA and RD extended to bilateral splenium of CC 
(sCC) (Lam, Halliday et al. 2014). Similar results were reported in bvFTD with all DTI 
measures in the frontal WM including gCC while this was not observed in sCC (Lu, 
Lee et al. 2014). Others reported the DTI changes to be in the bCC, bilaterally, in both 
cross-sectional and longitudinal DTI studies (Lam, Halliday et al. 2014) but the rates 
of change in FA and MD at later stage involved the bCC for FA, RD, MD and AD only 
in the c9orf72 group. All assessed DTI metrics showed significant changes in the sCC 
(Mahoney, Simpson et al. 2015). Using tractography in bvFTD subjects, the genu of 
CC shows altered diffusion anisotropy (Daianu, Mendez et al. 2015). DTI changes in 
CC were mostly dorsal and ventral in bvFTD compared to controls (Downey, Mahoney 
et al. 2015). With ROI, FA and MD changes in sCC were found to be significant in 
FTD group compared to controls. Similar results were seen when using voxel-wise 
analysis (Tovar-Moll, de Oliveira-Souza et al. 2014). 
 
Behavioral variables were found to be associated with DTI measures in gCC (Lu, Lee 
et al. 2014). Lillo et al found that FA changes in the anterior CC and forceps minor 
occurred in the bvFTD and ALS-FTD subjects when compared to other patient 
subgroups and controls but minimal changes in these regions were evident when 
comparing the pure ALS patients and healthy controls (Lillo, Mioshi et al. 2012). 
Within bvFTD group, impairment of emotion identification impairment was associated 
with WM alteration in CC (Downey, Mahoney et al. 2015). 
 
Brain stem tracts 
A total of three FTD studies examined DTI changes in brain stem, Table 4.8. Significant 
changes in FA was found in the bvFTD group in the CP when compared with healthy 
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controls only with FA but not with other DTI metrics (Agosta, Scola et al. 2011). The 
FTD group, who was C9ORF72 positive, had reduced FA in the superior CP compared 
to controls (Mahoney, Simpson et al. 2015). 
Overlap between ALS and FTD 
This review aimed to determine the overlap between ALS and FTD, and also to 
demonstrates the differences between ALS and FTD. The SLF, ILF, IFOF, UncF, ThR, 
Cg, Fx and CC were found to be abnormal in 50% or more of the studies in ALS and 
FTD. There was strong evidence of involvement of uncF in FTD, but only a minority 
of studies found abnormality of uncF in ALS. There were abnormalities in the cingulum 
and IFOF in both ALS and FTD, and forceps minor was reported to be abnormal in 
minority of studies of ALS but more evident in FTD studies. As shown in Table 4, there 
is extensive evidence that the CST was abnormal in ALS, and less evidence in FTD, 
where there were fewer studies that only examined the average FA of the whole CST. 
However, two studies have reported CR to show significant changes in FTD.  
 
Figures 4.2–4.4 show the tracts that were abnormal in ALS, FTD and in both ALS and 
FTD, respectively, using tracts that were abnormal in more than 66% of studies, where 
the evidence is strongest.  
 




Figure 4.4: Visual representation of WM tracts that are found to be significant 
and shared in both ALS and FTD studies. 
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Discussion 
DTI is a promising method to assess upper motor neuron dysfunction (Wang, Melhem 
et al. 2011, Turner, Agosta et al. 2012) and changes in frontal lobe function (Naik, 
Lundervold et al. 2010). We have systematically reviewed the abnormalities that are 
reported in ALS and in FTD using DTI. We report data obtained from 1674 patients 
across 64 studies. All studies have reported the results of FA; however, the other DTI 
measures were not consistently analyzed across all studies. Because there is an overlap 
of clinical features between ALS and FTD, we expected that there would be overlap of 
the white matter tracts involved. There have been previous meta-analyses of DTI 
abnormality in ALS (Foerster, Dwamena et al. 2012, Li, Pan et al. 2012). There are no 
previous systematic reviews of DTI in FTD. We were not able to obtain the raw data 
for most of these studies, and the studies varied in the use of sequences and in the 
techniques for analysis of the data, so we have made a comparison of the abnormalities 
that were reported. 
 
DTI measures were variously obtained using ROI, TBSS, tractography and other 
methods. ROI is susceptible to inclusion of cerebrospinal fluid (CSF) or gray matter 
(GM) (Snook, Plewes et al. 2007). TBSS is considered to be the standard approach for 
voxel-based analysis (VBA) of DTI data (Smith, Jenkinson et al. 2006), but has 
drawbacks as described previously such as misalignment and alteration in the thickness 
of the skeleton (Edden and Jones 2011, Zalesky 2011, Keihaninejad, Ryan et al. 2012, 
Bach, Laun et al. 2014). Tractography is unable to determine the precise origin and 
termination of tracts, but can guide the ROI analysis of WM (Gong, Jiang et al. 2005, 
Yushkevich, Zhang et al. 2008, Goodlett, Fletcher et al. 2009, Jbabdi, Behrens et al. 
2010). Because of the limited number of studies, we have combined the results of all 
the studies despite their different technical approaches, as outlined in the extracted data 
table in the appendix. However, we noted that some older studies were limited in 
resolution, power and field strength. This could account for some of the discrepancies. 
The tracts that showed significant changes are displayed in Figures 4.2 to 4.4. 
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ALS studies 
The most common finding in ALS is the reduction in FA in the CST. Classical 
pathological studies of ALS show loss of upper and lower motor neurons and sclerosis 
of the CST in the spinal cord (Rafałowska and Dziewulska 1995). Other post mortem 
studies found gliosis affecting the posterior third of the internal capsule (Abe, Fujimura 
et al. 1997). Animal studies found similar results in cerebral motor cortex, where the 
CST originates (Martin 1999). Thus, abnormality of the CST in DTI of ALS studies is 
an expected finding. DTI studies also showed extensive abnormality of the CC, the 
cingulum and thalamus, confirming the findings of a previous review (Li, Pan et al. 
2012).  
 
The abnormalities found in ALS with DTI are consistent with the results of the imaging 
studies using other techniques. For example, structural MRI studies in ALS indicated 
that hyperintensities in CST and hypointensity in motor cortex are consistent features 
(Hecht, Fellner et al. 2001, Zhang, Uluǧ et al. 2003). Analysis of regional atrophy in 
VBM studies in ALS patients suggests that the GM loss occurs in the motor cortex and 
frontal, temporal and limbic areas (Chang, Lomen-Hoerth et al. 2005, Kassubek, Unrath 
et al. 2005, Mezzapesa, Ceccarelli et al. 2007). Susceptibility weighted imaging (SWI) 
has also found abnormalities of these pathways in ALS (Prell, Hartung et al. 2015). 
Functional MRI (fMRI) in ALS patients has revealed that impaired letter fluency 
correlated with impaired activation in the frontal and cingulate gyri (Abrahams, 
Goldstein et al. 2004). Positron emission tomography (PET) also found reduced 
regional perfusion in the sensorimotor cortex, and also extra-motor areas such as 
prefrontal, cingulate, putamen and parietal cortices (Hatazawa, Brooks et al. 1988, 
Habert, Lacomblez et al. 2007) and that reduction is accompanied by mild 
neuropsychological deficit (Ludolph, Langen et al. 1992).  
 
In ALS, many of the DTI studies show positive correlation between FA and 
performance on some cognitive examinations such as Trail-making, Stroop test scores 
and letter fluency. These changes are mainly in the projection fibers, commissural tract 
and association fibers. However, negative correlation was found with emotional 
recognition in the association fibers. Verbal learning, memory test and the apathy scores 
on FsRBe correlated with FA in the limbic tracts. 
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Our results found that the clinical measures positively correlated with the disease 
duration and disease progression but negatively with the UMN scores. ALSFRS-R had 
weaker correlation with FA in the commissural and association fibers but stronger 
negative correlation with MD in the CST and thalamic radiation. This is in support of 
the theory that ALS involves more than just motor dysfunction. Previous meta-analysis 




The tracts that were abnormal in FTD included the SLF, ILF and IFOF as well as the 
corpus callosum and uncinated fasciculus. There also was abnormality of the CST. FTD 
is associated with neurodegeneration and atrophy of the frontal, parietal and temporal 
lobes (Whitwell, Jack et al. 2007). In a previous post-mortem DTI study, 
histopathologic correlation revealed changes and frontal degeneration with mild 
frontotemporal gliosis (Larsson, Englund et al. 2004). FTD subtype studies reported the 
involvement of association fibers in the disease prognosis particularly ILF, IFOF and 
SLF, and the callosal radiation in the left hemisphere in tvFTD.  
 
Other MRI studies of FTD patients have shown patterns of GM loss primarily in the 
frontal, orbitofrontal (Harlow 1868, Hornberger, Geng et al. 2011) and anterior 
temporal lobes (Baron, Chetelat et al. 2001, Diehl, Grimmer et al. 2004, Grimmer, 
Diehl et al. 2004, Ishii, Sasaki et al. 2005, Jeong, Cho et al. 2005). Functional studies 
have shown the changes to be prominent in the parietal lobe and the cingulate gyrus 
(Bartenstein, Minoshima et al. 1997, Johnson, Jahng et al. 2006). Although several 
researchers have discovered a contribution by the association tracts in disease 
progression of FTD, less is known about the tract-specific contribution in cognition and 
this has not been fully explored (Cairns, Bigio et al. 2007). 
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Overlap between ALS and FTD 
The pathways for which there is strong evidence of abnormality in both ALS and FTD 
are shown in Figures 4.2–4.4. It is thought that ALS and FTD lie on a spectrum and 
that subjects with the combination of ALS and FTD have worse survival than subjects 
with ALS without FTD (Mathuranath, Nestor et al. 2000). This review identified 
extensive evidence of CST abnormalities in ALS and also some evidence in FTD. The 
DTI studies show extra-motor involvement in ALS and FTD in the cingulum and the 
CC, especially the forceps minor which reflects the neuropathological findings of 
degeneration in the CC (Brownell, Oppenheimer et al. 1970) and corresponds to the 
severe atrophy of the most anterior CC that has been related to cognitive impairment 
(Yamauchi, Fukuyama et al. 1995). Earlier studies showed that a network of 
orbitofrontal, anterior temporal and mesial frontal brain regions and their connecting 
white matter tracts are involved in ALS and FTD (Hornberger, Geng et al. 2011, 
Mahoney, Beck et al. 2012). The integrity of WM tracts connecting these regions, 
namely uncF, forceps minor and callosal radiation appears critical. The atrophy of 
frontal regions is important as it is involved in Theory of Mind processing (Stone, 
Baron-Cohen et al. 1998, Ferstl and von Cramon 2002) and cognitive control (Miller 
2000, Ridderinkhof, Ullsperger et al. 2004). Involvement of the cingulate region in 
cognition is well established (Bush, Luu et al. 2000). Moreover, association fibers such 
as uncF (Agosta, Pagani et al. 2010) which is involved in naming and language 
function, (Papagno 2011) and SLF (Abrahams, Goldstein et al. 2005) were involved in 
ALS. Several of the studies have reported increased AD of the uncF in ALS and 
suggested that this may relate to the behavioral disturbances of ALS patients.  
 
Association tracts are also involved in cognition. In Alzheimer disease there is loss of 
integrity of the association fibers (Rose, Chen et al. 2000), and WM destruction and 
altered regional morphology of CC (Black, Moffat et al. 2000, Meng, Guo et al. 2012). 
Efficient organization of association fibers is essential for optimal cognitive 
performance (Schmithorst, Wilke et al. 2002, Frye, Hasan et al. 2010). There is 
evidence that emotional deficit follows selective damage in the ILF and IFOF (Philippi, 
Mehta et al. 2009). The role of the corticostriatal pathways in neurodegeneration has 
recently been emphasized (Shepherd 2013), so the involvement of subcortical area may 
underlie the cognitive and behavioral changes in ALS (Tsermentseli, Leigh et al. 2012). 
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The heterogeneity of impairment in ALS is well-studied and includes cognitive 
impairments encompassing language and memory impairment specifically the verbal 
fluency (Raaphorst, De Visser et al. 2010, Mackenzie, Ansorge et al. 2011). One 
complicating factor in most of the included studies is that not all subjects with ALS had 
cognitive testing. It is possible that the regions of abnormality that we have found to 
overlap between ALS and FTD are due to these abnormalities being present only in 
ALS subjects with cognitive impairment. 
 
DTI metrics demonstrate the significant differences between controls and patients and 
may be used to predict disease progression. Further investigations are needed to identify 
the overlap of ALS and FTD in cognitive processes to address the progression of the 
disease. Although DTI findings are important to the scientific findings, to date, they are 
not readily transferrable to clinical practice. Standardization of DTI analysis is 
necessary to allow for clinical studies, which is still a challenge due to the rapid 
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Chapter 5: Baseline scan evaluating 
whole brain gray and white matter in 





The systematic review (Chapter 4) highlighted the main shared WM tracts in ALS and 
FTD. To investigate aim two of this thesis “To identify brain regions involved in ALS 
patients with and without cognitive impairment compared to controls”, I performed 
gray matter analysis of structural MRI and white matter analysis of diffusion MRI using 
voxel-based approaches. This chapter consists of a manuscript titled “A combined tract 
based spatial statistics and voxel based morphometry study of the first MRI scan after 
diagnosis of Amyotrophic lateral sclerosis” that has been submitted for publication to 
Journal of Neuroradiology.  
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Gray and white matter alterations in amyotrophic lateral 
sclerosis (ALS) patients. 
Introduction 
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease, characterized 
by the loss of upper motor neurons of the primary motor cortex and lower motor 
neurons of brain stem (BS) and spinal cord (Kiernan, Vucic et al. 2011, Turner, 
Hardiman et al. 2013). In ALS, there is heterogeneity in the site of onset, disease 
progression and pattern of progression (Chiò, Calvo et al. 2011).  
 
The diagnosis of ALS is based on clinical and electrophysiological features, with 
widely accepted diagnostic criteria (Brooks, Miller et al. 2000, de Carvalho, Dengler et 
al. 2008). There is a need for validated imaging or body fluid biomarkers for monitoring 
of ALS subjects (Turner, Kiernan et al. 2009), but none has yet reached general 
acceptance (Foerster, Welsh et al. 2013, Chiò and Traynor 2014).  
 
Some ALS patients suffer from severe cognitive and behavioral dysfunction, and can 
be categorized as having frontotemporal dementia (FTD), usually of the behavioral 
variant (Achi and Rudnicki 2012). Other patients with ALS have mild cognitive 
dysfunction mainly in the domain of memory and language (Strong, Grace et al. 1996) 
and executive function (Raaphorst, De Visser et al. 2010, Phukan, Elamin et al. 2012, 
Elamin, Bede et al. 2013). The estimated frequency of cognitive dysfunction in ALS 
ranges from 10% – 75% (Frank, Haas et al. 1997, Barson, Kinsella et al. 2000, 
Ringholz, Appel et al. 2005, Rippon, Scarmeas et al. 2006, Phukan, Elamin et al. 2012). 
Consensus criteria have been developed to categorize patients as having ALS with 
cognitive impairment (ALScog) and ALS with behavioral impairment (Strong, Grace 
et al. 2009, Consonni, Iannaccone et al. 2013), but these are difficult to apply in routine 
clinical practice. 
 
Pathological and genetic studies have demonstrated that there is an overlap between 
FTD and ALS. Several genetic mutations including TDP-43 (Arai, Hasegawa et al. 
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2006, Seelaar, Kamphorst et al. 2008), c9orf72 (Irwin, Lippa et al. 2007, Benajiba, Le 
Ber et al. 2009, Serpente, Fenoglio et al. 2015), TARDBP and FUS (Mackenzie and 
Rademakers 2008, Vance, Rogelj et al. 2009) and progranulin gene (Mase, Ros et al. 
2001, Baker, Mackenzie et al. 2006, Seelaar, Kamphorst et al. 2008), have been found 
in some patients with ALS and some patients with FTD. 
 
Magnetic resonance imaging (MRI) allows non-invasive measurements of subtle 
changes in human brain structure and is increasingly being used to study ALS (Turner 
and Modo 2010). MRI can explore the anatomical configuration and shape of the brain 
and study the microscopic composition of brain tissue. Voxel based morphometry 
(VBM) is a fully automated method that is used to study changes in gray matter volume 
based on high-resolution structural MRI (Shah, Ebmeier et al. 1998, Vargha-Khadem, 
Watkins et al. 1998, Ashburner and Friston 2000). VBM whole brain normalization 
procedure ensures the analysis is not biased to one region (Chen, Ma et al. 2010, 
Tsujimoto, Senda et al. 2011). VBM has been used to demonstrate reduction in cortical 
volume in both frontal and temporal regions in the ALS population (Chang, Lomen-
Hoerth et al. 2005). Diffusion tensor imaging (DTI) on the other hand allows mapping 
of tissue microstructural characteristics and is widely used to infer white-matter 
structural connectivity of the human brain. DTI has been used to assess the integrity of 
white matter tracts in ALS (Prudlo, Bissbort et al. 2012).  
 
A number of quantitative metrics can be obtained from DTI. Fractional anisotropy (FA) 
is the most commonly used DTI measure and it has been shown to reflect myelination 
in white matter (WM) and fiber density (Pierpaoli, Jezzard et al. 1996, Le Bihan 2003). 
Mean diffusivity (MD) measures the total diffusion eigenvalues within a voxel, and is 
used clinically to identify damage in normal appearing white matter (Werring, Clark et 
al. 1999, Bammer, Augustin et al. 2000). Parallel diffusivity along the axonal fibers is 
referred to as axial diffusivity (AD). Radial diffusivity derived from DTI describes the 
averaged water movement perpendicular to the axonal fibers. There is little information 
about the value of these different measures in the study of ALS. Previous studies 
showed that ALS patients with cognitive impairment (ALScog) have greater frontal 
lobe structural changes in both gray and white matter (Lillo, Mioshi et al. 2012, Kasper, 
Schuster et al. 2014) than those with pure ALS with no cognitive impairment (ALSnon-
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cog). However, little is known about differences in DTI parameters between these 
groups. The question remains whether there are imaging differences that can distinguish 
patients with pure ALS (ALSnon-cog) from their counterparts who have cognitive 
involvement (ALScog).  
 
In this study, we used MRI to study patients with ALS with and without cognitive 
impairment, to determine characteristic changes in brain structures and DTI metrics 
that distinguish ALScog subjects from ALSnon-cog subjects. 
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Materials and methods 
Subjects and recruitment 
 
From May 2012 to December 2014, 30 patients (median age 62, range 28-80 years) 
with probable or definite ALS were recruited from the Royal Brisbane and Women’s 
Hospital motor neuron disease (MND) clinic. The clinical diagnosis of ALS was made 
according to El Escorial criteria (Brooks, Miller et al. 2000). Patients were excluded if 
they presented progressive muscular atrophy or primary lateral sclerosis; were younger 
than 18 years; had other neurological or pathological disease; were unable to lie flat in 
the MRI scanner; had other contraindications for MRI; or had severe weakness at the 
time of recruitment or respiratory failure defined by clinical signs. None of the ALS 
patients had percutaneous endoscopic gastrostomy or respiratory symptoms at the time 
of scanning. 
 
Nineteen healthy control participants (median age 58 range 39-74 years) with no history 
of neurological or psychiatric disorder were recruited from the community. Details of 
all participants are reported in Table 5.1.  
 
Ethical approval was obtained from the Human Research Ethic Committee (HREC) of 
the Royal Brisbane and Women’s Hospital (RBWH), (HREC 2008/98). Written 
informed consent was obtained for each participant. 
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Age (median, range) 60.7 









11:6 8:5 8:11  
Handedness (rt : lt) 13:4 12:1  - 
Familial: sporadic 3:14 3:10  - 
Limb/Bulbar/both 
onset 
15/2/0 11/2/0  - 





ALSFRS-R 40 (SD=5) 36 (SD=4)  0.051 
ACE-III 94 (SD=3) 83 (SD=7)  0.0001* 
Fab 16 (SD=1) 15 (SD=3)  0.074 







0.62 (SD=1) 0.47(SD=1.6)  0.136 
* only 14 subjects were tested with ALS-FTD-Q 
Clinical Evaluation  
Motor function 
Motor function was assessed with the revised Amyotrophic Lateral Sclerosis 
Functional Rating Scale (ALSFRS-R) (Cedarbaum, Stambler et al. 1999). The 
ALSFRS-R is a 12-item scale evaluating motor skills of ALS patients, including 
speech, breathing, swallowing, and walking (Cedarbaum, Stambler et al. 1999). Each 
item is scored from 0 to 4 (worst to best respectively) resulting in a maximum total 
score of 48. The disease progression rate was calculated using the following formula, 
adapted from Ellis et al (Ellis, Simmons et al. 1999): 
 
Disease progression rate = (48 – ALSFRS score)/disease duration 
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Cognitive and behavioral testing 
ALS patients received neuropsychological screening and behavioral evaluation on the 
same day as their MRI scans. Cognitive performance was assessed using the 
Addenbrooke’s Cognitive Examination (ACE-III) (Hsieh, Schubert et al. 2013), the 
Frontal Assessment Battery (FAB) (Dubois, Slachevsky et al. 2000), and the ALS-
FTD-Questionnaire (ALS-FTD-Q) (Raaphorst, Beeldman et al. 2012), which have been 
introduced in Chapter 1. 
MRI acquisition 
All MRI scans were performed at the Royal Brisbane and Women Hospital (RBWH) 
using a 3T Siemens Tim Trio (Siemens, Erlangen, Germany) equipped with a 12-
channel parallel head coil. In addition to a standard series of clinical sequences, 
Diffusion-weighted images (DWIs) were acquired along 64 non-collinear directions at 
b = 3000 s/mm2, with one non-diffusion weighted image. Acquisition parameters were: 
60 axial slices, FOV 30x30 cm, flip angel 90, slice thickness 2.5 mm, matrix 128x128, 
TR/TE 3200/91 ms, iPAT factor 2. A field map was acquired using two 2D gradient-
recalled echo images with TE1/TE2=4.92/7.3 and TR= 488 ms to assist in the 
correction of geometric distortions. The acquisition time for the diffusion dataset was 
9:40 min. These parameters have been used in our previous DTI studies of MND (Rose, 
Pannek et al. 2012, Rose, Rowland et al. 2012). The b value was chosen to allow 
detection of crossing fibres. In addition, a high-resolution structural image was acquired 
using 0.44 mm
3 isotropic with interpolation 3D T1 MPRAGE (slice thickness 0.9, FOV 
23 × 25.6 × 17.6 cm, TR/TE/TI 1900/2.24/900 ms, flip angle 9) with total scan time 
9:14 min.  
 
Diffusion processing 
Diffusion MRI data were preprocessed as described previously (Pannek, Boyd et al. 
2014). Processing included correction for head movement with rotation of the b-matrix, 
detection and removal of signal intensity outliers, and correction for geometric 
distortions and intensity inhomogeneity. Maps of FA, MD, axial diffusivity (AD) and 
radial diffusivity (RD) were calculated. 
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Tract based spatial statistics (TBSS) analysis  
Tract-based spatial statistics analysis was performed with the FSL package version 4.1 
(www.fmrib.ox.ac.uk/fsl/tbss) which is a fully automated whole brain analysis 
technique that uses voxel-wise statistics on FA data while simultaneously minimizing 
the effects of misalignment (Smith, Jenkinson et al. 2006). Briefly, the main steps were 
a) non-linear alignment of FA images to 1x1x1 mm MNI152 standard space, b) creation 
of the mean FA image and its white matter “skeleton” representing the tracts that are 
common to all subjects, c) projection of individual FA maps onto the image skeleton. 
Non-FA metrics (MD, AD, and RD) were also projected onto the skeleton. The mean 
FA skeleton threshold was 0.2. We then performed voxel-wise statistical analysis on 
the skeleton, with statistical tests as described below. To correct for multiple 
comparisons, we employed permutation testing (5000 permutations) and threshold-free 
cluster enhancement (TFCE;(Smith and Nichols 2009)). We consider results to be 
significant at fully corrected p < 0.05.  
 
Voxel-based Morphometry Analysis (VBM) 
Structural three-dimensional T1-weighted images were analyzed using FSL-VBM 
toolbox in FMRIB software library package 
(http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FSLVBM) (Douaud, Smith et al. 2007). FSL-
VBM uses an optimized VBM protocol (Good, Johnsrude et al. 2002) carried out with 
FSL tools (Smith, Jenkinson et al. 2004) in which GM maps are co-registered into a 
standard space, allowing comparisons of GM density between groups. All data volumes 
were resampled at 1 mm3 voxel size prior to FSL VBM processing. Structural images 
were brain-extracted and gray matter-segmented before registering to the MNI152 
standard space using non-linear registration (Andersson, Jenkinson et al. 2007). The 
resulting images were averaged and flipped along the x-axis to create a left-right 
symmetric, study-specific gray matter template. All native GM images were then non-
linearly registered to this study-specific template and "modulated" to correct for local 
expansion (or contraction) due to the non-linear component of the spatial 
transformation. The modulated gray matter images were then smoothed with an 
isotropic Gaussian kernel with a sigma of 4 mm. Finally, voxel-wise analysis was 
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performed using permutation-based non-parametric testing, correcting for multiple 
comparisons across space using TFCE (Smith and Nichols 2009).  
Statistical tests 
Age, neuropsychological (ACE-III) and behavioral (FAB and ALS-FTD-Q) tests, 
ALSFRS-R, disease duration and disease progression were compared across groups 
(ALScog, ALSnon-cog, and controls) using a two-tailed T-test.  
 
To identify group differences in diffusion metrics (TBSS) and gray matter density 
(VBM), we used the “randomise” tool of FSL, with 5000 permutations. Correction for 
multiple comparisons was performed using threshold-free cluster enhancement (TFCE, 





Patients were grouped into those with normal cognition (pure ALS [ALSnon-cog]) and 
those with impaired cognition [ALScog], on the basis of performance on the ACE-III 
with a cut-off point of 88. There were 14 ALScog subjects with median age 62.7 (range 
41-81 years) and 16 ALSnon-cog subjects with median age 60.74 (range 28 – 74 years). 
The ALScog group was slightly older than the ALSnon-cog group and had shorter 
disease duration. The details of participants, neurophysiological and behavioral tests 
and disease progression rate are shown in Table 5.1. ALScog group had significantly 
lower scores in all five cognitive domains compared to the ALSnon-cog group, Table 
5.2.  
 
Behavioral assessment using ALS-FTD-Q revealed greater abnormalities in the 
ALScog group than in the ALSnon-cog group. FAB showed a trend towards significant 
difference between the patient groups (p=0.041).  
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DTI studies of white matter (TBSS) 
We tested for differences in DTI measures (1) between all ALS subjects and controls, 
(2) between males and females with ALS, (3) between ALS subjects with normal 
cognition (ALSnon-cog) and controls, (4) between cognitively impaired ALS subjects 
(ALScog) and controls, and (5) between ALS subjects with (ALScog) and without 
impaired cognition (ALSnon-cog).  
 
TBSS revealed differences in FA, MD and AD between ALSnon-cog and controls, and 
between ALScog and controls, but not between ALSnon-cog and ALScog (p<0.05) 
(Figure 5.1). However, some trends of higher MD and RD in ALScog compared to 
ALSnon-cog patients (p<0.1) were detected (Figure 5.2). Table 5.3 demonstrates the 
significant measure of DTI metrics.  
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Table 5.2: ACE-III results for all domain comparing ALSnon-cog and ALScog. 
 Attention Memory Fluency Language Visuspatial 
























0.017* 0.013* 0.033* 0.027* 0.005* 
 
Table 5.3: DTI and MRI changes in ALS patients. ALS (n=30) and controls (n=19). 
 Presence of significant differences 
Method ALSnon-cog vs HC ALScog vs HC ALSnon-cog vs 
ALScog 
FA Yes (p<0.05) Yes (p<0.01) No 
MD Yes (p<0.05) Yes (p<0.01) Yes (p<0.1) 
RD No No Yes (p<0.1) 
AD No Yes (p<0.01) No 








Mean Diffusivity (MD)  
TBSS showed significant differences between the whole group of ALS subjects and 
controls in MD which was increased in widespread brain regions including CST, Cg, 
anterior thalamic radiation (aTR) and CC. In the association fibers, the IFO and uncF 
showed increased MD at p<0.05 (Figure 5.1).  
 
In Figure 5.1, comparing ALSnon-cog patients and healthy controls, MD was found to 
be significantly increased (p<0.05) bilaterally in patients in the uncinate fasciculus 
(unc.F), the inferior fronto-occipital fasciculus (IFOF), and the right temporal part of 
the superior longitudinal fasciculus (SLF). Increased MD in the body of the corpus 
callosum (bCC) showed changes that did not reach significance (p<0.1) especially in 
the forceps minor (FM) bilateral when comparing ALS subgroups (Figure 5.2).  
 
When comparing ALScog patients with healthy controls, there was an increase in MD 
diffusely spread over the WM (Figure 5.1), with highly significant differences (p<0.01) 
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noted in most of the association fibers including the SLF, IFOF, IFL, unc.F, along the 
corticospinal tract (CST) including anterior corona radiate (CR) and anterior limb of 
internal capsule (ALIC), posterior orbital gyrus WM, tracts in the precentral gyrus WM, 
supplementary motor cortex WM, inferior frontal gyrus WM and middle and inferior 
temporal gyrus WM. Less significant increase in diffusivity (p<0.04) was seen in the 
CC forceps major left cingulum.  
 
With MD, there was changes that did not reach significance (p<0.1) towards differences 
between ALSnon-cog and ALScog subjects in both the right frontal and temporal lobes, 
right CST at the level of internal capsule (IC) and the left anterior corpus callosum (CC) 
and bilaterally in the left CC (Figure 5.2). 
 
Fractional anisotropy (FA)  
FA was decreased in all ALS subjects compared to controls in the corticospinal tract 
(CST), the callosal radiation and the body of corpus callosum (CC), cingulum (Cg) at 
p<0.01, and in the association fibers in the superior longitudinal fasciculus (SLF) and 
the inferior longitudinal fasciculus (ILF) at p<0.05 (Figure 5.1).  
 
There was a significant reduction in FA in ALSnon-cog patients compared to healthy 
controls (p<0.05, corrected for multiple comparison) (Figure 5.1). Widespread WM 
changes were detected along most of brain tracts, particularly in the projection fibers 
(along the CST), commissural fibers (bilateral forceps minor, splenium and genu of 
CC, left forceps major), and association fibers (including the temporal part of SLF and 
bilateral IFOF). FA showed more significant differences (p<0.05) in the frontal lobe 
tracts and in the association fibers (IFOF, left SFOF, bilateral SLF and left Unc.F) 
including the bCC.  
 
In the ALScog group compared to controls, there was widespread reduction in FA in 
patients, and this was more prominent towards the right side of the brain. There was 
reduced FA bilaterally in the tracts that extend from frontal and central CC to the 
primary and premotor cortex including parts of the CST; superior CR and posterior 
limb of IC and rostral cerebral peduncle (p<0.01). Additional changes were observed 
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in the association fibers; IFO and ILF (p≤0.02) and SLF (p≤0.05). There were weaker 
regional differences in the precuneus, superior occipital gyrus WM, thalamus and tracts 
in the superior frontal gyrus (p≤0.03). Fornix and stria terminalis also showed FA 
reduction (p≤0.05) (Figure 5.1). 
 
There were no differences in FA between ALSnon-cog subjects and ALScog at p<0.05 
and p<0.1. 
Axial diffusivity (AD) 
Although the differences between the whole group of ALS subjects and controls in WM 
were less significant in AD (Figure 5.1), the changes seen in the association fibers were 
more widespread than with FA, and included changes in the SLF, ILF, IFOF and uncF. 
Changes in aTR and CST at the level of corona radiata were seen in AD. 
 
ALScog patients have lower AD than healthy controls. These changes can be clearly 
observed in the right hemisphere WM, including tracts in the frontal orbital WM. The 
right SLF, ILF and IFOF showed lower AD in ALScog group compared to controls. A 
similar significant result was also seen in the genu of CC and forceps minor (FM) and 
forceps major (Fmj) (Figure 5.1). There were no differences between the ALSnon-cog 
group and healthy controls (Figure 5.1), and between ALSnon-cog and ALScog groups. 
 
Radial diffusivity (RD) 
The differences between the whole group of ALS subjects and controls in WM were 
less significant in RD compared to other DTI measures. However, changes were mainly 
seen in the association fibers which were more widespread than with FA, and involving 
the SLF, ILF, IFOF and uncF (Figure 5.1). 
 
There was no significant change in RD in whole brain TBSS for any of the comparisons 
(ALSnon-cog vs healthy controls, and ALScog vs healthy controls); however when 
subcomparing ALSnon-cog with ALScog groups, some changes that did not reach 
significance in ALSnon-cog vs ALScog groups, and were observed in the right 
hemisphere WM in the corpus callosum, forceps minor and forceps major, the CST at 
the level of the corona radiata and the anterior limb of the internal capsule, the thalamic 
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radiation and the WM tracts in the temporal lobe and pre- and postcentral gyrus (p<0.1, 
Figure 5.2).   





Figure 5.1: WM TBSS analyses of DTI metrics highlighting differences between ALScog 
and ALSnon-cog compared to healthy controls. ALScog exhibit widespread changes in the 
frontal, parietal and temporal lobes in FA, MD and AD. (p<0.01). Compared to controls, 
ALSnon-cog subjects have no AD changes but significant FA and MD changes in the CST, CC 
and temporal part of SLF and bilateral IFOF (p<0.05). 
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Figure 5.2: TBSS comparison of ALSnon-cog and ALScog. Trends of higher 
MD and RD in subjects with cognition involved were detected in the right 
frontal and parietal lobes including CST at internal capsule (p<0.1, corrected 
for multiple comparisons). 
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There were no differences between male (n=18) and female (n=12) subjects with ALS 
in any of the DTI measures. 
 
VBM 
When comparing all ALS subjects with controls, the right post- and pre-central gyrus 
showed significant differences in GM density at p< 0.02, and small regions in the left 
middle frontal gyrus and right central opercular cortex, right superior temporal gyrus 
and right cingulate gyrus showed a trend towards significant changes at p< 0.06 (Figure 
5.3). These changes were confined to the right hemisphere except a small region in the 
left middle frontal gyrus. 
 
Figure 5.4 depicts the regional pattern of significant differences in GM volumes 
compared between the patient and control groups. Comparing ALSnon-cog patients and 
controls showed no differences at p<0.05 but there was a some evidence (p<0.1) 
towards a reduction in GM density in patients in two small regions in the right pre- and 
postcentral gyrus in the parietal lobe.  
 
Compared to controls, ALScog patients had widespread and substantial reduction 
(p<0.01) of GM volume in bilateral frontal and temporal poles, middle temporal gyri, 
paracingulate gyrus, left middle frontal gyrus and cortex, left temporo-fusiform cortex, 
left frontal operculum, right central opercular cortex and the right pre-central gyrus, 
(Figure 5.4). 
 
In the limbic system, VBM revealed significant GM loss in the amygdala, bilateral 
para-hippocampal gyrus and bilateral anterior parietal lobe, middle frontal gyrus, 
putamen, and posterior thalamus in ALScog compared to controls (p<0.05), Figure 5.4. 
 
ALScog patients had distinct bilateral loss of GM volume in the caudate nucleus (Cd) 
compared to ALSnon-cog at p<0.05 (Figure 5.4).  
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Figure 5.3: Clusters of significant GM density differences in VBM analysis 
when comparing all ALS subjects and controls. This shows reduction in the 
GM volume at p<0.02. The regions are pre- and post-central gyrus, opecular 
cortex, superior temporal gyrus and cingulate gyrus.  










Figure 5.4: Clusters of significant GM signal differences in VBM analysis 
when comparing ALS subgroups with healthy controls. Results are overlaid on 
the axial sections of a T1-weighted template in the MNI standard space in 
neurological convention (TFCE p<0.05 corrected). ALScog have distinct reduction 
in the volume of caudate compared to ALSnon-cog subjects (middle row). 
Compared to controls, ALScog subjects (bottom row) have more widespread 
structural T1 changes than ALSnon-cog subjects (top row).  





To study the underlying basis of cognitive impairment in ALS, this study investigated gray and 
white matter disruption in ALSnon-cog and ALScog patients, and compared the changes 
observed with DTI measures. We have demonstrated that ALS is associated with changes in 
both GM density and WM diffusivity and that the location of changes differs between ALSnon-
cog and ALScog.  
 
DTI changes were seen in the CST, and also in extra-motor areas. Changes in the CST are 
consistent with classical features of ALS and with previous MRI studies (Lillo, Mioshi et al. 
2012). We defined ALScog patients by their performance on the ACE-III. This categorization 
is not as stringent as the definition proposed by Strong et al. for ALScog (Strong, Grace et al. 
2009), but is the assessment that can be used in routine clinical practice. It does not test 
executive function, and in the future is likley to be replaced by other measures such as the 
ECASS (Abrahams, Newton et al. 2014) that were not available when this study was 
commenced on 2012. 
Our ALScog patients did not have significant behavioural changes when measured by FAB but 
mild to moderate behavioural disturbances were detected by ALS-FTD-Q. The changes seen 
with MRI were more severe in the ALScog group than the ALSnon-cog group, but this cannot 
be explained by disease duration, because the ALScog group had shorter disease duration than 
the ALSnon-cog group (p=0.1). There was a majority of male subjects in both patient groups, 
consistent with the findings that ALS is more common in males than females (McCombe and 
Henderson 2010). The majority of patients in both groups were right handed. It is important to 
control for handedness because this can influence the spread of disease (Devine, Pannek et al. 
2015). Others have found evidence of a significant correlation between DTI measures with 
disease severity measures in ALS (Ellis, Simmons et al. 1999). However, in the current study 
such correlation was not feasible due to the small sample size and variable disease presentation. 
 
In patients with ALScog there were marked changes in DTI and VBM in the frontal and 
prefrontal cortex. The prefrontal cortex constitutes nearly one-third of the neocortex (Shallice 
and Evans 1978) and is a store of short-term memory (Miller and Cohen 2001). Abnormality 
of frontal regions in ALS with dementia has been previously observed in Japanese ALS patients 




with high signal intensities on T2-weighted images in frontotemporal WM and precentral gyri 
(Van Zandijcke and Casselman 1995). 
 
In ALScog, DTI showed abnormality in most of the projection fibers (CST at the level of 
corona radiata and internal capsule and tracts in the pre- and post-central gyri) and the 
association tracts (SLF, IFOF, ILF). DTI changes were most prominent in the frontal 
connections. This may represent a reduction in functional connectivity with cognitive 
impairment. In ALScog these changes were observed in the SLF and were particularly severe 
in the anterior portion of the tract. The observation of predominantly anterior involvement is 
compatible with earlier studies (Kiernan and Hudson 1994). SLF DTI abnormality in ALScog 
patients is remarkable as this structure plays an important role in the language function (Catani 
and Mesulam 2008).  
 
The CC has been implicated in human behavior and cognition (Witelson 1989). A previous 
study had identified atrophy in the anterior half CC in ALS subjects with cognitive decline 
(Yamauchi, Fukuyama et al. 1995), similar to our findings in ALScog. An autopsy study on 
patients with ALS has shown pathologic changes in the isthmus and posterior mid-body of CC 
(Sugiyama, Takao et al. 2013). We found a significant decrease of FA in the splenium of CC, 
which has also been described in other studies (Agosta, Pagani et al. 2007, Bartels, Mertens et 
al. 2008, Rose, Pannek et al. 2012). 
 
DTI detected smaller difference in ALSnon-cog group vs controls compared to ALScog group 
vs controls. Between the ALSnon-cog and the ALScog group there were no significant 
differences at p<0.05, but at p<0.1, there were some evidence of changes in the motor cortex; 
pre- and postcentral gyrus, the commissural fibers in the fronto-parietal lobe; forceps minor 
and splenium of the corpu callosum, association fibers; inferior fronto-occipital and superior 
longitudinal fasciculus, and inferior longitudinal fasciculus in the temporal lobe. These changes 
were more prominent on the right hemisphere (Figure 5.2). 
 
Using VBM, when comparing all ALS subjects with healthy controls, we found a reduction in 
the gray matter volume in the fronto-temporal regions and the pre- and post-central gyri. These 
regions connected with WM tracts that were found to show significant changes on TBSS. These 
changes reflect the physiological relationship between GM and WM, similar to the results 




found in previously published studies (Bede, Bokde et al. 2013). ALSnon-cog patients showed 
asymmetric regional decrease of density in the grey matter of the right but not the left of 
primary motor cortex when compared to the control group. Previous studies have shown 
decreased signal intensity in the precentral gyrus on T2 and proton density weighted imaging 
(Oba, Araki et al. 1993, Cheung, Gawel et al. 1995, Bowen, Pattany et al. 2000). Rooney et al 
also found that NAA/ (Cho+Cr) spectroscopy correlated with the UMN disease severity in the 
motor cortex (Rooney, Miller et al. 1998). In a post-mortem study, Smith found that a large 
number of degenerating fibers pass to or from the precentral gyrus in ALS patient (Smith 1960). 
Our finding of reduced GM on the right side is consistent with the findings of a meta-analysis 
that found preferential atrophy in the right precentral gyrus (Chen and Ma 2010). However, 
using different techniques, previous work from our group has shown that there is preferential 
involvement of the dominant motor cortex in ALS (Devine, Kiernan et al. 2014). The 
relationship of handedness to disease therefore requires further clarification. 
 
Although disease duration was shorter in ALScog group, we found heterogeneous widespread 
volume reduction involving both anterior and posterior cerebral GM compared to controls. 
These early diffuse changes in the GM and WM in ALScog group may be an indicator of a 
later diagnosis of cognitive impairment in ALS patients. ALS patients with FTD were found 
to have shorter survival than those without (Olney, Murphy et al. 2005).  
 
The ALScog group showed loss of GM in the caudate nucleus, compared with the ALSnon-
cog group. There is mounting evidence that lesions in the caudate nucleus can cause cognitive 
deficits (Mendez, Adams et al. 1989). Previous post mortem studies have consistently found 
pathological changes in the frontotemporal cortex and subcortical structures such as caudate 
nucleus and putamen in ALS patients with dementia (Mackenzie and Feldman 2005). A 
previous quantitative imaging study revealed that involvement of subcortical GM structures 
including the caudate nucleus may form a key feature of ALS (Bede, Elamin et al. 2013) and 
other work found that these additional changes in ALS patients with cognitive impairment are 
correlated with neuropsychological and behavioral profiling (Kasper, Schuster et al. 2014).  
 
Our findings of loss of volume of the caudate nucleus in ALScog is consistent with the finding 
of reduced FA and increased MD in several clusters of the right anterior parts CC. This suggests 
that a more prominent disruption of temporo-frontal connection in ALScog patients may 




represent a hallmark for the presence of cognitive impairment. The diffusivity changes that we 
identified in many regions of WM were in tracts that connected atrophic GM tissue such as 
gCC and ant. SLF. This is a novel finding and suggests a mechanism of disease progression in 
relation to cognition. The medial temporal lobes are implicated in memory storage while the 
frontal lobe mainly serves in executive function and language.  
 
It is of note that in ALScog compared to ALSnon-cog, we found GM loss in bilateral caudate 
nuclei but more in the right caudate nucleus. The subjects were mostly right handed. As with 
the possible role of handedness in motor cortex atrophy, the role of handedness and limb 
dominance in cognitive impairment requires further study. We speculate that memory and 
language deficits observed in ALScog may be due to selective impairment in the motor control 
and memory circuit as a consequence of the changes observed in caudate nucleus. Some studies 
have shown that the caudate nucleus receives input from frontal and temporo-parietal cortical 
areas and forms fronto-caudate anatomical loops (Kemp and Powell 1971). We also 
hypothesize that microstructural alteration of fronto-temporal structures might have led to 
cognitive and behavioral changes in ALS patients. Clinicopathological studies have confirmed 
the clinical overlap between ALS and FTD in multiple domains of cognition (Lomen-Hoerth, 
Anderson et al. 2002, Lillo, Mioshi et al. 2012).  
 
DTI can generate eigenvector maps that provide visual comparison between trajectories of 
degenerated and intact tracts (Werring, Toosy et al. 2000). Although DTI studies typically 
report the findings with FA, more recently published work has reported other DTI metrics such 
as RD and AD and has linked the increase in both to loss of myelination (Song, Sun et al. 2002) 
and axonal degeneration (Budde, Xie et al. 2009), respectively. The need to gain insight into 
the white matter in ALS has raised prospects for the role of diffusion imaging. This insight has 
been achieved in our study through using four DTI metrics to assess cerebral tracts. Large MD 
increases were seen in all patients compared with controls and within subgroup comparison. 
Our findings highlight the potential advantages of DTI to detect the structural changes in white 
matter and associated degeneration of fiber pathways. Future longitudinal DTI studies may 
provide a better understanding of the pattern of WM changes in ALS. 
 
One limitation of this study is the small sample size. There was also a slight variation in age 
between patient groups and healthy controls. Another limitation is that we used clinical 




screening tools for assessment of cognitive function and did not use formal neuropsychological 
testing. These were used because they are readily available in the clinic. 
 
In summary, diffusion tensor imaging has shown greater frontal lobe involvement in subjects 
with ALScog than ALSnon-cog, and showed the involvement of the caudate nucleus in 
ALScog. Ongoing longitudinal studies should provide opportunity to assess the possible early 
feature of caudate nucleus as early predictor for cognitive impairment.  
  




Chapter 6: Two scans evaluation of motor 




As shown in Chapter 5, DTI in patients with ALS found significant changes in the motor and 
extra-motor pathways compared to controls, with extra-motor involvement being more 
prominent in subjects with cognitive impairment. This chapter explores the changes in WM of 
motor and extra-motor pathways over time. A subset of patients studied in Chapter 4 (n=23) 
had two MRI scans, 6 months apart. Changes were explored using region-of-interest (ROI) 
analysis in 21 regions.   




A 6–month evaluation using diffusion tensor imaging. 
Introduction 
Amyotrophic lateral sclerosis (ALS) is a disease that is defined by the loss of upper and lower 
motor neurons. However, extra–motor features can be found in ALS, with cognitive 
impairment being prominent (Beeldman, Raaphorst et al. 2016). MRI studies of ALS have 
reported pathological changes in white (WM) and gray matter (GM) (Agosta, Pagani et al. 
2007, Canu, Agosta et al. 2011).  
 
Diffusion tensor imaging (DTI), which measures movement of water molecules, can be used 
to assess the integrity of white matter (WM). DTI provides a variety of measures to characterize 
the diffusion of water, which is hindered and restricted by cellular microstructure. Currently, 
the most widely used DTI measure is fractional anisotropy (FA), which is a measure of the 
degree of anisotropy of diffusion (Koay, Chang et al. 2006). FA is believed to reflect 
myelination of white matter (WM) and fiber density (Pierpaoli, Jezzard et al. 1996, Le Bihan 
2003). Mean diffusivity (MD) is another DTI metric, which measures the overall speed of 
diffusion within a voxel. MD is used clinically to identify damage in white matter that appears 
normal on structural imaging (Werring, Clark et al. 1999, Bammer, Augustin et al. 2000). Most 
DTI studies of ALS have been cross–sectional studies at a single time–point and have focused 
on abnormalities in the white matter (WM) of the motor system (Carrara, Carapelli et al. 2012, 
Kwan, Meoded et al. 2013, Müller, Turner et al. 2016). However, some studies have reported 
the involvement of association tracts and subcortical structures (Pettit, Bastin et al. 2012, 
Sharma, Sheriff et al. 2012).  
 
Serial MRI studies could provide a measure for the rate of progression in neurological diseases 
and may also demonstrate the spread of pathology to different brain regions (Hu, Jin et al. 
2016). However, the few longitudinal DTI studies of ALS have small numbers of subjects and 
inconsistent findings (Nickerson, Koski et al. 2009, Zhang, Schuff et al. 2011, Keil, Prell et al. 
2012). Some have reported the progression of ALS by demonstrating decreasing FA over time 
along the corticospinal tract (CST) (Sage, Peeters et al. 2007, Nickerson, Koski et al. 2009). 
However, one study found that FA does not change on later scans (Blain, Williams et al. 2007) 
while others found negative results when using DTI and 1H MRSI (Mitsumoto, Ulug et al. 




2007). We hypothesize that there would be greater white matter damage in ALS in later 
timepoints and that white matter damage would correlate with disease severity. 
Methods 
 Participants 
Patients with ALS were recruited from the multidisciplinary Motor Neuron Disease clinic at 
the Royal Brisbane Women’s Hospital (RBWH). Twenty-three patients (n=16 males, n= 7 
females; age 32–84 years old, mean age=59±11  years) were included. All patients fulfilled the 
criteria for definite ALS according to revised El Escorial criteria (Brooks, Miller et al. 2000). 
This study was approved by the RBWH ethics committee (HREC 2008/98), and all patients 
provided written informed consent. 
Clinical assessment 
The revised ALS functional rating scale (ALSFRS-R) was administered at each clinical visit 
every three months (Cedarbaum, Stambler et al. 1999). On the same day as their MRI scans, 
ALS subjects also received cognitive and behavioral testing, using the Addenbrooke’s 
cognitive examination ACE-III (Hsieh, Schubert et al. 2013) and Frontal assessment battery 
(FAB) (Dubois, Slachevsky et al. 2000). 
Image acquisition 
All subjects had two MRI scans, 6 months apart. MRI scans were performed at RBWH using 
a 3T Siemens Tim Trio (Siemens, Erlangen, Germany) equipped with a 12–channel parallel 
head coil. In addition to a standard series of clinical sequences, diffusion-weighted images 
(DWIs) were acquired along 64 non-collinear directions at b = 3000 s/mm2, with one non-
diffusion weighted image. Acquisition parameters were: in-plane resolution 2.34x2.34, 60 
axial slices, FOV 30x30 cm, slice thickness 2.5 mm, matrix 128x128, TR/TE 9200/112 ms, 
iPAT factor 2. A field map was acquired using two 2D gradient-recalled echo images with 
TE=4.92 and TR= 488 ms to assist in the correction of geometric distortions. The acquisition 
time for the diffusion dataset was 9:40 min.  





Diffusion MRI data were preprocessed as described previously (Pannek, Boyd et al. 2014). 
Preprocessing methods included correction for head movement with rotation of the b-matrix, 
detection and replacement of signal intensity outliers, and correction for geometric distortions 
and intensity inhomogeneity. Maps of FA and MD were calculated using MRtrix 0.2.9. 
 
A custom FA template, generated using scripts provided with ANTs 
(http://picsl.upenn.edu/ANTS/) (Avants, Tustison et al. 2009), was derived from all subjects. 
We used ANTs symmetric diffeomeophic registrations using symmetric image normalization 
(Greedy SyN). The JHU 1mm FA was used for the initial rigid body registration to generate 
the template.  
The JHU atlas (Wakana, Jiang et al. 2004) was normalized to this study template using 
symmetric diffeomorphic registration. ROIs of the JHU atlas were subsequently transformed 
to the individual datasets in native space and mean values of FA and MD were calculated for 
each ROI.  
 
Region of interest (ROI) analysis  
We performed an ROI analysis of the diffusion tensor data in 21 regions; non-midline 
structures were measured on both sides separately. The regions that were studied are listed in 
Table 6.1. 
Using ITK-Snap software, the automated placement of ROIs was confirmed by one rater 
(A.R.A). Mean FA and MD values were extracted for each region Figure 6.1.  




Table 6.1: List of regions-of-interest investigated in this study.  
ROIs  
The corticospinal tracts (CST) 
Corona radiata (CR) (right and left) 
Medial lemniscus (ML) (right and left) 
Pons 
Posterior internal capsule (PLIC) (right and left) 
Callosal tracts  
Minor forceps (FMi) (left and right) 
Genu corpus callosum (gCC) 
Body corpus callosum (bCC) 
Splenium corpus callosum (sCC) 
Association fibers 
The superior longitudinal fasciculus (SLF) (right and left) 
The inferior longitudinal fasciculus (ILF) (right and left) 
Other extramotor tracts  
Cingulum (Cg). 
Hippocampus (Hpc) (right and left) 
Anterior limb of internal capsule (ALIC) (right and left) 





Figure 6.1: Regions of interest (ROIs) used in the analysis, overlaid on study 
specific template.




Tract-based spatial statistics (TBSS) 
Tract-based spatial statistics analysis was performed with FSL (version 5.0) 
(www.fmrib.ox.ac.uk/fsl/tbss). TBSS is a fully automated whole brain analysis 
technique that uses voxel-wise statistics on FA data while simultaneously minimizing 
the effects of misalignment (Smith, Jenkinson et al. 2006). Briefly, the main steps were 
a) non-linear alignment of FA images to 1x1x1 mm MNI152 standard space, b) creation 
of the mean FA image and its white matter “skeleton” representing the tracts that are 
common to all subjects, c) projection of individual FA maps onto the image skeleton. 
The mean FA skeleton threshold was 0.2. We performed voxel-wise statistical analysis 
on the skeleton, with statistical tests as described below.  
 
Statistical analysis 
Statistical analysis for ROI measurements were performed using SPSS for Mac (ver. 
23.0, SPSS Inc., Chicago, IL, USA). Mean and standard deviation values were 
calculated for each variable. All data were tested for normality using Shapiro-Wilk test. 
For data that were normally distributed, we used the paired-sample t-test, with 
significance taken to be p<0.05. For data that were not normally distributed, group 
differences were analyzed by Wilcoxon rank t-test, with a threshold for significance of 
p<0.05. To confirm our results, MANOVA was performed on the significant results 
correcting for age and gender as covariant. 
The ROI measures were used to explore the relationship of FA and MD with disease 
severity (using ALSRFRS-R) and disease duration for each patient over time using a 
Pearson correlation.  
 
TBSS analysis used a Two-Sample Paired T-test design to detect changes between two 
time-points from the same group of patients. To correct for multiple comparisons across 
space, we employed permutation testing (5000 permutations) and threshold-free cluster 
enhancement (TFCE; (Smith and Nichols 2009)). We consider results to be significant 
at a fully corrected p < 0.05. 






The clinical features of the individual subjects are shown in Table 6.2. Table 6.3 
summarizes the clinical data. There were more males than females (16:7). The timing 
of the first scan ranged from 3 to 112 months from date of onset (mean 27.6 months). 
Three patients had a longer disease duration (patient 4: 65 months, patient 7: 68 months; 
and patient 16: 112 months). In the interval between the first and second scans there 
was a significant decline in the ALSFRS-R score (p= 0.03) and also in ACE-III score 
(p=0.02) showing clinical progression of the disease over the 6-month interval. 





Table 6.2: Clinical features of ALS patients. 
Subjects Age Handedness El Escorial 
category 
Site of Onset* Riluzole Disease 
duration 
(months)** 
1 57 Right Definite  RLL Y 15 
2 68 Right Definite  LUL N 27 
3 74 Right Definite  RUL N 48 
4 63 Left Definite  LLL  – 65 
5 41 Right Definite  RUL Y 22 
6 65 Right Definite  LUL N 17 
7 51 Right Definite  LL (Bilateral) N 68 
8 47 Mixed Definite  LLL Y 30 
9 57 Right Definite  LUL Y 28 
10 81 Right Definite  RLL Y 19 
11 28 Right Definite LUL Y 13 
12 54 Right Definite LUL N 2.8 
13 66 Right Definite RLL Y 6 
14 63 Right Definite RUL N 8 
15 60 Right Definite LLL  – 31 
16 71 Right Definite RUL N 112 
17 52 Right Definite LUL Y 11 
18 68 Right Definite LLL N 14 
19 60 Right Definite Bulbar N 26 
20 53 Right Definite LL Y 27 
21 59 Left Definite RLL N 11 
22 60 Left Definite LLL N 24 
23 71 Right Definite Bulbar N 16 
*RUL: right upper limb, RLL: right lower limb, LUL: left upper limb, LLL: left lower limb, 
LL: lower limb 
**Disease duration at the time of the first scan 
 





Table 6.3: Summary of clinical data. 
 At first scan At second scan p value 
Number of subjects 23 23 – 
Mean age in years (Mean±SD) 
(range)  
59±11 (29–80) – – 
Gender (male:female) 16:7 – – 
Disease duration in months 
(Mean±SD) 
27.6±24 33.0±24 – 
ACE–III (Mean ±SD) 92±4 89±6 0.02 
FAB (Mean ±SD) 16±2 15±2 0.24 
ALSFRS–R (Mean ±SD) 39±5 38±4 0.03 
 
TBSS 
When whole brain analysis was performed using TBSS, there was no significant 
difference between the first and second scans.  
 
FA and MD changes in motor pathways 
The results for the individual patients for each ROI for FA are shown in Figure 6.2. It 
can be seen that there was only a small change in FA between the two scans. In some 
patients there was a decrease, and in other patients there was an increase in FA.  
 





Figure 6.2: Individual FA plot at two time-points in the motor pathways and 
callosal tracts. In the motor pathways: corona radiata (CR), posterior limb of internal 
capsule (PLIC), medial leminescus (ML), pons, and the callosal tracts: corpus callosum 
(CC) at the genu (gCC), body (bCC), and splenium (sCC) and forceps minor (FM). 




We also calculated, for each ROI, the mean of the differences between the two scans  
∆FA = FA1 - FA2  
∆MD = MD1 - MD2 
where the subscript 1 or 2 indicates the first or second scan, respectively. The mean 
differences are shown in Table 6.4. The absolute values were small. 
 
Table 6.4: Mean of FA and MD differences between two scans. 
ROI Mean (SD) ∆FA  Mean (SD) ∆MD 
Rt.CR 0.0000 (0.007) 0.0006 (0.056) 
Lt.CR –0.0005 (0.008) 0.0006 (0.076) 
Rt.PLIC –0.0008 (0.009) 0.0173 (0.083) 
Lt.PLIC –0.0027(0.010) 0.0000 (0.114) 
Rt.ML –0.0076 (0.015) 0.0395 (0.180) 
Lt.ML –0.0049 (0.016) 0.0288 (0.182) 
Pons  –0.0077 (0.017) 0.0709 (0.245) 
Rt.FMi –0.0008 (0.006) –0.0079 (0.068) 
Lt.FMi –0.0013 (0.005) –0.0208 (0.071) 
gCC –0.0021 (0.007) –0.0190 (0.104) 
bCC –0.0009 (0.001) 0.0171 (0.152) 
sCC –0.0025 (0.007) 0.0006 (0.092) 
Rt.Cg –0.0004 (0.009) –0.0165 (0.101) 
Lt.Cg –0.0021 (0.007) 0.0143 (0.115) 
Rt.ILF 0.0022 (0.010) –0.0045 (0.086) 
Lt.ILF –0.0003 (0.010) –0.0014 (0.096) 
Rt.SLF 0.0010 (0.007) –0.0094 (0.282) 
Lt.SLF –0.0002 (0.009) 0.0048 (0.252) 
Rt.ALIC –0.0043 (0.009) 0.0078 (0.162) 
Lt.ALIC –0.0037 (0.012) –0.0036 (0.095) 
Rt.Hpc –0.0063 (0.013) 0.0610 (0.167) 
Lt.Hpc –0.0037 (0.014) –0.0226 (0.174) 
 




Table 6.5 shows the mean FA for the first and second scans. These were compared with 
a paired t test. There was little difference between the mean values. There was a 
significant increase in the FA along the CST at the right medial lemniscus (ML) 
(p=0.029) and pons (p=0.032). After correcting for age and gender, right ML showed 
significant changes but pons did not. However, after correcting for multiple 
comparisons these differences would not be significant. Using MD, there were no 
significant changes over time at any level of the motor pathways (data not shown). 




Table 6.5: Comparison of FA at first and second scans.  
ROI FA Mean (SD)   
 First scan Second scan p-value  
Callosal Tracts 
Right FMi  0.3639 (0.03) 0.3647 (0.03) 0.586  
Left FMi 0.3605 (0.03) 0.3618 (0.03) 0.266  
gCC 0.4887 (0.04) 0.4908 (0.04) 0.190  
bCC 0.5221 (0.04) 0.5230 (0.04) 0.689  
sCC 0.5884 (0.03) 0.5909 (0.03) 0.124  
Cortico–spinal Tracts 
Right CR 0.4076 (0.03) 0.4076 (0.03) 0.988  
Left CR 0.4129 (0.03) 0.4133 (0.03) 0.801  
Right PLIC 0.5517 (0.03) 0.5525 (0.03) 0.700  
Left PLIC 0.5493 (0.03) 0.5520 (0.03) 0.220  
Right ML 0.4912 (0.02) 0.4988 (0.02) 0.029*  
Left ML 0.4958 (0.02) 0.5007 (0.03) 0.163  
Pons 0.3879 (0.03) 0.3956 (0.03) 0.032*  
Association Fibers 
Right ILF 0.4893 (0.03) 0.4895 (0.03) 0.306  
Left ILF 0.5053 (0.03) 0.5031 (0.04) 0.907  
Right SLF 0.4293 (0.02) 0.4283 (0.03) 0.506  
Left SLF 0.4216 (0.03) 0.4218 (0.03) 0.898  
Extra–motor Tracts 
Right ALIC 0.4803 (0.03) 0.4846 (0.03) 0.040*  
Left ALIC 0.4732 (0.03) 0.4769 (0.03) 0.169  
Right Hpc 0.3339 (0.02) 0.3402 (0.03) 0.038*  
Left Hpc 0.3364 (0.03) 0.3401 (0.02) 0.243  
Right Cg 0.4042 (0.03) 0.4046 (0.03) 0.832  
Left Cg 0.4171 (0.03) 0.4192 (0.03) 0.177  
* Significant at p<0.05 
 




FA and MD changes in extra-motor pathways  
The values of the FA in individual patients are shown in Figure 6.3 and Figure 6.4. The mean 
differences between the two scan are shown in Table 4. Table 5 shows the results of a paired 
t-test comparison of the FA at first and second scans for association tracts and subcortical 
structures. There was a significant increase in FA in the tracts of the right hippocampus 
(p=0.038) and the right anterior limb of internal capsule (ALIC) (p=0.04). However, after 
correction for multiple comparisons these would not be significant. After correcting for age 
and gender, right ALIC showed significant changes but hippocampus did not. 
 




Figure 6.3: The individual FA plot at two time-points in the extra-motor 
gateways: anterior limb of internal capsule (ALIC), cingulum (Cg) and 
hippocampal gatways (Hpc). 





Correlation between DTI and ALSFRS-R 
We investigated the correlation of DTI measures with ALSFRS-R and disease duration at both 
time-points. At the first scan, there was an inverse relationship between FA and ALSFRS-R 
scores in all ROIs except in the ML and right hippocampus, where the relationship was positive. 
Table 6.6 shows that significant correlations with ALSFRS-R at baseline were seen in the genu 
of CC, bilateral forceps minor and bilateral ILF at p<0.05. At the time of the second scan, there 
were no significant correlations (see Table 6.6). 
 
At the first scan, there was a positive correlation between MD and ALSFRS-R scores in all 
ROIs (Table 6.7). There were significant correlations between MD and ALSFRS-R scores in 
the left hippocampus and bilateral ALIC. The association fibers showed strong correlations 
with ALSFRS-R in both ILF and SLF bilaterally. The cingulum on both sides, the forceps 
minor and the genu of CC also showed significant correlation at p<0.05. In the motor pathways, 
MD at baseline correlated with ALSFRS-R only in the corona radiata (p<0.05). 
  
Figure 6.4: The individual FA plot at two time-points in the in the association 
tracts: superior longitudinal fasciculus (SLF) and inferior longitudinal fasciculus 
(ILF). 














At the second scan, in motor pathways, ALSFRS-R had positive correlation with MD in all 
ROIs other than the body of CC and left corona radiata. In the extra-motor pathways, significant 
correlations were seen only with the right hippocampus (p<0.05), (Table 6.7). 
DTI correlation with disease duration 
At the first scan, FA showed negative correlations with disease duration in all ROIs except the 
right PLIC and right hippocampus. The only significant correlations were only in left and right 
ALIC at p<0.05 (see Table 6.6). At the second scan, FA had a negative correlation with disease 
duration in all ROIs except the right PLIC (Table 6.7). Table 6.6 shows the significant 
correlations in the regions right ALIC and bilateral ILF. A negative correlation means that as 
disease duration increases there is a decrease in FA. 
 
At the first scan, MD had a positive relationship with disease duration in all ROIs except the 
hippocampus and pons where it showed a negative correlation (Table 6.7). However, the 
significant correlations were in the ALIC, corona radiata and SLF and right ILF and left forceps 
minor. At the second scan, MD had positive correlation except in the right hippocampus. ALIC, 
ILF and SLF had a significant correlation with disease duration. Left forceps minor and right 
corona radiate showed a positive correlation with disease duration (Table 6.7). A positive 
correlation means that as disease duration increases there is an increase in MD. 
 
Correlation between change in FA and change in ALSFRS-R 
There was a negative correlation between the change in FA and the change in ALSFRS-R in 
the splenium of the corpus callosum (p=0.029) and the right cingulum (p=0.009), Table 6.8. In 
all but two ROIs (left CR and left Cg) the sign of the Pearson correlation coefficient was 
negative, indicating an inverse relationship between the change in FA and the change in 
ALSFRS-R. However, this relationship was not statistically significant. 
  






Table 6.8: Correlation between change in FA and change in ALSFRS-R 
ROI Pearson correlation p-value (2 tailed) 
Rt.sCR –0.009 0.969 
Lt.sCR 0.066 0.764 
Rt.PLIC –0.140 0.523 
Lt.PLIC –0.016 0.942 
Rt.ML –0.362 0.090 
Lt.ML –0.186 0.395 
Pons –0.257 0.237 
Rt.FMi –0.150 0.496 
Lt.FMi –0.330 0.124 
gCC –0.095 0.665 
bCC –0.317 0.140 
sCC –0.454 0.029* 
Rt.ILF –0.188 0.391 
Lt.ILF –0.364 0.088 
Rt.SLF –0.045 0.840 
Lt.SLF –0.072 0.744 
Rt.Cg –0.534 0.009** 
Lt.Cg 0.329 0.125 
Rt.Hpc –0.392 0.064 
Lt.Hpc –0.376 0.077 
Rt.ALIC –0.156 0.476 
Lt.ALIC –0.287 0.185 





There is a need to measure the progression of ALS, for use in prognosis and in clinical 
trials and to understand disease pathogenesis (Bowser, Turner et al. 2011). There has 
been interest in the role of ROI studies in DTI of fiber tracts to evaluate progression of 
ALS (Kassubek, Müller et al. 2014) but the results have been variable. This study was 
performed to determine the usefulness of DTI of WM tracts in ALS, as a measure of 
disease progression over a 6–month interval.  
 
We used DTI to study WM changes on MRI scans performed 6–month apart. Over this 
time period there was some evidence of clinical progression as seen by decline in 
clinical scores of motor function and cognition. Over this time interval there was little 
difference in the mean values for FA and MD. ROI analysis of FA revealed marginally 
significant changes in the motor pathways. However, it should be noted that these 
changes would not be significant after correcting for multiple comparisons.  
 
If we do not correct for multiple comparison, then there was evidence of abnormality 
in the distal portion of the intracranial CST in both ALIC, ML and pons. Microstructural 
degeneration of the caudal WM tracts confirms previous DTI studies (van der Graaff, 
de Jong et al. 2009, Prudlo, Bissbort et al. 2012, Sheelakumari, Madhusoodanan et al. 
2015). Previous DTI studies using an ROI method showed a bilateral reduction in FA 
along the CST (Jacob, Finsterbusch et al. 2003) while other studies found changes in 
CST to be confined to the right hemisphere (Zhang, Schuff et al. 2011). The changes in 
motor pathways over time are consistent with the known atrophy in ALS (Jacob, 
Finsterbusch et al. 2003, Keil, Prell et al. 2012).  
 
We found some evidence of progressive changes in the hippocampus. No previous 
study has identified DTI changes over time in the hippocampus, but there is known to 
be atrophy of the hippocampus in ALS (Abdulla, Machts et al. 2014). Hippocampal 
abnormality was found previously in one MRI study of ALS at advanced stages of the 
disease (Stoppel, Vielhaber et al. 2014). We found no significant changes in FA or MD 
in whole brain analysis using TBSS. 





Therefore, our study therefore shows little change in DTI measures over 6 months in 
ALS patients, when the results are corrected for multiple comparisons. There have been 
inconsistent findings in other serial studies (Table 6.9), with some studies finding no 
change and others finding change in different directions. This study agrees with those 
who found little change over time. We scanned our patients in a higher field strength 
(3T) than some previous studies (Table 6). The lack of significant change between the 
ROIs or with TBSS could be due to the relatively short 6-month interval between scans, 
as other studies have reported that longer intervals have shown significant changes from 
baseline (Nickerson, Koski et al. 2009) or to the lack of sufficient progression in our 
patients over this time period. We note that some of our patients had long survival and 
so had slowly progressive disease. 
 
Significant change in FA and MD using TBSS again could be due to the relatively short 
6–month interval between scans, as other studies have reported that 9 months between 















A further possibility is that degeneration of upper motor neurons is an early event in ALS, and 
that by the time we have performed the scans, degeneration is complete in the tracts linked to 
the upper motor neurons. In this case, no further change would be observable by brain DTI. 
The evidence for early damage to upper motor neurons comes from studies showing early 
changes in cortical excitability (Menon, Kiernan et al. 2015) and our study that showed that 
upper motor neuron signs appear before lower motor neuron signs as the disease spreads 
(Devine, Kiernan et al. 2014). This was the explanation favored by Menke et al in their study 
(Menke, Körner et al. 2014), which found little change in DTI over time. 
 
Another reason for the lack of significant change could be the small sample size. If we did not 
correct for multiple comparisons, then there were some suggestive results. The necessity for 
correction for multiple comparison is argued (Rothman 1990). Possibly with increased 
numbers these would be more significant. 
 
We found changes only in the right hemisphere, which is consistent with previous work by 
Steinbach et al (Steinbach, Loewe et al. 2015). The role of handedness in ALS is poorly 
understood. It has been proposed that ALS with upper limb onset is more likely to be 
concordant with handedness than ALS with lower limb onset with footedness (Turner, Wicks 
et al. 2011). A recent study from our group has found that handedness influences both the site 
of onset and the spread of pathology (Devine, Kiernan et al. 2014). This asymmetry in brain 
pathology has also been found in other diseases such as FTD. 
 
In the present study, we found correlation between change in some DTI measures and disease 
progression measured by change in the ALSFRS–R in the CC and Cg. This is similar to 
findings of a previous study (Abhinav, Yeh et al. 2014). A relationship between DTI metrics 
in motor pathways and disease duration has been documented previously (Steinbach, Loewe et 
al. 2015). However, the significance of our findings is unclear because some of the correlations 
were with increasing FA, which is contrary to what is expected, and further work on DTI 
correlations is required. 
 




We also found that the change in FA over 6–months was negatively correlated with the change 
in ALSFRS–R over 6–months in all but two regions and was statistically significant in the 
corpus callosum. Our findings support a recent MRI study that highlighted the degeneration of 
the corpus callosum in ALS (Bartels, Mertens et al. 2008). The lack of any correlations between 
FA and disease severity measure (Mitsumoto, Ulug et al. 2007, Iwata, Aoki et al. 2008) or 
disease duration after correcting for multiple comparisons is in agreement with other studies 
(Trojsi, Corbo et al. 2013, Grapperon, Verschueren et al. 2014). Previous studies of the 
consistency and reporducibiuity are given in Chapter 7. 
 
In summary, this study shows little change with DTI over 6 months, but the change that we did 
observe were in the motor pathways and there was some correlation with clinical progression. 
Given the heterogeneity of ALS, in terms of the clinical features and progression, it is likely 
that larger studies are needed to explore this further. 
  




Chapter 7: 12–month follow-up DTI 
evaluating whole brain and corticospinal 




Results from the conducted systematic review (chapter 4), highlighted the consistent finding 
of the involvement of corticospinal tract. In the previous chapter (chapter 6), 21 regions of 
interest were examined from both motor and extra- motor pathways. Based on the results from 
both studies, in this chapter I will address aim four of this thesis “to investigate the DTI changes 
of CST over 12 months to determine if there are significant changes over time and whether the 
rate of change of DTI over 12 months correlates with clinical progression”. This will be 
submitted for publication as a manuscript entitled “Serial DTI studies over twelve months in 








Serial DTI studies over 12 months  
Introduction 
Amyotrophic lateral sclerosis (ALS) is a disease that is characterized by the progressive loss 
of lower motor neurons (LMN) in the spinal cord and brain stem and of upper motor neurons 
(UMN) in the motor and premotor cortex (Rafałowska and Dziewulska 1995). The pathology 
of ALS is accumulation of aggregates of proteins within cells, with the majority of patients 
having accumulation of the protein TDP-43 (Neumann, Sampathu et al. 2006, Kwong, 
Neumann et al. 2007). Pathological studies suggest that this protein accumulation gradually 
spreads to other regions as disease progresses (Brettschneider, Del Tredici et al. 2013). 
Eventually there is loss of the corticospinal tract and gliosis, which leads to the naming of the 
disease for the loss of muscle bulk (amyotrophy) and gliosis of the corticospinal tracts (lateral 
sclerosis) (Schiffer, Cordera et al. 1996). 
 
MRI studies in ALS have shown abnormalities in voxel–based morphometry (VBM) and 
diffusion weighted imaging (DWI) (Graham, Papadakis et al. 2004, Hong, Lee et al. 2004, 
Chang, Lomen-Hoerth et al. 2005, Kassubek, Unrath et al. 2005, Bede and Hardiman 2014). 
Diffusion-weighted imaging is sensitive to water motion; thus, any alterations in the degree of 
diffusion can reflect alterations in the microscopic environment of the water molecule. The 
restriction of water diffusion and higher diffusion anisotropy are associated with WM 
maturation and myelination. Measurements of diffusion can be obtained using diffusion tensor 
imaging (DTI). The measurement that is most widely used in clinical studies is fractional 
anisotropy (FA). 
 
DTI changes in can be evaluated using Tract-Based Spatial Statistics (TBSS), first described 
by Smith et al (Smith, Jenkinson et al. 2006). This is a voxel-wise method which increases the 
sensitivity and the interpretability of DTI images and aims to solve the drawbacks of simple 
voxel-wise methods by projecting measurements onto a white matter skeleton.  
 
DTI changes can also be evaluated using region of interest (ROI) studies. This analysis groups 
anatomically related voxels, which increases the statistical power. ROI analysis can be 
performed by manual or semi-automated methods (Aribisala, Cox et al. 2013). Manually drawn 




ROIs have been considered to have problems with reproducibility, because the technique is 
operator dependent. In the manually drawn ROI, selected regions typically contain fewer 
voxels than automated methods. However, manual ROI can easily be used in clinical 
laboratories. 
 
Cross-sectional DTI studies have consistently shown reduction in FA in the corticospinal tract 
(CST) in ALS patients compared to controls using either whole brain or regional analyses (Abe, 
Yamada et al. 2004, Karlsborg, Rosenbaum et al. 2004, Iwata 2007, Sarro, Agosta et al. 2011). 
In contrast to cross-sectional studies, longitudinal DTI studies of ALS have shown conflicting 
findings (Blain, Williams et al. 2007, Nickerson, Koski et al. 2009, Ajroud-Driss, Mansour et 
al. 2012, Keil, Prell et al. 2012, Verstraete, Walhout et al. 2012). Thus, it is yet unclear whether 
DTI is sensitive to changes in CST over time.  
 
Here we have performed a serial study of patients with ALS, with the aim of determining 
whether there are changes over time in the white matter tracts, using TBSS, and whether there 
are changes over time in the CST, using an ROI approach. The second aim was to compare the 
semi-automated ROI with manual ROI. The final aim was to examine the correlation of change 
in FA with survival. 
Methods 
Subjects: 
Fifteen ALS patients (mean age 60±13, 10 males and 5 females) were enrolled in this study. 
They were scanned three times at 6 monthly intervals. All patients had a diagnosis of ALS by 
the revised El Escorial criteria (Brooks, Miller et al. 2000). Three of the patients had slowly 
progressive course (survival of more than 60 months from the date of onset). Disease severity 
was measured using ALSFRS-R, which is used for assessing functional and respiratory decline 
in ALS patients (Cedarbaum, Stambler et al. 1999). Thirteen healthy controls (mean age 50±16, 
6 males and 7 females) were used as control group. This project was approved by the RBWH 
ethics committee HREC (2008/98). All subjects provided written informed consent. Table 7.1 
shows the details of patients and controls. 




Patients were grouped into those with normal cognition ALSnon-cog and those with impaired 
cognition (ALScog), on the basis of performance on the ACE-III with a cut-off point of 88. 
There were 4 ALScog subjects with median age 63 (range 51-80 years) and 11 ALSnon-cog 
subjects with median age 59 (range 28 – 73 years).










 6-months 12-months  
Age (years) Mean (SD) 62±11 60±13* 50±16* 
Gender (Male:female) 16:7 10:5# 6:7# 
ALSFRS-R Mean (SD) 
38±4 
38.7±4.5 NA 






Number of patients deceased at 
end of study 
 6 0 
ACE-III Mean (SD) 89±6 88±7 NA 
FAB Mean (SD) 15±2 15±3 NA 
 * p=0.005, # not significant 
 
MRI acquisition and pre–processing of HARDI 
MRI scans were obtained and pre-processed as described in Chapters 5 and 6. 
 
TBSS analysis 
Tract-based spatial statistics (TBSS) was used to perform voxel-wise statistical testing on DTI 
variables. The alignment of the DT images to a reference space is required. This allows 
spatially overlapping voxels of different datasets to correspond to the same anatomical 
structures. In this study we used TBSS to perform comparisons of two or three groups of scans. 
For the comparison of two groups, DTI whole brain analysis was performed following the 
standard procedure of voxel–wise cross-subject analysis using TBSS. After correcting for 
motion artefacts, the resulting individual FA volumes were directly registered to the FMRIB58 
template (Smith, Jenkinson et al. 2006, Smith, Johansen-Berg et al. 2007). The mean FA-image 
was created following registration and thinned to represent the mean FA skeleton using the 




FSL TBSS manual. Individual FA volumes were then projected onto this common skeleton 
(Liu, Spulber et al. 2011). Following these steps, data were fed into voxel-wise cross-subject 
statistical analysis with different group comparisons, including a paired test. The statistical 
analyses were performed by employing the voxel-wise general linear model (GLM) and 
significant clusters were formed by employing the TFCE method to correct for multiple 
comparisons (Smith and Nichols 2009), implemented in FSL randomise. P-values were 
determined using 5000 random permutations (Nichols and Holmes 2002). The results are 
considered significant at p<0.05, corrected for multiple comparisons using TFCE. 
 
To analyze differences among three groups, we combined the scans from all three time-points 
of patients in one group and ran the TBSS steps as above to create FA skeleton of whole group. 
Before the randomise run, we separated scans for each time-point from the FA skeleton. Next, 
two time-points were merged to one skeleton. Then, using randomise with multiple 
permutations and correcting for multiple comparisons using TFCE (p <0.05), we ran two 
different statistical approaches: (a) one sample t-test; by subtracting each time-point from the 
other one in six contrasts (1 minus 2, 1 minus 3, 2 minus 1, 2 minus 3, 3 minus 1, 3 minus 2) 
and the output is the difference between time-points; (b) paired sample t-test; comparing two 
time-points each time, separately, using the contrast as (scan 1 versus scan 2, scan 2 versus 
scan 3, scan 1 versus scan 3); c) triple t-test; comparing all three time-points; d) two-sample 
unpaired T-test to compared each time-point with controls. These statistical contrast were 
performed excluding longer disease duration and again with ALS patients sub-grouped based 
on their cognitive testing  
 
The final results from TBSS comparisons of ALS patients at each time-point were 
superimposed using FSL ( http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/ ). 
 
Automated ROI analysis methods 
For the automated ROI, Advanced Normalization Tools (ANTs) was used on FA data using 
the methods described in Chapter 6. The datasets were analyzed by one rater (A, R A) who was 
unaware of the identity of the subject. There were no FA skeleton created using ROI method. 
We examined the CST at the level of pons, which is shown in Figure 7.1 and the posterior limb 
of the internal capsule (PLIC) as shown in Figure 7.2. These regions were chosen because 




degeneration of the CST is a cardinal feature of ALS. We included the PLIC expecting the 
highest sensitivity where highest neuronal alignment and no crossing fibers present. The FA 





Figure 7.1: Atlas-based ROI of the CST at the pons. This figure illustrates, in 3 planes, 
the mask applied for the CST in the pons using the FA template with atlas-based ROI. 
(Left in blue and right in red). With this method, all the voxels from the entire 
structure are included in the ROI. 





Manual ROI methods 
Manual ROIs were drawn on the colored FA maps based on anatomical knowledge. One axial 
slice was selected for each region. To delineate the CST in the pons, the ROI was drawn at the 
level of brain stem where the pontine crossing tracts (pct) are a straight red line, which is part 
of the middle cerebral peduncle (mcp). The pontine CST can be seen as two blue-purple regions 
anterior to the pct (Figure 7.3, left).  
 
For the PLIC, the ROI was drawn on the last axial slice where the genu and splenium of corpus 
callosum and the fornix are seen in one plane. On colored FA maps, the PLIC appears as a 
blue-purple region; anterior to it is the green anterior limb of internal capsule (ALIC) and 






Figure 7.2: Atlas-based ROI of the PLIC. This Figure illustrates, in 3 planes, the mask 
applied for the PLIC, using the FA template with atlas-based ROI. (left in blue and 
right in red). With this method, all the voxels from the entire structure are included 
in the ROI. 






Statistical analyses were performed using SPSS for Mac (Ver. 23.0, SPSS Inc., Chicago, IL, 
USA). Mean and standard deviation values were calculated for each variable. All data were 
tested for normality using Shapiro–Wilk test. MANOVA was performed when testing ROIs at 
three time-points for each region of interest.  
 
We used TBSS to compare the values at three different time-points (Scan 1, Scan 2 and Scan 
3). We also repeated this analysis after excluding subjects with long survival, who would be 
expected to show a lesser change over time. We also compared the scans from ALS subjects at 
each time-point to controls. Finally we compared the patients with cognitive impairment with 
those without cognitive impairment at each time-point, and made a comparison of the first 
scans with the third scans. 
 
To examine whether the rate of loss of FA was related to clinical feature, the FA slope was 
calculated from raw FA data at three different time-points, for each subject, using MatLab 
Figure 7.3: Manual ROI of the CST at the pons and PLIC. This Figure illustrates in two 
different axial planes for individual patient FA maps and the mask applied for the manual 
ROI for the pontine CST (left) and PLIC (right). With this method, only the voxels from 
one plane are included in the mask of the ROI. 




(R2014b, The MathWorks Inc., Natick, MA). We then used Pearson correlation test 
implemented in MatLab to determine whether there was a correlation between the FA slope 
and survival from the date of onset to death or censoring. The correlation was performed to 
determine if the rate of change of FA is linked to disease progression. The Spearman’s 
correlation and the Pearson correlation were used to examine nonlinear and the linear 
relationship, respectively. We then pooled all the FA data from all subjects from all time-points 
into one regression analysis to examine the overall trend of the relationship between both ROI 
methods for each region. We examined the relationship between manual ROI and atlas ROI 
using Spearman’s correlation. 
 
The accuracy and reproducibility of ROIs is an important aspect of the quality control. It 
depends on the operator’s ability to draw the same region accurately and consistently. Here, 
five random patients were selected to repeat the manual ROI in one-month difference from the 
first measure.  
Results 
TBSS results 
The results of TBSS analysis are shown in Table 7.2. There was no significant difference 
among the scans of ALS subjects at three time-points when comparing whole ALS group or 
when excluding patients with longer disease duration. 
  





Table 7.2: Comparisons that were examined with TBSS. 
Group1 Group2 Group3 Significance 
Comparison of 3 groups 
Time-point 1 (N=15) Time-point 2 (N=15) Time-point 3(N=15) NS 
Time-point 1 exclude 
longer DD (N=12) 
Time-point 2 excluding 
longer DD (N=12) 
Time-point 3 excluding 
longer DD (N=12) 
NS 
Comparison of 2 groups 
Time-point 1 (N=15) Controls (N=13)  p<0.05 
Time-point 2 (N=15) Controls (N=13)  p<0.05 
Time-point 3 (N=15) Controls (N=13)  p<0.05 
Time-point 1 ALS non-
cog (N=11) 
Time-point 1 ALS-cog 
(N=4) 
 NS 
Time-point 2 ALS non-
cog (N=10) 
Time-point 2 ALS-cog 
(N=5) 
 NS 
Time-point 3 ALS non-
cog (N=10) 
Time-point 3 ALS-cog 
(N=5) 
 NS 
Time-point 1 (N=15) Time-point 3 (N=15)  NS 




However, at each of the three time-points, the overall FA in the ALS scans was reduced 
compared to that of controls. Figure 7.4 shows the TBSS results of three scans superimposed 
on the mean subject FA template (p<0.05; corrected TFCE). Figure 7.4 shows that the changes 
in the CST and CC were more widespread at the third scans (shown in green) than in the earlier 
time-points (shown in red and blue).  
 
 
When subgrouping patients based on their cognitive scores (ACE-II), there were no significant 
difference between ALS without cognitive impairment and those with cognitive impairment 
at, at any of the three time-points. 
R L 
Figure 7.4: TBSS results of three time-points for ALS subjects compared to controls. The 
differences between ALS and controls are more extensive in the third scan in the CST and 
corpus callosum. 





FA results at each time-point 
Atlas-based ROI 
The results of the atlas-based ROI analysis of FA for individual patients at each time-point are 
shown in Figure 7.5. There was considerable variation among individuals, with some showing 
increase in FA and some showing a decrease over time. 
 
 
Manual ROI  
The results of the manual ROI analysis of FA for individual patients at each Time-point are 
shown in Figure 7.6. There was considerable variation among individuals.  
Figure 7.5: Atlas-based ROI FA measurement for individual patients at three 
time- points in the PLIC and CST in the pons. Using MANOVA there were no 
significant difference among the mean values at each time-points. 






Average FA for each atlas based and manual ROI methods 
 
We performed MANOVA to determine whether the average FA values were significantly 
different over time (Table 7.3). There was no significant difference among the three time-points 
for either method. Therefore, we acquired the estimated marginal means for each time-point 
using both methods to test whether both methods are comparable, Figure 7.7. 
  
Figure 7.6: Manual ROI FA measurement for individual patients at three time-
points for the CST at the pons and PLIC. Using MANOVA there were no significant 
difference among the mean values at each time-points. 
 





Table 7.3: Means (SD) for FA at three Time-points using atlas-based ROI and manual 
ROI. 
 
Atlas based ROI 




rt CST 0.462 (0.026) 0.465 (0.042) 0.465 (0.034) 0.832 
lt CST 0.456 (0.027) 0.461 (0.035) 0.459 (0.027) 0.475 
rt 
PLIC 
0.559 (0.016) 0.560 (0.020_ 0.561 (0.019) 0.690 
lt PLIC 0.558 (0.021) 0.561 (0.023) 0.558 (0.025) 0.644 
Manual ROI 
rt CST 0.474 (0.065) 0.469 (0.070) 0.437 (0.050) 0.226 
lt CST 0.466 (0.056) 0.472 (0.064) 0.450 (0.040) 0.517 
rt 
PLIC 
0.599 (0.028 0.599 (0.023) 0.602 (0.024) 0.928 
lt PLIC 0.599 (0.038) 0.604 (0.044) 0.594 (0.037) 0.782 
 
 





A summary of the FA at the three time-points for each region, using both methods, can be seen 
in Figure 7.8. In general, the values for the manual ROI are greater than the atlas based values, 
and show greater spread. 
Figure 7.7: Estimated marginal means for every ROI in both methods (mROI in 
blue (1) and aROI in green (2)). There was better agreement for the PLIC (upper 







































To compare the FA value between the PLIC and pontine CST, we have combined the 90 FA 
values for both sides from all time-points and calculated the mean for two methods (Table 7.4). 
The average FA from the PLIC is significantly greater than that of the CST in the pons, using 
both methods. 
 
Table 7.4: FA averaged mean of ROIs in both methods. 
ROI Mean FA SD 
mPLIC 0.60 0.001 
aPLIC 0.56 0.003 
mCST 0.46 0.001 
aCST 0.46 0.003 
 
Figure 7.8: The mean and median differences for each ROI in every time-point 
































Correlation of mROI with aROI 
We performed a linear regression between atlas-based and manual-based measurements for 
each ROI using all the observations from the three time-points (Figure 7.9). There was better 







Figure 7.9: Regression results for FA values for all scans in every ROI 

















































































We also performed a Spearman’s correlation of ROI measurements to compare the manual 
versus atlas-based ROI methods testing if both methods are comparable (Table 7.5). The 
correlation in the left PLIC was significant (p=0.01, r=0.6) 
 
Table 7.5: Correlation of FA in both methods. 
 ROI p value R value 
Rt PLIC 0.069 0.482 
Lt PLIC 0.011 0.636 
rt CST 0.713 0.104 
lt CST 0.296 0.289 
 
  





Slope of the curve of FA at each time-point 
Linear regression was performed on three scans for each subject, to determine the slope of the 
curve using data from all three time-points. Results are shown in Tables 7.6 and 7.7. A negative 
value represents a decline in FA over time. 
 
Table 7.6: Slope the FA curve for the atlas-based ROI. 
 Slope of the FA curve for the aROI (*10-3 per month) 
Subject rt.CST Lt.CST Rt.PLIC lt.PLIC 
1 0.05719 0.00005 -0.01061 0.00361 
2 0.06433 0.01122 0.04388 -0.00717 
3 -0.03519 0.01126 0.01758 -0.01854 
4 0.01601 0.02797 0.02182 0.03035 
5 -0.06136 -0.02240 -0.00024 0.00748 
6 -0.02899 0.02037 -0.02489 -0.06796 
7 0.00915 0.05567 0.02065 0.03082 
8 0.02798 0.04801 -0.00460 0.02487 
9 -0.02847 -0.04821 -0.02336 0.00051 
10 0.02664 -0.00628 0.00911 0.01233 
11 0.00754 0.03414 -0.02787 -0.00180 
12 0.18502 0.14051 -0.00446 -0.00695 
13 -0.11025 -0.03194 0.02233 0.00925 
14 -0.00255 -0.01735 -0.00325 -0.00163 
15 0.00829 -0.07877 0.03232 -0.00936 
 
  





Table 7.7: Slope of the FA curve in manually drawn ROI. 
 Slope of the FA curve for the mROI (*10-3 per month) 
Subject Rt CST Lt CST Rt PLIC Lt PLIC 
1 -0.07528 -0.09136 0.08952 -0.00087 
2 -0.24096 0.18076 0.04642 0.00523 
3 -0.00532 -0.15835 -0.02525 0.00008 
4 0.01916 0.03263 -0.02132 -0.00318 
5 0.00681 -0.02550 -0.01938 -0.00121 
6 -0.19115 -0.04689 0.05721 0.00395 
7 0.32633 0.01437 0.00954 -0.00115 
8 -0.30329 -0.11183 0.07035 -0.00211 
9 -0.27625 -0.22039 -0.11235 -0.00037 
10 -0.06941 -0.13876 0.05965 -0.00175 
11 0.13134 0.03616 -0.08274 0.00416 
12 -0.04049 0.11661 -0.00965 0.00094 
13 -0.24392 -0.03962 0.11939 0.00450 
14 0.05890 0.06808 0.03191 -0.00424 
15 -0.45347 -0.23641 -0.07563 0.00277 
 
 




Figure 7.10 illustrates a summary of the results of the slope of the curve for change in FA. 
There was greater variability of the result obtained using the manual ROI than these obtained 
with the atlas based ROI.  
 
 
Correlation of rate of loss of FA with clinical features 
To determine if the rate of change of FA is linked to disease progression, the slope of the FA 
curve obtained with each method was correlated with survival from onset to death or censoring. 
This was done using both the Spearman’s correlation to examine nonlinear relationship (Table 
7.8) and the Pearson correlation; for the linear relationship (Table 7.9). A positive correlation 
indicates that as FA loss increases, survival is shorted and a negative correlation indicates that 
as loss of FA declines, survival is longer. Using Spearman’s correlation, there was a significant 
negative correlation of survival with the FA of the CST in the pons, using manual ROI. 
  
Figure 7.10: FA slope using both ROI analyses. There was a greater range of 



























Table 7.8: FA slope correlation with survival from onset to death or censoring using 
Spearman’s correlation. 
   Survival 
 Spearman’s correlation p-value 
mROI_rtCST 0.532 0.041* 
aROI_rt.CST 0.089 0.752 
mROI_ltCST 0.625 0.013* 
aROI_Lt.CST 0.107 0.704 
mROI_rtPLIC 0.096 0.732 
aROI_Rt.PLIC 0.189 0.499 
mROI_ltPLIC -0.029 0.919 
aROI_lt.PLIC 0.243 0.383 
 
Table 7.9: FA slope correlation with survival from onset to death or censoring using 
Pearson correlation. 
 Survival  
ROI Pearson correlation p-value 
mROI_rtCST 0.396 0.144 
aROI_rt.CST 0.052 0.854 
mROI_ltCST 0.574 0.025* 
aROI_Lt.CST 0.156 0.579 
mROI_rtPLIC -0.128 0.650 
aROI_Rt.PLIC 0.020 0.945 
mROI_ltPLIC -0.215 0.441 
aROI_lt.PLIC 0.181 0.517 
 
 
Using the same methods, we also investigated whether the rate of loss of FA was predictive of 
survival from the time of the third scan to death or censoring, Table 7.10 and 7.11. There was 
a correlation of survival with the FA of the left but not the right CST, using manual ROI. 
 
  




Table 7.10: FA slope correlation with survival from last scan to death or censoring. 
 
ROI Pearson Correlation p-value 
mROI_rtCST 0.207 0.460 
aROI_rt.CST 0.224 0.423 
mROI_ltCST 0.651 0.009** 
aROI_Lt.CST 0.361 0.186 
mROI_rtPLIC 0.352 0.199 
aROI_Rt.PLIC 0.315 0.253 
mROI_ltPLIC 0.201 0.473 




Table 7.11: FA slope correlation with survival from last scan to death or censoring. 
 
ROI Spearman's rho p-value 
mROI_rtCST 0.201 0.474 
aROI_rt.CST 0.376 0.167 
mROI_ltCST 0.641 0.010* 
aROI_Lt.CST 0.344 0.210 
mROI_rtPLIC 0.367 0.178 
aROI_Rt.PLIC 0.337 0.220 
mROI_ltPLIC 0.240 0.389 
aROI_lt.PLIC 0.555 0.032* 
   
 
Reproducibility of manual ROI 
Reproducibility of manual ROI was tested with one month difference between manula ROI 
placements. The within-subject coefficient of variation (CV) was 0.1–3.6% in the aROI and 
was 0.007–11% in the right PLIC in the mROI to be. In terms of reliability, the inter-rater and 
intra-rater variability can be assessed using the intra-class correlation coefficient (ICC) (Koch 




2004). This have been reported to be between 17% – 37% (Bonekamp, Nagae-Poetscher et al. 
2005). In our study, ICC was between 24% – 38% for the right pons while the left pons was 
74% – 85%. In the right PLIC, the ICC was 37% – 54% and the left PLIC was 65% – 79%. 
Discussion 
ALS is a disease that shows progressive muscle weakness leading to death in 3–5 years. The 
underlying pathology is death of upper motor neurons, degeneration of the CST, and death of 
lower motor neurons. In the CST in the cord there is eventual gliosis. To measure these 
processes during life is difficult. DTI is a measure of fiber tracts and in this study we have 
examined changes in DTI measures, with the hypothesis that there would be degeneration over 
time and that this would be seen as loss of FA. We used TBSS for an overview of all the fiber 
tracts and ROI of the PLIC and CST to determine whether MRI can show changes in these 
motor pathways that are known to degenerate in ALS. We also investigated whether the rate 
of change of FA in the motor pathways was related to survival. 
 
We have examined patients at three different time-points, 6 months apart. With TBSS there 
were no significant differences among the groups of scans at each time-point. Compared to 
controls, there were significant differences in the ALS patients at each time-point, and these 
were more extensive on the third scan than on the earlier scans. In the scans at the third time-
point, the changes were more extensive in the CST and the commissural fibers. Thus, with 
TBSS there was some evidence of change over time in motor pathways. 
 
We also used ROI analysis to test our hypothesis that there would be changes in the FA in the 
CST at pons and PLIC. The FA of different ROIs was calculated using atlas–based and manual 
methods. There were no significant differences in the average FA between time-point. 
However, there was considerable variation among patients, and some patients showed loss of 
FA overtime while others did not. This difference between TBSS and ROI has been noted 
previously, in a study that found that ROI methods showed less significant results than TBSS 
methods (Kasper, Schuster et al. 2014). 
 
There are possible reasons why there would be little change in FA over time. Firstly, ALS 
patients are heterogeneous in their survival, with some patients showing prolonged survival 




(Turner, Parton et al. 2003, Mateen, Carone et al. 2010, Pupillo, Messina et al. 2014). In our 
cohort, some of the patients had long survival and slowly progressive disease, and therefore 
would not be expected to show rapid change in fiber tracts.  
 
Next, it is likely that after a fiber tract has progressively degenerated, there will be no further 
change in DTI. Some of our patients were later in the stage of the disease, and would be likely 
to have reached a state when the fiber tracts had been lost. If loss of fiber tracts leads to decline 
in FA, then the decline would be expected to cease at this point and therefore were incapable 
of further pathological change. After there has been loss of fibers, there is a subsequent phase 
of reactive gliosis, for which there is unlikely to be any further change in FA (Schiffer, 
Attanasio et al. 1994). 
 
However, it is also possible that, even early in disease, the degeneration in the motor tracts is 
substantially complete. In a study by Menke, similar results were found with little change in 
DTI over time (Menke, Körner et al. 2014). These authors suggested that this indicates that 
upper motor neuron degeneration occurs early in the disease which is clinically evident. Our 
previous study of clinical signs in ALS show that UMN degeneration also occurs early (Devine, 
Kiernan et al. 2014), and neurophysiological studies of excitability also suggest that upper 
motor neuron degeneration occurs early (Vucic 2011). This could mean that changes in FA 
occur early in disease. 
 
However, even though there was no significant change in DTI in the whole group, there was 
change in some patients and some correlation of rate of change in FA with survival (Vucic 
2011). This could suggest that in those patients in whom change in FA is seen, this is a marker 
of progression. 
 
In the current study we compared the value for atlas based and manual ROI. The manual 
methods gave a wider spread of values of FA. Our results would suggest that better results are 
obtained from the PLIC than the CST in the pons. This is in alignment with previous work that 
targeted FA measurement at the PLIC and suggested that PLIC may provide prognostic 
information (Menke, Abraham et al. 2012). Linear regression showed a significant relationship 
between the manual and atlas based methods for the PLIC but not the pons. This can be 
explained by the WM pathways crossing at this level which can lead to a substantial drop of 




FA in the map which may affect the result reliability. Using Spearman’s correlation, there was 
a significant correlation of the values for the left PLIC and the correlation approached 
significance for the right PLIC. Manual ROI has been criticized for being operator dependent 
and thus less reliable than atlas based methods (Prokscha, Guo et al. 2014). However, we found 
that both methods are still comparable which is in support of previous studies (Mori, Oishi et 
al. 2008, Oishi, Faria et al. 2009). Rigorous published work have compared different automated 
methods (Babalola, Patenaude et al. 2009) and test-retest reproducibility (Morey, Selgrade et 
al. 2010) in segmentation approaches and suggests that atlas-based methods are the best 
(Aribisala, Cox et al. 2013). 
 
Limitations of our study are the small sample size, and the duration between scans during the 
study. We did not perform serial MRI in controls, so we cannot comment on whether the 
changes that we see on repeated testing differ from those of controls. Previous studies have 
reported that although inter-site DTI measurement variability was found to be quite high (Zhu, 
Hu et al. 2011), the intra-subject variation was less than 1% in different brain regions using 
DTI (Magnotta, Matsui et al. 2012). Our patients showed variation of more than 1%, therefore 
changes we observed are unlikely to be caused by measurement error alone. The ICC from the 
current study are similar to these of published studies except for the differences between the 
left and right side of the pons. The pons is well recognized to be a difficult site for DTI because 
of the crossing fibers (Bonekamp, Nagae-Poetscher et al. 2005). We have also noted that there 
is asymmetry of the changes in ALS. 
 
In conclusion, we found little evidence of progression of ALS using DTI. We found that there 
were greater changes in TBSS with increasing time and some correlation of change in FA with 
disease progression, as well as reduced FA in the pons compared to the PLIC. However, the 
changes were small, and not significant in serial ROI studies. Larger studies, with patients with 
more rapidly progressive disease are needed to confirm this, but we find little evidence that 
serial DTI studies will be a good marker for progression of ALS. 
 
 




Chapter 8: Discussion 
 
This study was concerned with the role of MRI in assessing changes in the brain of 
patients with ALS. It focused particularly on the MRI abnormalities associated with 
cognitive change in patients with ALS, and the use of serial DTI to monitor disease 
progression. Up to three MRI scans were performed at 6–month intervals. Patients were 
screened for cognition and behavioral impairment using ACE-III and FAB. 
 
The overall aim of the thesis was to investigate the use of DTI in studies of disease 
progression of ALS. The specific aims were; 
1. To identify the tracts that are altered in both ALS and FTD by performing a 
thorough review of the literature on DTI in these diseases.  
2. To identify brain regions involved in ALS patients with and without cognitive 
impairment compared to controls by using WM and GM analyses to investigate 
the DTI and structural changes. 
3. To investigate the WM changes, either in motor or extra-motor pathways in 
ALS patients, in serial DTI over 6 months. Based on the results of my second 
aim, I used whole brain and region-of-interest analyses.  
4. To explore the DTI changes of CST in ALS patients over 12 months to 
determine if there are significant changes over time and whether the rate of 
change of DTI over 12 month correlates with clinical progression. This was 
performed using whole brain and two ROI analyses. 
Systematic Review of DTI in ALS and FTD 
To establish the existing evidence of brain microstructural changes in ALS patients 
with or without cognitive impairment, we first performed a systematic review of the 
literature. All studies reporting on DTI in the brain in patients with ALS and FTD were 
included. We found that the most common abnormality shared between ALS and FTD 
was a reduction in FA in the CST, corpus callosum and SLF.  




The corticospinal tract (CST) controls motor function of the limbs and trunk. From the 
pre- and postcentral cortices, the corticospinal and corticobulbar fibers descend in the 
internal capsule and the middle portion of the cerebral peduncle to the spinal cord. 
Pathological studies have identified the degeneration of motor pathways as a cardinal 
feature of ALS (Cosottini, Giannelli et al. 2010, Rajagopalan, Yue et al. 2012). The 
abnormality of motor pathways has been confirmed with MRI. There are also some 
reports of CST abnormality in FTD, based on MRI (Avants, Cook et al. 2010). Such 
motor abnormalities are not a classical feature of FTD, however some patients with 
FTD, particularly those with C9orf72 repeat expansion, can have co-existing ALS 
(Prado, Bicalho et al. 2015). 
 
The CC is the largest fiber bundle that connects the brain’s right and left hemispheres. 
The callosal WM fibers from part of the commissural fibers, playing a role in the motor, 
sensory and cognitive transfer between hemispheres. The CC has been implicated in 
human behavior and cognition (Witelson 1989). An autopsy study on patients with ALS 
has shown pathologic changes in the isthmus and posterior mid-body of CC (Sugiyama, 
Takao et al. 2013). Resting state fMRI of ALS patients suggested that significant 
decrease in interhemispheric functional connectivity can be a feature of early disease 
(Jelsone-Swain, Fling et al. 2010), which is consistent with structural callosal 
involvement observed with DTI (Filippini, Douaud et al. 2010). Efficient organization 
of association fibers is essential for optimal cognitive performance (Schmithorst, Wilke 
et al. 2002, Frye, Hasan et al. 2010).  
 
SLF connects the tempro-parietal regions to the ipsilateral frontal areas (Madhavan, 
McQueeny et al. 2014)and plays an important role in the language function (Catani and 
Mesulam 2008). The medial temporal lobes are implicated in memory storage while 
the frontal lobes mainly serve in executive function and language (Karlsgodt, van Erp 
et al. 2008, McKinnon, Nica et al. 2008). In DTI studies, SLF have been found to be 
involved in behavioral changes in ALS (Trojsi, Corbo et al. 2013). 
 
There have been reports of abnormalities of extra-motor pathways in ALS (Sato, Aoki 
et al. 2010, Barbagallo, Nicoletti et al. 2014, Kasper, Schuster et al. 2014, Menke, 
Körner et al. 2014, Sarica, Cerasa et al. 2014) and FTD (Avants, Cook et al. 2010, 




Whitwell, Avula et al. 2010, Agosta, Scola et al. 2011). The majority of studies 
involving ALS subjects did not test cognition; it is therefore possible that the extra-
motor abnormalities found on DTI in ALS are due to a subset of patients with clinical 
features of extra-motor disease such as cognitive impairment, which is found in some 
patients with ALS (Lillo, Savage et al. 2012). As well as cognitive impairment, some 
ALS patients have other extra-motor features such as sensory disturbance (Pugdahl, 
Fuglsang-Frederiksen et al. 2007), autonomic disturbance (Baltadzhieva, Gurevich et 
al. 2005) and cerebellar disturbance (Tan, Devenney et al. 2014). In some patients there 
is thought to be an ALS plus syndrome, with prominent extra-motor features. These 
patients are likely to have more widespread pathology than those with pure ALS 
(McCluskey, Vandriel et al. 2014). 
 
There is also clinical heterogeneity in the site of onset, disease progression and pattern 
of progression of ALS and FTD which can cause difficulty when comparing studies. 
However, the consistent finding of the review is that the CST, SLF and callosal tracts 
show abnormalities in DTI metrics in both ALS and FTD (Rajagopalan, Allexandre et 
al. 2011, Lillo, Mioshi et al. 2012, Trojsi, Corbo et al. 2013, Cardenas-Blanco, Machts 
et al. 2014).  
Differences between ALS patients with and without cognitive 
impairment 
Our baseline MRIs, which had the largest number of subjects, showed some evidence 
of differences in brain microstructure and macrostructure between ALS patients with 
cognitive impairment and those without. These patients were defined on the basis of 
performance on the ACE-III R , which is a screening tool, rather than with detailed 
cognitive evaluation. 
 
Using a direct comparison between the ALS patient subgroups in whole brain analysis, 
there was significance only at p<0.1. However, by comparing each group with healthy 
controls it could be seen that, for patients with cognitive impairment, the changes were 
more widespread and evident in the frontal lobe. This is consistent with the finding that 
some patients with ALS also have FTD (Chang, Lomen-Hoerth et al. 2005, Lillo, 




Savage et al. 2012). Fronto-subcortical circuits are thought to be involved in 
determining behavioral impairment (Meier, Charleston et al. 2010). It is not fully 
understood why some ALS patients progress to FTD or have cognitive dysfunction. 
Some of the patients with cognitive dysfunction in ALS have C9orf 72 repeat 
expansions, or other genes that are linked to FTD, but others do not. The explanation 
for cognitive and extra-motor abnormalities needs further study, and further MRI 
studies of extra-motor white matter tracts may deepen our understanding of this co-
morbidity. 
 
In addition to the microstructural changes mentioned above, we also found 
microstructural changes in the caudate nucleus in patients with ALS with cognitive 
impairment compared to those without the cognitive impairment. This has been found 
by other studies (Mendez, Adams et al. 1989) and is consistent with the known role of 
the caudate nucleus in cognition (Elamin, Bede et al. 2013). The caudate nuclei are part 
of the fronto-striatal circuit, serve as the input for the basal ganglia, and receive cerebral 
cortical and the prefrontal cortex input (Karnath, Himmelbach et al. 2002). It is believed 
that caudate nucleus serves in executive cognitive functions (Chow and Cummings 
1999), and in planning and problem solving (Voelbel, Bates et al. 2006). It has also 
been correlated with working memory and contributes to classification learning (Seger 
and Cincotta 2005). Earlier observations found the caudate nucleus to be associated 
with pathological behavior (Caplan, Schmahmann et al. 1990, Kumral, Evyapan et al. 
1999). Abnormalities in the caudate nucleus might result in neurobehavioral deficits 
(Bhatia and Marsden 1994). This finding of basal ganglia involvement in ALS is new 
and not part of our usual understanding of ALS. However, there are some studies that 
report widespread pathology in ALS, including the basal ganglia and some ALS 
patients have clinical signs suggestive of Parkinsonism (Pupillo, Bianchi et al. 2015). 
Previous MRI studies have revealed that there is a callosal connection to the caudate 
nuclei (Huang, Zhang et al. 2005, Josephs, Whitwell et al. 2010, Murray, DeJesus-
Hernandez et al. 2011). Understanding the role of this circuit in cognition may be 
relevant to the understanding of cognitive and behavioral impairment in ALS.  
 
We also found that the WM regions that show changes in ALS are the ones that connect 
to the GM structures that showed structural changes. The pre- and post-central gyri 




showed abnormality in our GM analysis along with the CST on the WM analysis. In 
addition, the caudate nuclei were involved on GM study while abnormalities of the 
frontal lobe WM tracts were statistically significant in our WM results. These structures 
are believed to share a neuronal network (Huang, Zhang et al. 2005, Murray, DeJesus-
Hernandez et al. 2011). Studies that examine only WM are limited in that they do not 
provide the functional specificity of GM region-based analysis. Combining structural 
and functional methods can increase the anatomical data from the functional data (Kim, 
Kim et al. 2008). 
 
Serial MRI studies 
While all patients were invited to participate in the serial study, only 23 of 30 patients 
returned for followed up assessment at 6 months. Of these 15 went on to have a follow-
up assessment at 12 months. The patients who were unable to return for 12–month 
follow–up had increasing weakness in muscle movement and swallowing, as it is 
expected in ALS.  
 
In the group of patients who had baseline and 6–month MRI, we observed little change 
in brain microstructure over time. Our whole-brain analysis of two scans showed 
greater changes in the more distal CST in the later serial scans. We found some 
evidence for involvement of the hippocampus in ALS, as has been reported previously 
(Abdulla, Machts et al. 2014). In the 3 time-point serial scans, the whole brain voxel-
wise analysis showed more CST and corpus callosum involved at later stages of the 
disease. Our ROI-based method allowed specific hypothesis testing for changes in CST 
at three time-points at the level of PLIC and pons. Both manual and atlas ROI methods 
at PLIC and pons found no difference over time. However, the changes with ROI were 
less significant than those of TBSS (Kasper, Schuster et al. 2014). 
 
Most DTI studies of ALS have been cross-sectional studies at a single time-point, which 
have focused on abnormalities in the white matter (WM) of the motor system (Carrara, 
Carapelli et al. 2012, Kwan, Meoded et al. 2013, Müller, Turner et al. 2016). Advanced 
MR techniques such as DTI and spectroscopy have shown significant reduction in FA 




(Sood, Gupta et al. 2010) and NAA/creatine (Govind, Sharma et al. 2012), along CST. 
The findings of greater changes more distal to CST is in support of previous work 
suggesting greater pathology in the distal parts of the CST (Toosy, Werring et al. 2003, 
Sheelakumari, Madhusoodanan et al. 2015). This would be consistent with a process of 
Wallerian degeneration. The pathology of ALS includes defects in neuronal energy 
metabolism and mitochondrial function. This is thought to lead to problems with axonal 
transport of proteins, and could explain the distal degeneration (Millecamps and Julien 
2013).  
 
Some other DTI studies have reported the involvement of association tracts and 
subcortical structures in ALS (Pettit, Bastin et al. 2012, Sharma, Sheriff et al. 2012). 
Other studies found that ubiquinated protein aggregates are present in the hippocampus 
and frontal cortex in ALS (Irwin, Lippa et al. 2007) with increased density in ALS with 
dementia (Wilson, Grace et al. 2001). There are several recent suggestions that 
hippocampus has its own contribution to the control of behavior (Nadel 1968, Fortin, 
Agster et al. 2002) and plays a role in the temporal sequencing of events (Bannerman, 
Rawlins et al. 2004). Abnormality of these functions of the hippocampus could 
contribute to cognitive changes in ALS. 
 
Studies in structural MRI such as Fluid-attenuated inversion recovery (FLAIR) 
(Cheung, Gawel et al. 1995) proton-density weighted imaging (Hecht, Fellner et al. 
2001), and magnetization transfer imaging (Kato, Matsumura et al. 1997) reported 
changes in the internal capsule of ALS patients. One study found that reduced FA in 
the distal CST from PLIC and pons were more evident in ALS subjects than in subjects 
with primary lateral sclerosis (PLS) (Iwata, Kwan et al. 2011). We know that CST is 
the signature for ALS pathology but these studies confirm the selectiveness of CST 
changes in MRI. 
 
Although there was some evidence of change on CST over time, this was neither large 
nor significant when corrected for multiple comparisons. This is similar to the findings 
in a previous study (Menke, Körner et al. 2014). This lack of change could be due to 
small sample size, heterogeneity in ALS clinical presentation, or to the lack of clinical 
progression in some patients. The clinical heterogeneity could be due to individual 




patients having involvement of different brain regions. This variability could lead to 
difficulty in studying changes in ALS when patients are grouped together. This can be 
overcome by subgrouping patients based on their cognitive performance.  
 
There have been proponents of the dying back hypothesis, where distal degeneration of 
motor axons is the first abnormality in ALS (Karlsborg, Rosenbaum et al. 2004). 
However, modern evidence supports the hypothesis that upper motor neurons are the 
site of the first pathology in ALS (Ishikawa, Nagura et al. 1993, Vucic 2011, Devine, 
Pannek et al. 2015) which is supported by our findings in this project. Autopsy studies 
of ALS clearly show that there is loss of upper and lower motor neurons and 
degeneration of the corticospinal tracts. The sequence and timing of these events is 
unclear. Once the corticospinal tract has degenerated, there is a phase of gliosis (Troost, 
Sillevis Smitt et al. 1992, Schiffer, Cordera et al. 1996), which could explain the 
variations in FA in serial DTI measurement as further pathology evolves.  
 
When performing serial studies, it is important to know the reproducibility of the test 
as this allows verifying the longitudinal results. In our longitudinal studies, results of 
within-subject coefficient of variation (CV), were 0.1–3.6% in the aROI in the right 
PLIC and 0.007–11% in the mROI. Unfortunately, healthy controls underwent only a 
single MRI, and we therefore cannot determine the reproducibility of our measures 
directly. Previous DTI studies of healthy volunteers have evaluated the reproducibility 
of different DTI metrics in human brain and reported a small variability; FA maps 
showed coefficient of variation below 2% (Sasaki, Yamada et al. 2008, Pagani, Hirsch 
et al. 2010, Vollmar, O'Muircheartaigh et al. 2010). However, it has been illustrated 
that the imaging processing pipeline is important for reproducibility (Vollmar, 
O'Muircheartaigh et al. 2010). The differences in DTI due to different numbers of 
diffusion gradients and acquisition parameters are small relative to the variability of FA 
measures between sessions, which is in accordance with previous systematic evaluation 
of the reproducibility of FA (Bisdas, Bohning et al. 2008, Vollmar, O'Muircheartaigh 
et al. 2010). Whole brain analysis has good reproducibility but cannot be sensitive to 
pathological changes in clinical studies because it is hard to estimate the pathological 
state of the tissue (Jansen, Kooi et al. 2007, Assaf and Pasternak 2008). The clinically 
more relevant ROI methods that do not require preprocessing of the data, can show 




greater sensitivity to pathological changes, but have lower reproducibility as a result of 
operator variations from image processing (Vollmar, O'Muircheartaigh et al. 2010). 
However, in previous studies, DTI exhibited between-subject coefficient of variation 
(CV) ranging from 1–13% and within-subject CV less than 10% (Liu, Yang et al. 2014). 
In terms of reliability, the inter-rater and intra-rater variability can be assessed using 
the intra-class correlation coefficient (ICC) (Koch 2004). This have been reported to be 
between 17% – 37% (Bonekamp, Nagae-Poetscher et al. 2005). In our study, ICC was 
between 24% – 38% for the right pons while the left pons was 74% – 85%. The 
variability can be another issue in the relative lack of change that we observed. The 
difference in ICC between the right and left pons is difficult to explain, but as noted 
there are asymmetries in degeneration in ALS. 
 
In addition to the manual ROI, an atlas-based method was used to seek converging 
evidence of abnormalities in the selected ROIs and to compare the results of both 
methods. We have explored the agreement between the manual ROI and the atlas-based 
ROI and found that both methods are comparable. The manual ROI method is still 
regarded as the gold standard in clinical practice (Babalola, Patenaude et al. 2009). 
Others have shown that atlas-based ROI is the most successful and time efficient 
method with less variability compared to other automated methods (Aribisala, Cox et 
al. 2013) if there were no major pathological or imaging distortion.  
 
 
DTI provides information about the fiber orientation based on the diffusion of water 
molecule. WM that appears normal on conventional MRI can be abnormal on DTI 
(O’Sullivan, Morris et al. 2004). Any changes in FA are thought to be sensitive to WM 
microstructural changes but not to be specific to pathology (Assaf and Pasternak 2008). 
MD reflects the diffusion of water in the WM and is increased in cases such as edema 
(Filippi, Iannucci et al. 2000). In ALS it is known that there is degeneration of fibers, 
and the changes with DTI are thought to reflect this. However, the pathological basis 
for changes in FA, the most widely reported measure, are not certain. Some studies 
have suggested that longitudinal FA changes may be driven by the changes in 
demyelination rather than axonal damage (Farbota, Bendlin et al. 2012).  
 




Furthermore, in ALS, after the stage of axonal loss there are other changes (Bruijn, 
Miller et al. 2004). Particularly, in ALS, gliosis occurs secondary to the loss of motor 
neurons in CST (Schiffer, Cordera et al. 1996). Some ALS cases have reactive 
astrocytes distribution (Nagy, Kato et al. 1994). However, these astrocytes can form a 
glial scarring around the cells as part of the healing process. This could result in a more 
anisotropic diffusion which could explain the increase in FA in some patient in the 
second scan, as with. When axonal loss occurs due to gliosis, diffusion is closer to being 
isotropic and thus FA drops. 
Limitations and future directions 
There are a number of limitations to this study. One limitation is that the number of 
patients was small. Because ALS is a progressive disease, it is difficult for patients to 
return for MRI studies as they become weaker. Indeed, there is difficulty in lying flat 
and still for many subjects with ALS, making an MRI scan a challenge. Of 30 ALS 
subjects, 8 are deceased and 7 withdrew due to relocation or because they were too 
advanced in the disease. While this study recruited 30 patients who participated 
baseline MRI, only 23 returned for the 6–month follow-up, and 15 for the 12–month 
follow-up.  
 
Another limitation is that we used screening tools to detect cognitive impairment rather 
than detailed neuropsychological testing. With screening tools, we were not able to 
detect subtle differences in cognition. However, these simple screening tests have the 
benefit of being applicable in ALS clinics and enabled us to define two groups of ALS 
patients (with and without cognitive impairment) who differed on MRI. The screening 
tools used in this study were the ACE-III and the FAB. Other screening tools that have 
now been developed for ALS are the Edinburgh cognitive and behavioural screen 
(ECASS) (Abrahams, Newton et al. 2014) and the ALS cognitive behavioural screen 
(CBS)(Woolley, York et al. 2010). 
 
For a serial study, 12 months of follow-up is short. However, due to the progressive 
nature of ALS, after 12 months more severely affected patients are unable to continue. 
Indeed, in a serial study, the patients who persist are likely to be those with slowly 




progressive disease. Some patients have very long survival, but these are not typical of 
the majority of ALS patients. The other limitation is that some of the baseline scans 
were performed late after the date of onset or diagnosis and so are not representative of 
early ALS. Earlier and more frequent follow-up could improve the quality of the study. 
 
A more fundamental limitation of DTI studies is the need for a clear understanding of 
the pathological and clinical correlates of MRI changes in ALS (Furtula, Johnsen et al. 
2013), and the lack of serial pathological studies of changes in white matter tracts in 
ALS. There are limitations to DTI that are well-acknowledged. The sensitivity to any 
physiological motion could interfere with DTI results. Long scanning time that is 
required for DTI may also affect motion suppression, which is difficult to control in 
patients with ALS. In addition, tensor calculations require the measurements to be 
acquired along multiple directions which can reduce the amount of information from 
anatomical structures (Mori and Zhang 2006). 
 
DTI studies can have heterogeneity in imaging acquisition, processing and analysis 
methods. However, neuroimaging modalities along with other forms of biomarkers 
show promise in helping to understand the etiology of the disease. Both sensitivity and 
specificity for imaging in ALS can be improved by combining different MRI techniques 
(Filippini, Douaud et al. 2010). Earlier, longer and more frequent, with 3-month 
interval, serial studies with standardized techniques are warranted to prove the validity 
of DTI in ALS. Choosing a homogenous sample based on a validated ALS staging 
system has several benefits and subgrouping patients based on cognitive testing may 
improve the validity of the research conclusions.  
Conclusion 
In conclusion, the present study results indicate that the motor and extra-motor tracts 
are both affected in patients with ALS. We found a reduction in the gray matter volume 
in the fronto-temporal regions and the pre- and post-central gyri. These regions 
connected with WM tracts that were found to show significant changes on WM 
analysis. This also confirms the subcortical structures involvement in ALS. 
Longitudinally, FA revealed marginally significant changes in the motor pathways and 




hippocampus. We observe greater changes in whole brain analysis towards distal CST 
and CC with some correlation with survival. The pathological changes underlying WM 
abnormalities in ALS may include genetic (Siddique and Deng 1996, Al-Chalabi, Jones 
et al. 2012) and environmental (Juntas-Morales, Pageot et al. 2014) factors (Al-Chalabi 
and Hardiman 2013). Studying the presence of factors in combination with DTI is an 
important area for future research. 
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• ≥ 18 y.o. 
• El Escorial &/or Neary criteria 
• Adequate descriptions of sample (M/F, age, other neuro dx) 
• DTI tractography or ROI for WM tracts (ALS or FTD vs. HC) 
• Adequate description of imaging protocol (MR sequence, b-value, diffusion directions, threshold) & stats (mean, SD) 
• Measured FA and MD values in specific WM tracts with defined coordinates 
QUADAS CRITERIA: 
 










































































• Results all presented in graphs  
• ↓ trend in FA  
o From peduncles to pyramids (p = 
0.0001), but no different in ALS and 
HC (p = 0.48) 
o Mean FA is lower in ALS compared to 
HC at IC (p=0.036), CP, pons and 
pyramids (p=0.038) 
• ↓ mean FA in ALS than HC at all levels 
(results given for midpoint 55 y.o.): 
o Lt. IC mean difference in FA = 0.049 (p = 
0.032); rt. IC mean difference in FA = 0.058 
(p = 0.011) 
o Lt below IC mean difference in FA = 0.052 
(p = 0.001); rt. below IC mean difference in 
FA = 0.042 (p = 0.01) 
• ↑ trend in MD from IC to pyramids 
o Significant difference in MD between 
ALS and HC at Left IC only (p = 0.01) 
1. Yes 
2. No (no exclusion 
criteria) 
3. Yes 
























































• ↓ FA in ALS compared to HC 
 
o Rt. frontal subgyral WM ↓ FA (p 
< 0.007) 
o Lt. frontal preCG (p < 0.042) 
 
• Tractography corresponded to ↓ FA in average 
CST 
 
• No exact values for FA provided (visual only) 
 
























































• Overall ADC of CST higher than in HC (p = 
0.04) and overall FA lower than in HC (p = 
0.01); (no raw values given) 
 
o CR ADC = 0.80 ± 0.03 (p = 0.66 vs 
HC) 
1. Unclear (small numbers) 
2. Yes 
3. Yes 
4. Yes (El Escorial applied 
at time of MRI) 
5. Yes 













o IC ADC = 0.79 ± 0.02 (p = 0.02 vs HC) 
o Pons ADC = 0.79 ± 0.04 (p = 0.06 vs 
HC) 
o CR FA = 0.44 ± 0.06 (p = 0.48 vs HC) 
o IC FA = 0.59 ± 0.04 (p = 0.06 vs HC) 
o Pons FA = 0.57 ± 0.03 (p = 0.03 vs HC) 
6. Yes 
7. Yes 
8. Unclear (software not 
stated) 
9. Yes 
























































• ↓ FA in ALS cf. HC: 
o rt PLIC (p < 0.00001) 
o lt PLIC (p = 0.012) 
o rt.CR under PMC (p = 0.03) 
o lt.CR under PMC (p = 0.006) 
o rt.CR under PreMC (p = 0.018) 
o lt.CR under PreMC (p = 0.001) 
o rt pyramidal tract in BS (p = 0.022) 
o lt pyramidal tract in BS (p = 0.042) 
o CC (p < 0.01) 
o rt.Th (p < 0.01) 
1. Yes 
2. Yes 
3. Unclear (not all patients 
fulfilled El Escorial at the 
time of MRI, but all later 
fulfilled the El Escorial at 
follow-up) 






10. No (El Escorial already 
known) 
11. Unclear (6 patients had 
repeat El Escorial after 
the MRI scan) 
12. Yes 
13. Unclear 
14. Unclear (no 
withdrawals) 

























FA VBM , DTI 
DTI in single 
subject using 
(FACT in Brain 
Visa software) 
10 mm 6 1000 
s/mm2 
NA SLF, ILF, 
IFOF 
VBM analysis of GM and WM 
• fvFTD vs HC: 
GM atrophy (p<0.05) in: 
• Dorsolateral FC 
• ant Cg C 
• Insula 
• Superior temporal G 
• Bilateral Th 
• tvFTD vs HC  
GM atrophy (p<0.05) in: 
• Middle inferior TG 
• Temporal pole 
• Orbitofrontal G 
• Sup TG. 
• Superior FG. 
•  
DTI analysis of WM 
o fvFTD vs HC (p<0.05) 
• ↓ FA in rt SLF 
o tvFTD vs HC (p<0.05) 
• ↓ FA in bilateral ILF and IFOF 
• ↓ FA in lt CC, lt SLF 
 
Correlation analysis of FA and behavioral and 
neuropsychological examination 
• No correlation between FA and 
demographics 
• In SLF, -ve correlation between FA and 
FBI A, FBI B and FBI AB. 
• Personal neglect (eg, lack of personal 
hygiene, disorganization in planning 
and organizing complex activity, 
impulsivity or poor judgment and 
utilization behavior were related to ↓ 
FA in SLF. 
 
Multiple regression analysis 
1. Yes. 


















• Trail-making Test B scoring have –ve 
correlation with FA in SLF. 
• tvFTD correlation were not 
investigated due to sample size. 
• The significantly associated FBI sub 
items independently related to ↓ FA. 
 
























1.5 Mean FA,  
Diffusion 
constant 







• At Baseline FA and MD (n=64): 
o No sig in ALS at PLIC  
o Sig in fALS (p<0.002) 
• Correlation with clinical measures: 
o No sig with FA or MD with (DD, 
ALSFRS-R, MMT) 
• Analysis of changes overtime (n=30): 
o No sig. changes in imaging markers 
(from DTI and MRSI) 
 
 
Refer to the original paper for more 






























1.5 FA SSEPI 
ROI 
NA 13 1000 
s/mm3 


















• ↓FA in ALS than HC: 
o Sig at CR, PLIC, CP, basis pontis and 
medulla oblongata (p<0.0001) 
o Not sig at the extramotor WM 
• Correlations with clinical measure: 
o Reduced FA with higher UMN scores at 
CR, IC, pyramids of medulla oblongata. 
o Not sig at extramotor WM 
o No sig with ALSFRS-R in any ROI 
• Correlation between FA and CMTCs: 
o Decreased FA along CST with delayed 
CMCTs and CTX-BS 
 
more detailed results on TMS can be 
found in the original paper. 
1. Yes 
2. Yes (only based on El 
Escorial criteria without 
exclusion criteria) 
3. Yes 




8. No (no reference to the 




































mFA measure in FTD and HC: 
o ↓ FA in association fibers (Arc.F, 
UnciF, ILF) in FTD than HC (p<0.01) 
o ↓ FA lower in FTD than HC in gCC 












o No sig difference in pyramidal tracts. 
o No sig difference in between FTD 
subgroups (early vs advanced) except in 
lt.UnciF (p<0.05) 
Correlation between FA and neuropsychological 
scores 
Sig correlated in lt.UnciF (p<0.05) 
7. Yes 
8. Yes 
9. Yes  
10. Unclear (diagnosis of 
FTD already known) 
11. Unclear  
12. Yes 
13. Unclear 
















4 FA, DR, DA GRAPPA, 



















o Lt.d.Cg, lt.Unc, lt.a.Cg (p<0.0001), 
rt.Unc (p=0.005), rt.d.Cg (p=0.003), 
a.CC (p=0.0002), rt.a.Cg (p=0.005) 
RD:  
o lt.p.Cg (p=0.008), rt.p.Cg (p=0.01), lt. 
and rt.a.Cg (p<0.0001), a.CC 
(p=0.0002), p.CC and rt.CST (p=0.01), 
rt.d.Cg (p=0.003), L.d.Cg (p=0.001) 
AD:  
o a.CC (p<0.0001 ), rt.a.Cg (p= 0.03), 
L.d.Cg (p= 0.008), R.d.Cg (p= 0.04), 
L.Unc (p= 0.001), R.Unc (p 
<0.0001) 













12. Unclear  
13. Unclear  
14. Unclear  


















1.5 FA, MD SSPE-EPI 
 
ROI analysis 
(on b=0 then 
transferred to 















o Lt.Temporal (p<0.05) , R.ant.PV 
(p<0.05), bilateral post.PV (p<0.05) 
. 
• MD: 
o Bilateral Temporal (p<0.05) , 
Rt.ant.SC (p<0.05), bilateral 















13. Unclear  

















































• WM significant correlated with cortical 
thickness: 















13. Unclear  
























NA 60 1000 
s/mm3 
NA CC, CST FA between ALS vs HC (p<0.05 corrected): 
o Within CC 
o Bilateral WM tracts from central CC to 
PMC and preMC. 
o Rostral CST 
o Weaker difference in CST at BS 
(p<0.05 uncorrected) 
↓ FA correlated clinical score in ALS: 
o ↑ UMN score Bilateral CST (p<0.05 
corrected) but not in CC 
o ↓ ALSFRS-R weaker correlation 
(p<0.05 uncorrected) in CC. 
1. Yes 






8. Yes (provided online) 
9. Yes 
10. No (El Escorial already 
known) 
11. Unclear 




o ↑ DD Bilateral CST (p<0.05 corrected) 
↑ RD correlated clinical score in ALS 
o In CC and bilateral WM connecting 
PMC and preMC (p<0.05 corrected) 
 
No significance found in mean or axial 
diffusivity. 
 
↓ GM volumetric atrophy corresponding with FA 
and RD:  
o PMC, preMC, supplementary MC, Cg 
cortex, TL 
Post hoc combining measure: 
o FA correlated with GM differences p= 
0.64, p < 10-4 
RD correlated with GM differences 
GM: p=0.61, p <10-4 
12. Yes 
13. Yes (uncorrected data 
reported in the result but 
not shown) 

































• DTI changes in WM in bvFTD (p<0.05 
corrected): 
o ↓ FA and ↑RD bilateral Unc.F, AC. ant. 
SLF, ant. ILF with altered RD in gCC 
and post. ILF 
o ↑FA in CST 
 
 
Refer to original paper for details of 


































































• bvFTD vs HC (p<0.05, corrected) 
o ↓ FA in CC, Cg, CR, External Capsule 
(ExC), IC, subcortical WM near frontal 
cortex (FC), parietal cortex (PC), 
temporal, occipital WM, Fx, cerebellar 
peduncle (CP). 
1. Yes 
2. Unclear (selection 
criteria clear for HC but 





























o ↑ MD in CC, Fx, bilateral EC, frontal 
and temporal WM. Bilateral superior 
and inferior parietal WM 
o ↑ RD similar tracts to the ↓ FA except 
cerebellum. 
o ↑ AD in CC, bilateral orbital and 
dorsolateral frontal WM, Fx, rtCR, 
ExC, ant.Temporal WM. 
• NFA vs HCPPA 
o ↓ FA in bilateral (CC, Cg, Fx) but was 
decreased only in the left hemisphere in 
(CR, ExC, inferior and dorsolateral 
frontal WM, temporal and occipital 
WM. 
o ↑ MD in CC, ltCg, ExC, ltCR, 
lt.orbitofrontal and temporal WM. 
o ↑ RD similar to the regions with ↓ FA 
except the occipital WM. 
o ↑ AD in lt.ant dorsolateral frontal WM 
and lt.inf parietal WM. 
• Semantic vs HCPPA 
o ↓ FA in antCC, lt.CR, ltExc, lt. 
orbitofrontal WM, lt dorsolateral 
frontal WM, bilateral ant. Temporal 
WM 
o ↑ AD, RD and MD were found in CC, 
Cg, CR, ExC and IC, bilateral 
orbitofrontal and temporal WM, BS and 
cerebellum  
• Logopenic vs HCPPA (p<0.05 uncorrected) 
o ↓ FA in bilateral (CC, Cg, Fx) but was 
decreased only in the left hemisphere in 
(CR, ExC, inferior and dorsolateral 
frontal WM, temporal and occipital 
WM. 
o ↑ MD in CC, ltExC, orbital dorsolateral 
frontal, inferior pareital and 
ant.temporal WM. 
o ↑ RD in lt. antCC, lt.Cg, lt. orbital and 
dorsolateral frontal WM, lt inferior 







13. Yes (in supplementary 
material) 
14. Yes (no withdrawals) 




o ↓ FA in lt.ant CC, lt. ant and post. Cg, 
ltCR, lt Exc, bilateral orbitofrontal and 
left inferior frontal WM, lt temporal and 
lt. inferior parietal WM. 
o ↑ AD in CC, lt.Cg, Fx, lt Temporal and 





































• DTI ↓ FA (p<0.001, uncorrected) in: 
o Unc.F  
o CF  
o FMF 






o FA of UncF and Hayling task, -ve. 
o FA of FM and Cg 
o FA of UncF and Neuropsychiatric 













13. Unclear  
























NA 12 1000 
s/mm3 





• FLAIR hyperintensities: 
o Bilateral CST; caudal PLIC, CR and 
ventral BS 
• DTI ALS vs HC: 
o ↑ MD of CC (p<0.04), CST (right, 
p=0.001, left, p=0.002), bilateral SLF 
(p=0.02), rt.Cg (p=0.2), bilateral Unci.F 
(p=0.02) 
o ↓ FA in CST (right, p=0.001, left, 
p=0.002) 
o ↑ RD in bilateral CST (p<0.001), 
bilateral SLF (p<0.03), Unci.F (p=0,3) 
o ↑ AD in rt.SLF (p=0.4), rt.Cg (p=0.3), 
bilateral Unci.F (right, p=0.03, left, 
p=0.002) 
• Regression analysis between DTI metrics 
and neuropsychological tests: 
o Trail-making test scores correlated with 













13. Unclear (reported only 
significant data) 
14. Yes (excluded 2 
patients) 




Cg, IFOF, ILF all bilaterally (FA), rt. 
Unci.F (FA). 
o Stroop test scores associated with CC, 
rt.IFOF, ILF (FA) 
o Wisconsin Card sorting test correlated 
with bilateral IFOF and ILF (MD), 
rt.IFOF (FA). 
o Phonemic fluency test scores correlated 
with lt. Cg (FA) 
o Verbal learning and memory test scores 
correlated with Fx (FA and MD) 



















































• ↓ FA in bilateral CST and frontal lobe gyri; ↑ 
MD in bilateral CST (all p < 0.001; visual no 
absolute values) 
• Correlations between FA and increased 
apathy score on FrSBe:  
o Rt. mFG, R sub-gyral FL areas, rt. 
middle FG, R para.Hpc G, rt.ant.CG, lt 
Th, lt.sup.FG (all p ≤0.002) 
• Correlations between MD and increased 
apathy score in FrSBe:  
o Lt.sup FG, rt.sup.TG (all p ≤ 0.002); see 















































• DTI ↓ FA in FTD vs HC (p<0.001, 
uncorrected): 
o frontal and temporal lobes 
o a.CC 
o a.Cg 
• VBM ↓GM in bvFTD vs HC 
o Frontal and temporal lobes 
o Rt. frontoinsular gyrus 


















o Subcortical nuclei including the 
bilateral caudate  
o The thalamus 
o The lateral parietal lobes. 
 
12. Yes 
13. Unclear  































• DTI ↓ FA in FTD vs HC  
o bilateral CST, IFO, ILF, SLF, and 
UncF, CC most prominent in 
anterior portions of these tracts. 
 
• DTI ↓ FA in FTLD vs AD  
o More in the ant.CC in FTLD 
o No sig areas in AD group 
 
 
Other irrelevant results on GM density 

















































• Comparisons: (p < 0.05 FWE corrected) 
o bvFTD vs. HC: WM degeneration in FM, 
ant. CC, ant. ILF, CST 
o ALS-FTD vs. HC: WM degeneration same 
as above, but less in FM and ant. CC (more 
in ant ILF and CST) 
o ALS vs. HC: WM degeneration in CST 
(only small changes in FM, ant. CC and 
ILF) 
o bvFTD vs. [ALS-FTD and ALS]: more 
WM degeneration in FM, ant. CC and ILF; 
less in CST and temporal poles 
o ALS-FTD vs. ALS: more WM 
degeneration in FM, ant. CC and ILF; less 
in CST 
1. Yes 
2. Yes (revised FTD 









10. No (ALD/FTD 
classification already 




14. Unclear (no 
withdrawals) 
















30 ALS  
30 HC 
1.5 FA, MD Whole brain 
Single shot SE 
EPI 

















ROI analysis sig. gp difference in frontal regions: 
o Ant. Cg, ant.ThR (FA,MD) Unci.F 
(MD) 
In prefrontal regions: 
o Sup., inf., mid FG (FA, MD) 
o Ant.CR (MD) 
In temporal regions: 
o  hippocampus and Cg (MD) 
o Temporal G, ILF, CR (FA) 
CST and CC (FA, MD) 
CC segmentation: 
o FA (P=0.02) 
o MD (P=0.02) 
No sig between DTI measures and optic radiation 
or OG 
No sig correlation with FVC, onset site or 
cognitive tests 
 
Neuropsychological data correlation with MRI 
Letter fluency: 
o Sup.FG (MD, p=0.012),  
o inf.FG (FA, p=0.017),  
o CST (FA, p=0.01),  
o CC (FA, p=0.049) 
Reverse digit span 





















































• Multiple areas of significance (large tables and 
images in paper); no raw values given, but set 
at p < 0.05 corrected. 
• Comparisons: 
o ADC in ALS vs. HC 
o FA in ALS vs. HC 
o ADC in Bulbar ALS vs. HC 
o ADC in Limb ALS vs. HC 
o FA in Bulbar ALS vs. HC 
o FA in Limb ALS vs. HC 
o ADC in Bulbar ALS vs. Limb 
ALS (n.s.) 
1. Yes 
2. Yes (El Escorial , but no 
ref given) 
3. Yes 
4. Unclear (not stated 
which El Escorial 
category they were at 









o FA in Bulbar ALS vs. Limb 
ALS (n.s.) 
9. Unclear (no ref 
provided) 



















































[Comparisons at p < 0.05 significance 
level] 
↓ FA in All ALS (n=22) vs. HC (n=21): 
o CST, ATR, aLIC, pLIC, GCC, Fj, FM, 
UncF, SLF, ILF, IFOF, Cg, MCP 
↓ FA in Classic ALS (n=7) vs. HC 
(n=7): 
o CST, ATR, aLIC, pLIC, bCC, Fj, FM, 
Unc.F, SLF, ILF, IFOF, Cg, MCP, ICP 
↓ FA in LMN -ALS (n=7) vs. HC (n=7): 
o CST, ATR, aLIC, pLIC, GCC, Fj, FM, 
UF, SLF, ILF, IFOF, MCP, ICP 
↓ FA in Classic ALS (7) vs. LMN 
variant (7): 





































 64 1000 
s/mm3 







Tract integrity ALS vs HC 
o ↑ MD in all 12 tracts and significant in 
rt. CCG (p=0.03), lt.CST (p=0.02), 
rt.CST (p=0.001),  
o ↓ FA in lt. CST(p=0.002), rt. CST 
(P=6X10-5), rt. UnciF (p=0.07) 
 
Tract shape difference: 
o Sig. in lt.CST (p=0.04), rt. CST 
(p=0.02), rt. UnciF (p<0.05) 
Correlation with disease progression: 
o ⇓ correlation with FA along lt.CST 
(p=0.02), rt. CST (p=0.01) 









8. Yes (appears to have 
enough detail about 
MRI method) 
9. Yes 








13. Yes (table with all 
significant and non-
significant results) 

























NA 32 0,1,100 
s/mm2 






• DTI in C9pos vs C9neg (p<0.05, corrected): 
o FA, RD,MD changes in frontotemporal 
abnormalities in C9pos 
o More changes involved in motor WM. 
o Overlap WM pathology in both groups 
was significant in bCC and superior 
CST. 
o gCC, AC and bilateral Th related to 
genotype-specific gp. 
• Cortical thickness analysis 
o Atrophy GM in C9pos vs C9neg: 
lt.fusiform, lt. supramarginal, lt.sup 
TG, lt. OFC, lt. lateral OC, lt. posterior 
CG. 
o C9pos vs HC: bilateral prefrontal 
cotices, insular cortex, fusiform G, 
supramarginal C, lateral OC, 
precuneus, temporal poles, inferior FG. 
o No significant findings in C9neg and 
HC 
• VBM: 
o Orbitofrontal, opercular and temporal 














13. Unclear  


















































DTI between FTLD and HC: 
o Widespread pattern of ↓ FA and ↑ MD 
across all regions of CC. 
 
Similar finding when comparing each 
group against HC. 
 
DTI between FTLD(+GRN) and 
FTLD(-GRN)  
o ↓ FA and ↑ MD in the most antCC; 
bilaterally more prominent in the left 
side. 
1. Yes 
2. No (same subjects 
recruited for previous 
study) 
3. Yes 































VBM between FTLD(+GRN) and 
FTLD(-GRN)  
o ↓ mGM near the most antCC 
Correlation analysis 
o VBM: mGM positively correlated with 
mean FA and negatively with mean MD 
for the most antCC in FTLD(+GRN) 
but not FTLD(-GRN) 
o Voxel wise analysis (VWA) confirmed 
the same findings as VBM between 





13. No  



























• No significant difference in mean FA 
between ALS and HC (CST, PLIC) 
 
• In ALS, no significant difference in FA 
between more affected and less affected side 
of CST 
 
• No correlation between FA (CST or PLIC) 
and ALSFRS-R or disease duration 
1. Unclear (2 patients 
diagnosed with PMA) 
2. Yes (ALS according to 
El Escorial + 2 extra 








10. No (El Escorial / PMA 
status already known) 
11. Yes 
12. Yes 
13. Yes (all data completely 
reported for each 
individual patient) 
14. Yes (withdrawal(s) 
explained) 

























3 T FA,MD, RD, 
AD 
 Track Vis 
Tractography 
QuTE analysis 
NA 48 800 
s/mm2 
0.2 Cg DTI bvFTD vs HC: 
• ↓ FA in the ant Cg.but not the posterior part. 
• Lt hemisphere is slightly more affected more 
than rt. 
• ↓ FA (p<0.001) and ↓ MD (p<0.003) and ↑ RD 
(p<0.002) and ↑ AD (p<0.002) but the RD was 
the DTI that showed greatest differences 
between bvFTD and HC followed by MD. 
 
VBM bvFTD vs HC: 
• Moderate differences in the lt more than the 
rt but not statistically significant. 
• 4 possible bvFTD showed slightly 
significant cortical thinning compared to HC 
(p=0.022). 
 
Correlation between DTI and VBM: 
• In the lt hemisphere VBM correlated with 
FA (p=0.002) and MD (p<0.001), RD 
(p<0.001) and AD (p=0.001). 
 
Regression analysis between DTI and cortical 
integrity: 
• AUC of VBM and DTI parameters were 
larger in the lt hemisphere than the rt. 
Thickness can correctly classify 78% of cases, 
VBM 83%, FA 84%, MD 90%, AD 88% and RD 
92%. 
1. Yes. 
2. Yes (part of Lund 
Prospective FTD study) 
3. Yes. 






9. Yes (Rascovsky 
reference provided) 































NA 30 1000 
s/mm3 
0.2 CST Structural CST impairment in ALS gp: 
o ↓ Z-MD (p=0.004) and Z-RD (p=0.001) 
o ↑ Z-FA (p=0.055). 
Correlation DTI vs clinical parameter: 
o Z-MD of lt.CST correlated with UMN 
scores (p=0.014) and Z-RD of lt.CST 
(p=0.048) 
 

















(Unrelated results not reported) 
10. No (El Escorial already 
known) 
11. Yes (El Escorial applied 
before MRI was done) 
12. Yes 
13. Unclear 



















































• 4 subgroups:  
o UMN-CST hyperintense+ 
o UMN-CST hyperintense- 
o Mixed UMN/LMN 
o ALS-FTD 
• ALL ALS vs. controls:  
o ↓ FA at IC, CSoLV, subPMC (not 
CP) 
o ↓ FA at left subPMC only in UMN 
groups 
o ↓ FA at right PLIC in all 4 ALS 
groups 
o MD in lt and rt PLIC and lt. 
CSoLV in ALS-FTD, compared 
with both HC and other ALS 
groups 
o ↑ RD at lt.CP in all ALS groups 
o ↑ RD at lt. IC, and rt and lt.CSoLV 
in ALS-FTD 
• Correlation with clinical measures when all 
ALS patient pooled together, no FDR 
correction 
o MD and RD versus ALSFRS-R 
scores=-ve (p=0.001) at lt. CSoLV 
o AD and Disease duration=+ve 
(p=0.001) at lt CSoLV. 
o FA and disease progression rate=-
ve at IC; rt (p=0.002) and lt. 
(p=0.001) 
o FA and disease progression rate=-
ve at lt and rt CSoLV (p=0.001 and 
p=0.018) 
• No significant correlations when correction 
for multiple comparison 
1. Yes 
















** Note this 
study’s 
presentation of data 
has some errors 
(e.g. comparing 
what is reported in 
























3T GFA GRE EPI 
TBSS 
VOI 
NA 32 1000 
s/mm3 




↓ GFA ALS vs HC 
o CST (p<0,05, corrected) within rostral 
WM below lt and rt.pre.CG, lt.PMJ, 
ant.Th, ant.Cg, splenium and body CC, 
Fx, lt. UncF, lt.ant.FOF, lt.SLF 
 Correlation ALS vs clinical measures 
o ⇓ with UMN scores: along lt. CST at 
PMJ (p=0.031) 
o ⇓ with UMN scores: body CC, 
ant.Cg,SLF and bi.WM tracts from 
Central CC to pri.MC and preMC. 
o ⇓ with FrSBe: WM in lt. priMC, Body 
CC, lt.SLF, CST at PMJ 
o No sig between GFA and ALSFRS-R, 













9. Yes  































































• Overall: DTI (especially RD) most accurate 
for FTD subtype classification 
• FA, RD and AD all presented visually in paper 
(in each subtype of FTLD vs. HC)  
 
TOI analysis bvFTD vs HC (supplementary data 
online) 
• ↑RD in rt.paraHpc (p<0.02), Fx, lt a.Cg, 
bilateral UncF,a.CC and p.CC (p<0.001), 
lt.paraHpc (p<0.04), rt.paraHpc (p<0.03), 
• ↓FA in the Fx, a.CC, lt.aCg (p<0.001), p.CC 
(p<0.03), lt.UncF (p<0.005), and rt.UncF 
(p<0.002). 
• ↑AD in the aCC, Fx, and bilateral UncF 
(p<0.001), pCC(p<0.03), and rt.paraHpc 
(p<0.05). 
1. Yes 









10. No (classification 
already known when 




14. Unclear (no 
withdrawals) 








































• PLS vs. HC (p < 0.05, FWE):  
o ↓FA in entire CST (pyramids –
PLIC -preCG), CC (midbody, 
genu, splenium), ALIC, SLF, Fx, 
Th, parietal lobes 
o ↑MD and RD in CST, CC 
(midbody), ALIC, thalamus, 
parietal lobes 
• ALS vs. HC (p < 0.05, FWE): 
o ↓FA (and increased RD) in entire 
CST (pyramids –PLIC –
preCG,CR), CC (midbody), SLF, 
parietal lobes 
o No significant differences in MD 
• PLS vs. ALS (p < 0.05, FWE) 
o ↓FA in CC (mid-body), patchy 
areas of motor, premotor, 
prefrontal and parietal WM, 
cerebellum 
o ↑MD and ↑RD in CC (mid-body), 
cerebral peduncles, thalamic 
radiations, Fx, rt. PLIC, patchy 
areas of motor and premotor WM 
• TRACTOGRAPHY: 
o PLS vs. HC: 
▪ CST, CC-PMC, CC-
SMA 
o ALS vs. HC: 
▪ CST, CC-PMC 
o PLS vs. ALS: 





5. Yes (El Escorial, or 










13. Yes (all non-significant 
results appear to be 
reported) 



















3T FA, MD SE-EPI 
 
Automated 
















• DTI metrics were averaged due to absence of 
difference between lt vs rt . 
• DTI in ALS (n=24) vs HC: 
o ↑ MD in patient at FC (p=0.023), 
caudate (p=0.01), Th (p= 0.019), Hpc 
(p=0.002) and Ag (p= 0.012). 
o No sig in FA in any structure. 
• Correlation between clinical features and 
MD: 
o +ve correlation with DD in caudate 


















o –ve correlation with ALSFRS-R scores 
in Th (p=0.02), Ag (p=0.02) and FC 
(p=0.001). 
• Correlation between neuropsychological 
scores (n=13) and MD: 
o -ve correlation with MSCT in caudate 
(p=0.007),  hippocampus (p=0.001),Ag 
(p=0.015) and FC (p= 0.002).  
o -ve correlation with FAB scores 
caudate (p=0.017),  hippocampus 
















































CST • ALS-Bulbar (TBSS):  
o ↓FA in CST (p < 0.05 corrected);  
o RD ↑only at thalamic CST;  
o no changes in MD or AD 
• ALS-Limb (TBSS): 
o  patchy ↓FA and ↑RD in CST 
(only at p< 0.05 uncorrected) 
o no changes in MD or AD 
• ROI Analysis:  
o also showed significantly ↑MD in 
ALS-Bulbar CST 













































NA 30 1000 0.15 Bilateral 
UncF 
ALS vs. HC: 
• ↑ AD in the bilateral UncF in ALS, 
compared with HC (p < 0.05); other 











10. No (El Escorial known) 
11. Yes. 
12. Yes. 



















































• ALS vs. HC: 
o ↓FA (p < 0.05 FWE) in bilateral 
CST, body of CC 
o No significant differences in MD 
o Abnormal MO (p < 0.05 FWE) in 
right CST and (p < 0.005 
uncorrected) in SLF, IFOF, ILF, 
genu of corpus callosum and 
forceps minor 
 
• Correlation between FA/MO of rt. ILF and 
IFOF, and emotional recognition (faces) in 
ALS 
o +ve global performance and mean 
FA in rt.ILF (p=0.04) 
o +ve relationship with cumulative 
scores of assessing negative 
emotions and the ability to 
recognize specific negative 
emotions with FA in rt.ILF 
(p=0.004) specifically with 
identification of fear (p=0.03), 
disgust (p=.0.01) and sadness 
(p=0.008) while in IFOF (p=0.02) 
correlated with fear (p=0.008), 
anger (p=0.05) and sadness 
(p=0.02) 
o No correlation between emotion 
recognition abilities and mean MO 
along tracts of interest. 
For additional analyses refer to the result section 
















14. Yes (withdrawals from 
MRI stage clearly 
explained) 



















































• All patients (ALS/PLS) vs. HC:  
o widespread decreased FA and 
↑MD (subcortical WM, IC, CC) 
P<0.05 corrected 
 
• Patients with Pseudobulbar Affect (PBA+) 
vs. those without (PBA-) – ALS and PLS 
introduced as covariates:  
o reduced FA at left sub-preCG 
WM; Increased MD at bilateral 
MCP, transverse pontine fibers, 
bilateral PLIC, lt. ALIC, Th, 
frontotemporal subcortical WM, 
bilateral sub-preCG WM, and CC 


















14. Unclear  
















11 HC; 9 
ALS 
 










































• ALS: ↑connectivity in resting (default-mode 
network) between: 
o Lt IPL – Rt IPL 
o Lt IPL – Lt paraHpc 
o Rt IPL – Lt paraHpc 
o Lt paraHpc – PCC 
• ALS:  
o significantly ↓FA (p<0.05) in 
tracts to Rt anterior PC, R OFC, 
PreCG (Rt and Lt), Lt superior PL, 

























































DTI bvFTD vs HC (p<0.05) 
o ↓ FA bilaterally in: 
• IFOF 
• UncF 
• ILF and SLF 
• Ant ThR 
• FMi and FMj 
• Cg 
VBM bvFTD vs HC 
• Rt cerebellum, rt inf TG, rt TP, bilateral 
para Hpc G, rt  hippocampus, bilateral 
Ag, rt Th, rt and lt insular C, rt and lt 
OFC, rt mPFC, lt ant Cg, lt TP, lt 
inferior TG 
FA correlations with autobiographical memory 
performance 
• FA +ve correlation with ABM retrieval 
in the VBM analysis 
• FA for each WM tracts (p<0.01) show 
+ve correlations with recent and remote 
ABM. 
• Remote ABM retrieval correlated 
significantly with FA in lt UncF 
(p=0.001), lt Cg (CC part p=0.008 and  
hippocampus p=0.002) FMi (p=0.001). 
• Recent ABM retrieval associated 
significantly with FA values in FMi 












9. Yes (Rascovsky 
reference provided) 



















































(ROI methods gave less significant results than 
TBSS methods, p<0.05, corrected)  
 
ALS (no CI) vs. HC: 
• ↓ FA and ↑ RD in bilateral CST, PLIC and 
bCC 
ALS (CI) vs. HC: 
• As for the other ALS subjects, but also ↓ FA, 
↑ RD and ↑ MD in the ant. ThR, Cg, IFOF, 
SLF, ILF and UncF (all changes bilateral but 
lt > rt hemisphere) 
ALS (no CI) vs. ALS (CI): 
• ↑ RD and ↑ MD in the ant. ThR, Cg, IFOF, 











9. Yes (reference 
provided) 























on 1.5 T, 
(B)33 
scanned 











FA, AD, RD (A) 1.5 T 
scanner  
 






























TFAS vs ROI  
• At 1.5 T: 
o ROI (sensitivity 78%, specificity 
69%) 
o TFAS (sensitivity 79%, specificity 
71%) 
• At 3 T  
o ROI (sensitivity 82%, specificity 
68%) 
o TFAS (sensitivity 79%, specificity 
73%) 
DTI metrics ALS vs HC: 
o Bilateral CST FA=sig 
o RD,AD both significant along 
CST 
• Correlation of ALS stages: 
o ALSFRS-R and disease duration 
correlated significantly with the staging 
scheme  
o (ALSFRS, p=0.0017) 
o (Disease duration, p=0.0019) 
 
1. Yes 
2. Unclear (inclusion 













14. Yes (no withdrawal) 
 







































↓ FA in ALS vs HC: 
o BA4 (p=0.003) 
o BA6 (p=0.01) 
o BA9/46 (p=0.0005) 
o No sig →BA1/2/3, BA11/47, BA44/45 
Cortical ROI ↓ FA in ALS vs HC: 
o preCG (p=0.0036) 
o mid.FC (p=0.016) 











10. No (El Escorial already 
known) 
11. Yes  
12. Yes 



























3 T FA, MD, 
RD, AD 




DTI bvFTD vs HC (p<0.05): 
At base-line: ↓ FA, ↑ MD, ↑ AD, ↑ RD significant 
bilateral changes in frontotemporal regions, 
ant.ThR, ant.Cg, sup ILF, IFOF, UncF, gCC. 
Changes in MD and RD are most extensive in this 
group. 
At 12 months: bilateral changes sCC, 
longitudinal changes were most in FA and RD. rt 
ant Cg.  
Changes in MD obvious in Lt SLF.  
Changes in AD found bilateral ant Cg, SLF and 
ILF. 
Overlap between WM and GM changes (after 12 
months): 











9. Yes (references 
provided) 































DTI group comparisons: 
• bvFTD showed significant group 
differences in all DTI metrics in frontal 




4. Yes (mean +/- SD age at 
onset and at scan 
provided) 




• bvFTD had more WM changes 
compared to HC and AD in same 
regions. 
• No changes in sCC across all DTI 
metrics. 
 
Correlations with behavioral variables: 
• SEB rating associated with gCC DTI 
measures; FA (p=0.005), AD 
(p=0.007), RD (p=0.005) and MD 
(p=0.0006). Worse WM integrity 
associated with more symptoms of 
emotional blunting. 
• Examining two clinical groups 
separately showed a correlation 







9. Yes (Rascovsky 
reference provided) 
10. No (El Escorial known) 



































Cross DTI bvFTD vs HC 
• ↓ FA and ↑ MD (p< 0.02) in bCC, 
bilateral UncF and rt Cg (para Hpc 
part). 
• ↑ AD (p<0.01) in bCC and lt Cg (para 
Hpc part), Fx (p<0.04) and rt UncF 
(p<0.03) 
• ↑ RD (p<0.01) in bCC, bilateral Cg at 
para Hpc part and lt UncF abd rt UncF 
(p<0.001). 
Cross DTI MPAT carriers vs HC 
• ↓ FA rt Cg (p=0.009), ↑ MD in rt UncF 
(p=0.001)and rt Cg (p=0.01). 
Cross DTI sporadic bvFTD vs HC 
• ↓ FA lt UncF (p=0.01) and rt Cg 
(p=0.03). 
• ↑ MD in lt UncF (p=0.002) 
Cross DTI C9ORF72 carriers vs HC 
• ↓ FA bilater superior CP (p=0.03)  
1. Yes. 
2. Unclear (exclusion 
criteria not explicitly 
stated) 
3. Yes. 
4. Yes (disease duration 






9. Yes (Rascovsky 
reference provided) 









Longitudinal DTI bvFTD vs HC 
• rate of changes in FA and MD were 
significant is bCC (p=0.003), sCC 
(p=0.001), bilateral Cg (p<0.001) and rt 
UncF (p<0.001) and lt UncF (=0.005). 
• RD significant changes in subgroups 
RD bvFTD MAPT Sporadic C9ORF7
2 
bCC 0.002 0.001 - - 
sCC 0.001 0.01 0.01 - 
Rt Cg 0.001 0.04 0.002 - 
Lt Cg 0.001 0.01 0.001 - 
Rt Cg 
Hpc 
0.01 0.01 - - 
Lt Cg 
Hpc 
0.03 0.001 - - 
Rt UncF 0.001 0.001 0.03 - 
Lt UncF 0.01 0.001 - 0.02 
• AD significant changes in subgroups 
AD bvFTD MAPT Sporadic C9ORF7
2 
gCC - - 0.03 - 
bCC - -  0.003 
sCC 0.02 0.04 -  
Rt Cg 
para 
0.001 0.001 - - 
Lt Cg 
Hpc 
0.005 0.001 - - 
Rt UncF 0.001 0.001 - - 
Lt UncF 0.009 0.001 - 0.03 
sCP 0.008 0.03 - 0.003 
DTI metrics sensitivity and specificity 
• Cross sectionally: RD best then MD 
followed by FA and AD 
• Longitudinaly were best achieved by 
































In ALS gp at T0: 
1. VBM ↓ GM  
o lt. primary MC and lt. FL. 
o Th, bilateral caudate head 
2. DTI: 
o ↑AD, MD in CC 
o ↑AD in ltCST 
UMN scores: 














o ↓FA, ↑AD in CST 
o ↑MD, ↑RD in CST,SLF, CC 
2. ROI → ↓FA in rt.SLF 
3. VBM → No sig 
ALSFRS:  
o TBSS, VBM→ no sig 
o ROI→ RD –ve correlation in lt.SLF 
progression rate:  
1. TBSS, VBM→ no sig 
2. ROI→  
o ↑RD , ↓FA in rt.SLF, CST 
o ↑AD in CC 
3. VBM ↓ GM –ve correlation in lt. 
primary MC 
ACE: 
o TBSS, VBM →No sig 
o ROI : verbal fluency and AD →+ve 
correlation  
o VBM: verbal fluency and Broca’s area, 
dorsolateral prefrontal cortex→+ve 
correlation 




13. Yes (supplementary 
material available 
online) 
































• ↓FA in bilateral CST in ALS (most 
significant using atlas ROI with TBSS 
approach; p = 0.0002) 
 
• ROC analysis showed best test performance 
was using atlas ROI with TBSS approach 


















































define the tracts 









1000 NA CST ALS vs. HC: 
• In the CST’s, there was significant ↓ FA (p = 
0.011), ↑ MD (p = 0.023) and ↑ RD (0.007) 
No significant difference in AD 
1. Yes  
2. Unclear (exclusion 







9. Yes (reference 
provided) 




















































• Tractography (ALS vs. HC, p<0.05, 
corrected for multiple comparisons): 
o Lt. cingulum-cingulate gyrus 
(supracallosal) bundle (RD, ↑MD) 
o Rt. CST (↓FA, ↑RD, ↑MD) 
o Rt. supracallosal bundle (↑MD, 
↑AD)  
o Lt.ATR (↓FA, ↑RD, ↑MD) and rt 
Cg (↑AD and ↑MD) 
uncorrectep<0.05. 
• TBSS (ALS vs. HC, p<0.05, TFCE 
corrected): 
o Bilateral CST (FA, MD, RD) 
o Bilateral SLF (FA, MD) 
o Bilateral anterior thalamic 
radiation (FA, MD, RD) 
o Bilateral Unc.F (MD) 
o Bilateral CR (FA, MD, RD) 
o Cg (FA, MD, RD) 
o Bilateral ILF (MD, RD) 
o CC (FA, MD, RD) 
o No significant changes in AD 




4. Yes (except one patient 











13. Yes (negative results 
also reported in table) 
14. Unclear (no evidence of 
withdrawals) 




o Rt. CST (RD and MD) correlated 
negatively with ALSFRS-R 
(p=0.0009) 
o Rt. CST (FA) showed a trend 






















15 HC  
























DTI ROI results (p<0.05): 
o Patients vs HC: 
• ↓ FA and ↑ MD in all tracts except IC 
and sCC. 
o bvFTD vs HC 
• Showed more changes in the Cg G, 
UncF in frontal and temporal parts. 
 
DTI VWA results (p<0.05): 
o bvFTD vs HC 
• Abnormalities in CC, AC, CR, UncF, 
IFOF, ILF, SFOF, SLF, Cg and MFB. 
• Ant limb of IC.  
o bvFTD vs CBS 
• WM damage restricted to FMi and 
gCC, UncF, MFB and rostral SLF. 
• Rt hemisphere was damaged more than 
the lt in gCC, UncF and rostral SLF. 
 
Correlations with clinical ratings 
In bvFTD:  
o Posterior Cg correlated with: 
• NPI-apathy subscores (MD, p<0.01) 
• Mattis total (MD and FA, p<0.05) 
o UncF: 
• NPI-aberrant motor behavior subscore 
with frontal part (MD and FA, p<0.05) 











9. Yes (Neary & McKhann 
references provided) 



































• Between ALS and HC: 
o CST FA (p=0.01) and MD (p=0.003) 
o Linear relations with UMN score and 
ALSFRS-R. 
o No association with disease duration 
• Regression results: 
o MD and FA in CST was significant 
(p=0.02) 
o MD in Fj =no sig 
o UMN score (MD, p=0.005) (FA, 
p=0.003) and age (MD, p=0.03) both 
were significant predictor but not age 
and FA. 
o ALSFRS-R and disease duration = no 
sig 
































3T FA, RD, AD, SE-EPI 
TBSS AND 
PDT 









• VWA: ↓ FA in ALS vs HC  
o Bilateral Sup.CR 
o Caudal CST (rt.CP), Lt. PLIC. 
o Body CC. 
o Rt. preCG 
• PDT: ↓ FA and ↑ RD in ALS vs HC  
o Bilateral CST to preCG 
o CC fibers (bilateral SMA and preCG) 
o Rt.AF (SLF) – different result 
• Cortical thinning: 
o Lt.OFC 
o Rt.SMA 
o Bilateral preCG 
o Dorsal preMC. 
o Sup.PL 
o Lt. mid. OG  
o SMG 





















































1000 0.2 Whole 
brain 
• WM changes more widespread than GM (all 
groups) 
• Results p < 0.05, FWE corrected 














ALS vs HC: 
• ↑ MD and ↓ FA in bilateral CR and posterior 
bCC. 
ALS-plus/bvFTD/PNFA vs. HC: 
• ↑ MD and ↓ FA in the CC, orbitofrontal WM, 
frontoparietal WM, occipital WM, IC, BS, 
temporal WM (all bilateral) 
SD vs. HC: 
• ↑ MD in the lt (> rt) IC and External capsule 
(ExC) , bCC, orbitofrontal, frontal, ant. 
temporal and inferior parietal WM (sparing 
of occipital lobes and BS) 
• ↓ FA in bCC and gCC, lt SLF, Cg, ExC and 
IC, ant. and middle temporal WM 





9. Yes (references 
provided) 
10. No (El Escorial and 























3 T NA ROI 
VBM 




















VBM and DTI: 
ALS vs HC (p<0.05): 
o Minor changes is the  




o WM showed greater changes is these regions 
including CST 
 
bvFTD vd HC (p<0.05): 
o Sever degeneration across 
• Motor system 
• Cerebellum 
o WM that connect these regions is severely 
affected. 
ALS vs bvFTD (p<0.05): 
o Minimal GM atrophy in the cerebellum. 
o WM changes in lt. Th in ALS. 
o While bvFTD patients showed more atrophy 
in: 
1. Yes. 
2. Yes (El Escorial and 
Rascovsky) 
3. Yes. 






9. Yes (reference 
provided) 















































NA 30 1000 
s/mm2 







bvFTD vs HC: 
 
• MD and RD detected most changes. 
• Frontal and temporal tracts are most 
impacted. 
• All 21 tracts were severly affected with 
↑ MD (p=0.035).  
• ↓ FA (p=0.024) with ↑ AD (p=0.019), 
RD (p=0.034) and MD were significant 
(above 60%) in rt. Ant ThR. And 
bilateral UncF.  
• Commissural fibers: most significant is 
the frontal fibers in more than 99%. 
gCC shows late myelination 
• Long association fibers: more than 99% 
in bilateral UncF, lt. SLF and bilateral 
IFOF. 
• Limbic system: dorsal Cg and ant. ThR 
 
Motor system: CST was the least affected tract. 
1. Yes. 







9. Yes (reference 
provided) 























37 HC  



















Brain maps bvFTD vs HC 
o GM: bi hemisohereic atripgy in: 
• Ant TL, mTL structures, insular, 
prefrontal and orbitofrontal cortices. 
o WM (p<0.05):  
• Changes were dorsal and ventral mostly 
in Cg, bi UncF, CC  
• Less posteriorly in parieto-occipital 
ILF. 
 
Correlations with social cognition performance 
(p<0.05, corrected) 
1. Yes. 










9. Yes (references 
provided) 
10. No (El Escorial known) 




• -ve correlation betweem TASIT 
emotion identification score and DTI 
metrics (AD,TR and RD). 
• +ve correlated with FA in dorsal and 
ventral commissural WM bilaterally.  
• Frontal subcortical projection pathways 
(rt ant ThR) and Fx 
• Within bvFTD group, emotion 
identification impairment was 
associated with WM alteration in CC 
and Fx. 
• -ve correlation between TASIT total 
sarcasm with AD, RD and TR in the rt 
temporal WM, and inferior frontal WM 
• +ve correlation in sarcasm 
identification scores with rt side of WM 
but bilateral in Temporal inferior FWM, 


































31 1000 0.2 CST ALS vs. HC: 
• ROI in the bilateral lower CST in both 
hemispheres 











9. Yes (reference 
provided) 




14. Yes (not all OCT 
patients consented to the 
MRI component) 










































ALS vs. HC: 
• PONS: ALS subjects had ↓ FA (p = 0.001) 
and ↑ MD (p = 0.003) 
MEDULLA: ALS subjects had ↑ MD (p = 0.011); 










9. Yes (reference 
provided) 





















































ALS vs. HC: 
• ↓ CI in the CST’s (p = 0.03), negative 
correlation with disease duration 
↓ CI in the VC-PRC tract (p = 0.02), no significant 









9. Yes (reference 
provided) 






























• Data from rt and lt sides averaged 
 











• ↓ FA in centrum semiovale, deep frontal 
WM, deep parietal WM, CR, PLIC, gCC of 
CC, sCC, CP. 
↑ ADC in centrum semiovale, deep frontal WM, 
deep parietal WM 
7. Yes. 
8. Yes. 
9. Yes (reference 
provided) 







































1000 0.2 Whole 
brain 
ALS vs. HC (TBSS method): 
• Significant (p ≤ 0.05 corr) ↓ FA and ↑ RD in 





5. Yes (no El Escorial 
criteria/reference 
provided, but same 
patients scored in Ben 





10. No (El Escorial 
provided in previous 





































ALS vs. HC: 
• ↓ FA and ↑ MD in bilateral PMC WM, PLIC, 
gCC and sCC (p < 0.05) 
• ↓ FA lt medullary pyramid (p = 0.007) 
CC and medullary pyramid changes were not 
significant when looking at the “possible ALS” 
1. Yes. 
2. Yes (divided into 







8. Unclear (some details 
not included) 
















Supplementary Table 2: FA correlations in ALS 
Disease Tracts DTI 
measure 





-ve CST UMN scores 
-ve  DD 
+ve  CMCT 
  Cortical_brain 
stem conduction 
time 
  Trail making test 
scores 
  Stroop test scores 
  Letter fluency 
-ve  FrSBe  
-ve 
(weaker) 
Rt CST ALSFRS-R 












+ve Lt IFOF 
ILF 
Stroop test scores 
-ve SLF • FBI A, FBI B 



















-ve SLF FrSBe 
-ve SLF • UMN scores 
• Trail-making 
Test B scoring 
 
-ve Rt ILF Cumulative 
scores of single 
emotions 




↓ FA Weaker  ALSFRS-R 
FA 
  Trail making test 
scores 
  Stroop test 






 Fornix Verbal learning 
 Fornix Memory test 
scores 
 Para Hpc 
Lt Th 
Increased Apathy 
scores on FrSBe 















Supplementary Table 3: MD correlations in ALS 






















CC Stroop test 




-ve Rt CST ALSFRS-R 
 
 




Supplementary Table 4: radial diffusivity and correlations in ALS 
Disease Tracts DTI 
measure 






























-ve Rt CST ALSFRS-R 
Association 
Fibers 
-ve Rt SLF ALSFRS-R 
 
+ve Rt SLF Disease 
progression 











Supplementary Table 5: Axial diffusivity and correlations in ALS studies 
Disease Tracts DTI 
measure 
Correlation ROI Disease 
measure 
ALS Projection ↑ Daxial 
 CST* ↑ UMN 
scores 
CST* ↑ DD 
 




Supplementary Table 6: FA correlations in FTD studies. 
Diseas
e 





































FA  Post Cg Mattis total 






-ve gCC SEB rating 
 Whole 
Brain 

















The staging system proposed by Roche et al. for ALS is as following (211):  
Stage 1: symptom onset;  
Stage 2A: diagnosis; 
Stage 2B: involvement of a second region;  
Stage 3: involvement of a third region;  
Stage 4A: need for gastrostomy;  
Stage 4B: need for respiratory support 
